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Queda prohibido no sonreír a los problemas, 
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It is prohibited to cry without learning, 
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to abandon everything because of fear, 
not to turn your dreams into reality… 
It is prohibited not to create your own history… 
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Abstract 
The primary aim of this thesis was to monitor in vivo intestinal ischemia using rapid 
sampling on-line microdialysis.  
A new variant of a clinical assay system was developed for use in gastrointestinal surgery. 
The assay could process on-line microdialysis samples for glucose and lactate 
concentrations at 30 seconds intervals in the concentration range of 25 µM to 30 mM. 
Intramural human bowel ischaemia was monitored intra-operatively in a clinical 
collaboration with Prof. Darzi and Prof. Hanna in St. Maryʼs Hospital, London using a 
microdialysis probe implantation technique devised by Mr. Samer Deeba. Dialysate levels 
stabilised within 10-15 minutes following implantation of the CMA 62 microdialysis probe. 
Clipping of arteries feeding the gastrointestinal tissue to be resected, did not lead to an 
immediate change in dialysate levels, but a fall in glucose and rise in lactate delayed by 17 
± 2 minutes, n=9. This suggests an additional pool of glucose availability in the bowel, and 
indicates a possible therapeutic window during bowel surgery. 
Parallel experimental work was carried out in swine model in the surgical labs of the 
healthcare company Tyco (Covidien) in Paris. Rapid sampling microdialysis was used to 
examine the effect of total ischaemia on an anastomosis site. The anastomotic site was 
devascularised by clamping the mesentery of both sides. Here the tissue reacted to 
ischaemia immediately, 5 minutes following clamping of feeding artery, compared with a 
healthy human bowel, suggesting that the additional glucose pool was unavailable in this 
situation. Physiological variable effects were studied to investigate further any difference 
with respect to the human in pig bowel physiology, which were not found. The no-net-flux 
method of in vivo recovery was used to determine the extracellular levels of glucose (0.47 ± 
0.05 mM) in the intramural pig bowel. These were substantially lower than blood glucose 
values, representing a 10% of plasma levels and suggest a difference with human bowel. 
Finally, 7 patients were monitored after abdominal aortic aneurism repair surgery, for up to 
2 days in the intensive care unit, to detect the possible on-set of ischaemia as a 
complication of inferior mesenteric artery occlusion. Basal microdialysis levels at 3.98 ± 
0.75 mM for glucose and 1.38 ± 0.20 mM for lactate agreed well with those measured 
acutely during surgery, and were not sensitive to changes in plasma values. The 
lactate/glucose ratio between 1-2 days post-implantation was typically between 0.5-1.0 
again similar to the ratio found intra-operatively. This validates the use of microdialysis 
intra-operatively and confirms the importance of this ratio. An in vivo calibration was 
performed in one patient with the variable flow rate method providing extracellular levels for 
glucose (5.8 ± 0.4 mM) and lactate (3.3 ± 0.2 mM) in intramural human bowel. These agree 
well with measured blood glucose values. Although major ischaemic failure was not seen in 
these patients, transient ischaemic events lasting 40 minutes and characterised by a 
lactate/glucose ratio increase to 2 were noticed. Finally, a quasi-periodic oscillatory pattern 
with inverse changes in glucose and lactate was observed during these patientsʼ 
monitoring. This was ascribed to gut peristalsis.  
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Chapter 1: 
Introduction 
 
 
 
This chapter offers an overview of the function and physiology of the gastrointestinal 
system, and describes the enteric nervous system, an independent nervous system that 
controls the gut motility and function and its connection with the central nervous system. 
Pathology of the bowel is portrayed, in particular that caused by a poor circulation. 
Monitoring aspects of tissue energy metabolism offers important information to study 
physiology and pathology changes of different systems. The energy demand and 
consumption balance can be studied with the sampling technique microdialysis, which is 
used extensively for brain monitoring. The basic principles of microdialysis are described, 
its past use in bowel monitoring, and the on-line rapid sampling biosensor system is 
depicted as a detection tool for the monitoring used in this thesis. 
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1.1 Gastrointestinal System 
The gastrointestinal (GI) system consists of a group of organs, 
• The intestinal tract, which is a tubular structure that connects the mouth and anus. 
• The pancreas, which produces digestives juices. 
• The liver and biliary system, which execute important metabolic roles for the 
digestion and absorption of nutrients [1]. 
Intestinal tract is present in all multicellular organisms. While the simple organisms present 
a simple linear tract, the human intestinal tract is complex in structure and specialised in 
function. The tract begins with the mouth and teeth connected via the oesophagus and this 
to the stomach and duodenum, where the food is stored and processed. The gut is formed 
by the small intestine (jejunum and ileum) and the large intestine (colon). The small 
intestine is where the digestion and absorption of nutrients occur, helped by pancreatic 
enzymes released into the lumen. If damaged, at least 1 metre of small intestine must 
remain to complete absorption of nutrients. The large intestine is divided in four parts 
(ascending, transverse, descending and sigmoid), the ascending colon begins after the 
appendix and caecum and the sigmoid colon joins the rectum. In the colon the water is 
absorbed through the walls and the waste is expelled via the lumen. The appendix and 
caecum have no apparently function in humans, while in other species they are well 
developed, containing bacteria that metabolise plant carbohydrates, such as cellulose. The 
large intestine while not essential for life is affected by a number of common, serious 
diseases, such as inflammatory bowel disease and colorectal cancer [1]. 
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Figure 1.1: The human Gastrointestinal tract. 
All the parts of the GI tract are named, mouth, oesophagus, bowel and vital organs. Picture modified from [2]. 
Gastrointestinal Physiology and Function  
The GI system has as major function to control the motility, secretion, regulation, digestion 
and circulation.  
Motility 
The motility or movement of the bowel is due to the presence of electrical slow waves. 
These waves are originated spontaneously in the network of interstitial cells of Cajal (ICC). 
The ICC, electrically active cells, present in the smooth muscle of the intestine and 
associated with Auerbachʼs plexus (Figure 1.4), are the pacemakers of the intestinal 
peristalsis (defined subsequently). Contraction is initiated by the increased of intracellular 
Ca2+ concentration. Ca2+ channels of the smooth muscle opens and the action potential 
occurs, creating a low frequency wave of electrical depolarization and repolarisation, the 
duration of which is dependent in the amount of Ca2+ that enters the cell [1]. 
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The phases of the contractions are:  
• Peristalsis, a wave of muscular relaxation is followed by a wave of contraction down 
the intestinal tract, generally at a rate of 2 to 25 cm/s.  
• Gastric churning, repeatedly squeezing and mixing of the stomach and contractions 
of its sphincter. 
• Segmentation movement, non-propagating circular muscle contractions. 
• Colonic mass movement, sweeping contractions that stimulate defecation. 
• Interdigestive migrating motor complex (IMMC), occurs in three phases between 
meals, to keep the intestine and stomach clean of food. 
The mixing patterns allow food and digestive enzymes to be in uniform composition and 
ensure contact with the epithelium for correct absorption. All the contractions are regulated 
by hormones, neurotransmitters and the autonomic nervous system. 
Secretion 
Body fluids and electrolytes need to be replenished daily to compensate for losses, these 
count for at least 1000 ml of water per day that are replaced by absorption in the intestine. 
Actual fluid fluxes (containing ions, digestive enzymes, mucus, bile) secreted everyday by 
the digestive system count for around seven litres. While more than half is secreted by the 
liver, pancreas and salivary glands, the epithelial cells of the intestines have a major role to 
secrete the rest.  
Most of the fluids and electrolytes need to cross the monolayer of epithelial cells joined by 
tight junctions that form the intestinal wall. This layer regulates the fluxes and maintains the 
gradients through specialised pores, channels and ions pumps. However, there exists a 
paracellular movement of fluid due to some permeability of these tight junctions. In fact, this 
permeability can be altered by diseases [1]. 
The largest component secreted by the GI tract is water and ions, such as H+, K+, Cl-, 
HCO-3 and Na+. Water passively follows osmotic gradients generated by secretion and 
absorption of ions. The movement of ions is controlled by proteins that trigger channels 
opening, facilitating active transport. In the stomach parietal cells actively exchange K+ for 
H+ consuming energy (ATP), and Cl- ions are released into the stomach lumen, this creates 
the highly acidic conditions (pH = 1) of the stomach neutralised by the secretion of 
bicarbonate (HCO-3) [3]. Bicarbonate is released within the mucosa by intestinal 
enterochromaffin cells and transported to the duodenal lumen by enterocytes offering 
protection to the duodenum. Bicarbonate secretion is mediated by melatonin via neural 
stimulation [4], [5].  
Enzymes are crucial for the digestion of nutrients, they are secreted within the mouth, 
stomach and intestines. Some of these enzymes are secreted in an active form (amylase, 
lipase) and others are inactive (trypsinogen, chymotrypsinogen, procarboxypeptidase) until 
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they reach the duodenum lumen where they are activated by a particular proenzyme 
(enterokinase). The secretion of mucus serves as a protection and lubrication for the 
mucosa of the tract. Bile, formed by bile salts, bilirubin and cholesterol, is released during 
meals into the duodenum via the bile duct [3]. 
There are two types of secretion mechanism. Active secretion, when the pump or channels 
in the epithelial cells are active and solutes enter in the lumen against electrochemical 
gradient [6], requiring oxygen to support the cell metabolism. Passive secretion is due to an 
imbalance in Starling forces of the vascular system. To maintain the exchange of oxygen 
and carbon dioxide between cells and blood supply, the capillary wall controls the fluid 
movement. The forces controlling these movements are known as Starling forces, where 
hydrostatic pressure expels water out of the capillary and oncotic pressure pulls water into 
the capillaries. The difference between these two pressures will decide the direction of the 
flow. When there is an imbalance, fluid is lost from the circulation and leakage occurs 
across the mucosa to the lumen [7], [8]. Studies suggest active secretion occurs from the 
crypts (base) and passive secretion from the villi (filaments) [8], [9], [10], [11]. 
When Cl- channels open and Cl- enters the lumen active secretion starts. As a 
consequence of these channels opening, a small dehydration of the interstitial space occurs 
when water follows the solute, leading to a reduction of hydrostatic pressure and lymph flow 
[6]. At the same time, an increase of osmotic pressure in colloid tissue will also lead to 
dehydration and the filtration from plasma to interstitial space will increase to compensate 
this dehydration. 
Epithelial conductance can increase due to damage of a villus (see figure 1.2) and this is 
associated with passive secretion. Passive secretion can be induced by intravenous saline 
solution, increasing venous or lymphatic pressure or by drugs or hormones [8]. Secretion 
induced by pressure, such as the occlusion of a vein, causes the separation of the 
epithelium from the basal intestinal layer and the loss of cells from the villous tips [10]. The 
epithelium become porous, the spaces between cells and cell tips opens and tight junction 
dilates [12], [13], [14]. This increase in epithelial permeability is expected to cause further 
secretion induced by pressure [15]. 
Although passive secretion is not oxygen dependent, it can be associated with an increase 
in oxygen consumption [16]. The interstitial space receives more fluid than is carried away 
by blood, lymph or mucosa. This can cause an increase in tissue pressure that leads to an 
increase in mucosa permeability. The tissue reacts to this increase of pressure by 
discharging fluid from the interstitium. However, an increase of interstitial hydratation can 
cause hydraulic conductivity increase, and when this reaches a threshold value more fluid 
enters the interstitium [8]. Other consequences of increase of pressure by fluid entering the 
interstitial space is the dilution of proteins and decrease of tissue colloid osmotic pressure, 
which reduces the loss of fluid from the capillaries and the entry of fluid in the interstitial 
space. 
Secretion is regulated by enteric endocrine and neural signals, although hormonal, 
paracrine signals and immune response also regulate fluid balance, which can also be 
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modified by bacteria, toxins and drugs. Nevertheless, secretion is increased in general by 
parasympathetic stimulation [17]. Active secretion is regulated by enteric reflex [18]. 
Reflexes occur as serotonin (5-HT) is released by enterochromaffin cells [19], [20] in the 
mucosa causing stimulation of afferent nerves in the submucosa plexus [21], [22].  
Digestion 
Digestion is the main function of the GI tract. The surface area is an important factor for 
absorption of nutrients and while the small intestine is the main absorptive surface, some 
nutrients can be absorbed through the oral mucosa or the stomach. 
The intestine wall has a complex structure that increases the surface area of absorption. 
The transverse folds (plicae circulare) increase the area by three, all the villi with their finger 
structure increase the surface area 10-fold and the microvilli, which are projections on the 
surface of the epithelial cells also with finger structure, increase the area by 600-fold. 
Hence in total the area of absorption in the intestines is increased by 18000-fold.  
 
Figure 1.2: Structure of the gut lumen. 
a) The GI tract is form of four major layers (serosa, muscularis, submucosa, and mucosa) from the most 
external one to the inner one. The mucosa is formed of villi that increase the surface area by 10-fold, b) every 
villi, formed of microvilli, has its own blood and lymph supply, they are located centrally to the villus forming a 
net under the submucosa. The peak of the villi is the villus and the valley, the crypt. Part a) modified from [23]. 
The human diet is mainly formed by carbohydrates, proteins and lipids, which are known as 
macronutrients. These offer us the necessary dietary energy and the structural material for 
the body tissues. Micronutrients, vitamins and minerals, are also necessary in human diet, 
however in minimum amounts. Special mechanism in the tract regulates the absorption and 
elimination of some potential toxic micronutrients.  
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Once the food is down the oesophagus the involuntary enteric and autonomic nervous 
systems and hormones produced by the entero-endocrine system coordinate digestion and 
absorption [1]. 
Circulation 
All the specialised functions that the gastrointestinal tract controls need a highly organised 
vascular system, this is called collectively splanchnic circulation. This system, containing 
20-40% of the total blood volume, is one of the major blood reservoirs. Most of the 
splanchnic blood, up to 60%, resides in capillaries, providing the primary source for blood 
mobilised in a crisis. Secretion by the digestive system, as described before, amounts to a 
total of 7 litres/day with 1 litre/day of water consumed, which is approximately three times 
the body plasma volume. Hence, changes in GI tract and systemic circulation flux exchange 
can modify plasma volume [24]. 
Perfusion of the different organs of the GI tract is essential to provide the tissue with the 
energetic demand for its correct function. The mesenteric circulation, which supplies the 
intestine, possesses a regulatory mechanism between blood flow and tissue function of the 
bowel [25], [26], [27]. 
The mesenteric arteries are connected to each other in such a way that when the flow of 
one region of the bowel is decreased the nearby region can compensate the fault through 
collateral flow [28], [29]. Hence, some agents such as nitric oxide can disturb the 
mesenteric vessels without affecting the circulation of the intestine [30]. The villi and the 
crypts of the mucosa are supplied by arterioles that form capillaries within the villus. These 
villus capillaries have sphincter that regulate tissue perfusion depending on the blood flow 
received [31]. 
The circulation of the villus is a typical arrangement of counter-current exchange systems, 
the arteriole, that supplies blood to the villus, runs parallel to the venule that drains the 
villus. These are located centrally to the villus while the capillaries form a net under the 
submucosa [32]. The diffusion of substance between arteriole and venule in the direction of 
the gradient of concentration is the basic mechanism of counter-current exchange. Arterial 
blood is high in oxygen concentration while venous blood is low, hence oxygen diffuses 
from artery to vein. The reduction of oxygen in the villus tip results in a decrease of 
metabolism, increasing the risk of injury and tissue rupture on these cells [33]. 
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Figure 1.3: Counter-current exchange circulation in the villus.  
The blood is supplied to the villus through the arteriole, this runs parallel to the venule, that drain the villus. 
Oxygen is exchanged through the circulation in the villus. When there is a normal flow, oxygen can be supplied 
to all the enterocytes. When there is a poor perfusion of blood (such the case of ischaemia or hypoxia), necrosis 
is initiated in the enterocytes lacking oxygen often at the tip and further injury can be developed.   
The bowel needs oxygen for its active absorption, secretion and for cell functionality. 
However in the entire intestine a correlation does not always exist between absorption or 
secretion and oxygen consumption [34]. The reduction of blood flow to the intestine results 
in a reduction of oxygen delivery, when this occurs the resting gut increases oxygen 
extraction to keep constant the oxygen consumption rate. Autoregulatory responses lower 
blood vessels resistance trying to maintain constant blood flow and oxygen delivery when 
there is a reduction in blood pressure. When blood flow decreases, counter-current 
exchanges are more efficient, forcing oxygen out of the villus, hence reducing further 
oxygen delivery. Counter-current loss of oxygen is thought to be the factor of higher 
damage to the villus tips during decreased villus blood flow, such as ischaemic hypoxia 
[33]. 
Active secretion is thought to be in the crypts and passive secretion and active absorption 
on the villi, however at present there is no technique for measuring crypt and villi blood flow 
that can prove this. Several advances have been done to measure intestinal circulation 
[35]. Shepherd et al. injected microspheres into the circulation and measured the 
distribution in the intestinal regions. [36] More advanced techniques, such as Laser Doppler 
Flowmetry (LDF) have been used to observe relative changes in mucosa blood flow 
continuously [37], [38], [39], [40], [41]. 
Chapter 1: Introduction 
 24 
Neural fibres are present close to the villus, crypt epithelium and microcirculation vessels. 
Adrenergic nerve fibres, although not many, are localised mostly in the crypt, while 
cholinergic fibres are found in high concentration in the mucosa rather than the villi [42]. 
Epithelial transport and microcirculation control intestinal secretion and all of them are in 
turn regulated by the enteric autonomic system [43], [44], [45], [46]. Sympathetic stimulation 
decreases blood flow to the alimentary canal through vasoconstrictor nerves (α-adrenergic). 
While there is no apparent direct parasympathetic innervation of blood vessels in the 
splanchnic circulation, parasympathetic nerves can cause significant changes in metabolic 
activity of the alimentary canal increasing blood flow [24]. 
Regulation 
The complex GI system needs a strict regulation lead by both intrinsic and extrinsic 
neuronal and endocrine mechanism.  
Long reflexes originated from the central nervous system (CNS) send information to the 
digestive system, including food or danger triggering effects or emotional responses. Short 
reflexes are within the enteric nervous system (ENS), where the information is received, 
processed and sent by the ENS itself. The GI cells release GI peptides into the blood where 
they control excitatory and inhibitory responses controlling the effects of motility, secretion 
and the feeling of hunger and satiety. All these reflexes work together to regulate the GI 
system [24]. 
This independent nervous system, the ENS, regulates each GI function, from motility to 
circulation. The importance and complexity of the regulatory effect in the digestive system is 
such that a new discipline has emerged in the last years for the study of the gastrointestinal 
nervous system, neurogastroenterology. 
1.2 Neurogastroenterology  
Gastrointestinal motility was a discipline that comprised studies of gut smooth muscle and 
motor activity. Back in the 1960s these studies matched with the name of the discipline, 
however, the successive addition from other disciplines, such as neuroscience, psychiatry, 
immunology, endocrinology and epidemiology sharing an interest in the gastrointestinal 
system, but not in the gut motility, forced rename of this area of research [47]. 
Neurogastroenterology, as a recent discipline, focuses on the understanding of the brain-
gut axis and the combined role of the central nervous system (CNS) and enteric nervous 
system (ENS).  
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1.2.1 Enteric Nervous System  
The gastrointestinal tract contains around 100 million neurons, approximately the number 
found in the spinal cord and constitutes what is been called the “brain of the gut” or more 
strictly the enteric nervous system (ENS) [48]. This functions independently of the central 
nervous system [49] and controls the motility [50] exocrine and endocrine secretions [51] 
and microcirculation [52] of the gastrointestinal tract. It is also involved in regulation, 
immune and inflammatory processes [53]. 
Originally the ENS was though to be part of the peripheral nervous system and its neurons, 
postganglionic parasympathetic neurons. However, in the early 1900s the idea of a “brain 
on its own” materialised when the finding that the reflexes of the peristalsis waves were 
coordinated by the intramural nerves and that the enteric neurons were not in direct contact 
with the parasympathetic axons of the central nervous system (CNS). The ENS is 
connected to the CNS by the central autonomic neural network. All these connections 
provide the neural control of the ENS over the functions of the GI tract [49]. 
The wall of the GI tract is composed of circumferential and longitudinal layers (Figure 1.4).  
In these layers, the enteric nerves cell bodies are grouped in ganglia and connected by 
collection of nerve processes that form two plexuses. The myenteric (Auerbachʼs) plexus is 
found between the circular and longitudinal layer of the muscle throughout the entire length 
of the gut and regulates the motility and the sphincter function. The submucosal 
(Meissnerʼs) plexus is found in the submucosa and regulates epithelial cell and submucosal 
blood vessel function [48].  
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Figure 1.4: Muscular layers and nerve plexes of the gut. 
a) Longitudinal view: the myenteric (Auerbachʼs) plexus is found between the circular and longitudinal layer of 
the muscle, the deep muscular plexus is found in the circular muscle layer. The submucosal (Meissnerʼs) plexus 
is found in the submucosa. The most inner layers are the muscularis muscosae and the mucosa, b) transversal 
view: paravascular and perivascular nerve can be observed under the mesentery. The myenteric, submucosal 
and mucosal plexes are also distinguished [54]. 
The mucosa comprises epithelial cells that regulate the secretion of electrolytes, mucous 
and enzymes; absorb nutrients and present neuroimmune function. Some of these 
epithelial cells are enteroendocrine cells, also known as enterochromaffin cells that contain 
various neurotransmitters. The following layers are the lamina propia and the muscularis 
mucosae that are responsible for the movement of the villi. The submucosa contains blood 
and lymph vessels and the submucosal plexus and the circular smooth muscle layer is 
responsible for the contraction movements of the luminal content. Next is the myenteric 
plexus and the final layers are the longitudinal muscle and the serosa [55]. 
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There are many different types of enteric neurons that form complex circuits that control 
and regulate motility, secretion and vascular tone [56], [57]. However, two main types of 
neurons have been identified in the ENS: Type I, with a single long processes, Type II, 
multipolar and with many long, smooth processes. Most neurons contain several 
neurotransmitters; in fact more than 20 types of neurotransmitters have been identified, 
such as acetylcholine, nitric oxide, aminoacids and peptides [49]. Nevertheless different 
species present different neurotransmitters in the intestine [45], [46], [58], [59], [17]. Enteric 
nerves act in response to stimuli from other enteric nerves, to autonomic nerves and to 
epithelial cells. Furthermore the neural effects can be presynaptic or postsynaptic [58], [60], 
[61].  
In addition to enteric nerves, the ENS contains immune cells, smooth muscle cells and 
interstitial cells of Cajal (ICC). The ICC are electrically active cells that produce the slow 
wave directed to smooth muscle cells and they are found in different layers of the gut [62], 
[63]. Cajal hypothesised in 1911 that ICC may modify smooth muscle contraction. These 
smooth muscle contractions or peristalsis do not have external innervations, reinforcing the 
idea of the complexity and completeness of the ENS system. Enteric nerve cells control 
secretion and autoregulate the blood flow, however, their function can be modified by the 
autonomic innervations. Sympathetic nerves decrease intestinal motility and secretion and 
increase sphincter tone, using neurotransmitters such as noradrenaline (NA), dopamine 
(DA), neuropeptide Y (PY) and adenosine-5-triphosphate (ATP) [64], [65]. Parasympathetic 
nerves, instead, increase secretion and motility, using acetylcholine (Ach) and 
cholecystokinin (CCK) [1]. 
The pattern of innervation of the ENS is similar along the canal, either in the oesophagus, 
stomach, small or large intestine. In the small intestine and colon the ENS has three major 
roles: wall movement, water and electrolyte secretion and local blood flow regulation. While 
the presence of the ENS in the oesophagus is not essential (the muscle is innervated 
directly to the central neurons), its existence is crucial for the control of the colon; if missing 
or damaged, the probability of survival is minimal. The stomach, instead, lies in an 
intermediate state, the intrinsic nerves are not completely developed and it is controlled by 
the brain via the enteric neurons [57], [66], [67], [68]. 
Further studies of the enteric nervous system are needed to understand the basic 
physiology and to improve therapeutic intervention.  
Chapter 1: Introduction 
 28 
1.2.2 Gut-Brain similarities 
Further examinations of the functional and chemical characteristics of the enteric neurons 
suggested that the enteric nervous system closely resemble the central nervous system 
[49]. 
The enteric nervous system comprises a large number of neurons, yet a greater number of 
glial cells (up to fourfold) have been found [69], [70]. Glial cells are an important component 
of the ENS and resemble the astrocytes of the CNS. They cover the major part of the 
surface of the enteric neuronal cell body with its laminar extension and modulate the 
inflammatory response in the intestine [71]. 
In the brain, the blood brain barrier (BBB) prevents the access of chemical substances and 
bacteria from the blood stream to the neural network, however, allowing essential 
substances for metabolic functions. The capillaries are highly selective, but this selectivity is 
due to the intercellular protein complex structure formed by adjacent endothelial cells 
membranes, what is known as the tight junction [72]. Transport then occurs via specialised 
carrier proteins. 
In the intestines, while there is not a tight junction barrier between blood vessels and tissue, 
there is a barrier analogous to the BBB between the intestine lumen and the tissue. There 
is an epithelial layer that covers the entire surface of the intestine and that is joined together 
by the tight junctions. And in the same way as the brain barrier, the intestinal barrier 
prevents or regulates the entrance of bacteria, toxins and other molecules from the 
intestinal lumen to the blood [73], [74].  
Chapter 1: Introduction 
 29 
 
 
Figure 1.5: Blood brain barrier and gut lumen barrier.  
Blood Brain Barrier: An epithelial layer joined by tight junctions forms the barrier between the blood vessels and 
the brain tissue, avoiding toxic substances penetrate the brain tissue. The astrocytes play a major role in the 
brain as an intermediate communicator between blood vessels and neurons. Intestinal Barrier: the barrier 
formed by enterocytes layer is in this case between the intestine lumen and the tissue. This barrier stops 
bacteria and food in the lumen penetrating the rest of intestinal tissue. In the intestines the glial cells play an 
analogous role as the astrocytes in the brain.  
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Development 
The development of neurons occurs in steps in all parts of the nervous system. It starts with 
neural progenitors, that proliferate and migrate into an immature neuron. Then the axons 
grow to reach a target, and the synapses are formed and finally the immature neuron 
develops to a mature neuron, which presents electrical properties. The ENS begins with 
neural crest cells, progenitors from the hindbrain, enter the foregut and colonise the entire 
gastrointestinal tract. [75] A small percentage, 10-20%, of enteric neural crest-derived cells 
develops into immature cells while migrating along the gut, however the electrical activity of 
these is unknown [76], [77].  
Spitzer et al. showed in studies carried out in the development of the CNS that precursor 
neurons and early neurons are electrically active and release neurotransmitters 
spontaneously before the synapses formation [78]. The electrical activity of the early 
neurons can differ from the same neuron at a latter stage. In some parts of the developing 
CNS the electrical activity and the spontaneous release of neurotransmitters influence the 
neural proliferation, the migration and differentiation [78]. 
The axons of many early enteric neurons are projected along the same line and associated 
with migrating enteric neural crest-derived cells bodies. This close relationship between 
immature neurons and migrating precursors leads to the hypothesis that the electrical 
activity of immature neurons influences the proliferation, migration and the differentiation of 
neural precursors in the gut [77]. In the developing ENS, expression of molecules involved 
in synaptic functions have been found, thus, increasing the possibility that the immature 
neurons are able to release neurotransmitters and present postsynaptic responses [79], 
[80].  
Synapses 
The synapses between neuron and neuron in the ENS are structurally similar to the 
synapses in the CNS [81]. Synapses between enteric motor neurons and ICC also exist in 
some regions of the gut [82]. Although a complex synaptic circuit has been found in the 
ENS that triggers motility reflexes, there is no knowledge of how the axon of one type of 
neuron recognises another type of enteric neuron and forms synapses [81].  
It is not yet known whether ENS synapses are unsheathed by glial end feet in the same 
way as in the brain. 
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Similarities and differences described here are listed in table 1.1:  
 
CNS ENS 
1012 neurons 108 neurons ~ spinal cord 
Astrocytes Glial cells 
Blood brain barrier Intestinal barrier 
Tight junctions Tight junctions 
Neuron-neuron synapses Neuron-neuron synapses 
Axon-Neuron synapses Axon-Neuron synapses unknown 
Neuron progenitors and early neurons –
electrical activity known 
Neuron progenitors and early neurons –
electrical activity unknown 
Table 1.1: Similarities and differences of the CNS and ENS. 
The main components of the CNS are listed and compared with the components of the ENS. 
The ENS is independent of the CNS, however, the CNS plays a major role coordinating the 
activity of the gut through sympathetic and sensory systems. Therefore, it is better to 
consider the ENS as an extension of the CNS that keeps tight communication through the 
sympathetic and parasympathetic afferent and efferent neurons. 
Our group has been focusing on the study of brain activity for a long time, by monitoring 
neurochemicals in the human brain of injured patients to understand the mechanisms and 
the development of the injury. We aim to apply now this knowledge using the same 
technique to comprehend and identify the mechanisms of injury in the human bowel. 
1.3 Gut Pathology 
The surface of the GI system is relatively large and needs to be protected against microbial 
infection either exogenously from food or endogenously from intestine population of 
bacteria (intestinal flora). The mucosal immune system is crucial for the protection and 
regulation of the intestine response.  
Intestinal function has been traditionally assessed monitoring mainly stomach physiology 
and intestinal motility [83]. Clinicians then assumed that normal intestinal motility denoted 
normal intestinal function and focused in the prevention of gastric bleeding [84]. The colon 
was viewed in the past as an organ with its primary function being water absorption. Today 
is finally recognised as an active organ with an important role in the endocrine, metabolic 
and immunological functions [85]. The role of intestinal barrier failure is of recent interest 
and studies point to it as a main cause in the development of systemic infection and 
multiple organ failure in critically ill or injured patients [74]. 
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1.3.1 Intestinal Ischaemia and its Role in Shock 
Ischaemia is a restriction of blood supply and can produce damage or dysfunction of the 
tissue. Hypoxia on the other hand is the deprivation of the oxygen supply to the tissue. In 
general ischaemia leads to hypoxia causing death of cells and tissue necrosis.  
Intestinal or mesenteric ischaemia is recognised as a poor blood supply of the intestine that 
leads to inflammation and injury [86]. The intestinal tract is one of the main organs that, 
after hemorrhage or shock, appears to be involved in an ischaemic/reperfusion injury. On 
the other hand sepsis can be derived from an ischaemic insult and end in shock. Shock is a 
life threatening condition caused by the impaired blood supply to the body tissues. 
Mesenteric ischaemia can increase intestinal cell membrane permeability, which is the 
capability of small molecules to enter the GI mucosa. This can provoke bacterial 
translocation that leads to injury of the gut barrier and results in sepsis and multiple organ 
failure (MOF) [87], [88], [89], [90]. The tight junctions can modify this permeability, therefore 
the measure of intestinal permeability can be valuable for the diagnosis of diseases [91], 
[92]. 
The human GI tract, under normal conditions, is colonised by the bacterial flora, which 
contains high population of microorganism, 1012 bacteria, 109 pathogenic gram-negative 
enteric bacteria and endotoxins. These bacteria are enough to kill the host, which is 
protected by the intestinal barrier [73]. This barrier, formed by epithelial cells covering the 
surface of the GI tract prevents the absorption of toxins, antigens, proteases and 
microorganism across the intestinal wall [93]. Nevertheless, bacterial translocation is of 
common occurrence in healthy patients. In critically ill patients this bacterial translocation 
can lead to further damage, worsening the health condition [73].  
The intestinal barrier has been a focus of studies in recent year, however, its function and 
exact mechanism are not fully understood [94], [95]. The correlation between bacteria 
translocation and intestinal permeability is controversial. Kanwar et al. [95] did not find any 
correlation between failure of the gut barrier function and septic complication after major GI 
surgery. In rodents, the loss of intestinal barrier function was associated with translocation 
of bacteria, however, in humans bacterial translocations were not related to increased 
permeability or villous atrophy [92]. In the absence of damaged mucosal barrier, a primary 
mechanism of translocation was proposed, where migration of organism across the bowel 
occurred by pinocytosis in epithelial cells [96], [97]. On the other hand, studies have 
identified alterations in intestinal permeability in critically ill patients. Freter et al. suggested 
that loss of tight junction and cell at the villous tip were the primary causes of changes in 
intestinal permeability [98].  
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The process of translocation begins with the adherence of the bacteria onto the 
enterocytes, which enter the barrier via transcellular and paracellular mechanisms [96], 
[99]. The paracellular mechanism occurs by the disruption of the tight junctions [100]. Both 
mechanisms, however, are triggered by common injuries such as ischaemia/reperfusion, 
oxidative stress and bacterial action. Once the bacteria have crossed the barrier, the 
immune system will attack it. If it survives, sepsis or endotoxemia occurs, and further 
damage will develop into multiple organ failure [101], [73]. 
  
Figure 1.6: Bacteria translocation in the intestine. 
The translocation of bacteria via transcellular mechanism occurs when bacteria adheres to the enterocyte and 
penetrates through the enterocyte. The paracellular mechanism begins also by adherence of the bacteria to the 
enterocytes, but this time the bacteria break through the tight junctions and penetrate the barrier.  
Multiple organ failure (MOF) is produced as a consequence of a systemic inflammatory 
response syndrome (SIRS) and the main organ involved is the intestine. The inflammatory 
response generally proceeds from insults such as hemorrhage, ischaemia/reperfusion, 
infection or trauma and ends in shock if untreated. The main cause of all these intestinal 
dysfunctions is claimed to be bacterial and toxin translocation [102]; the toxins release 
cytokines, leukotrienes and platelets-activating factors (PAF), which play a major role in the 
initiation of shock [103], [104], [105]. The tight relationship between bacteria translocation 
and the role of intestinal ischaemia in the increase of membrane permeability has already 
been stated. The proximity of the intestine to luminal bacteria and toxins means it is an 
easy target to translocation, vasoconstriction and hypoxic villi [106].  
Shock can also be initiated by reduction in blood flow or activation of endotoxins, which 
release vasoactive substances and stimulate tissue formation of oxygen free radicals [107], 
[108], [103], [102]. Hence, loss of plasma volume and proteins into the interstitium space, 
reducing blood flow, also causes MOF [109], [110], [111], [112], [113].  
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Nitric oxide (NO) has an effect that opposes those of cytokines and PAF, and provides a 
protective effect [114]. NO reduces platelet and leukocytes adhesion to blood vessels, and 
also has a vasodilator effect that increases blood flow and maintains mucosa integrity. This 
effect could prematurely disrupt the shock avoiding further cytokine release [107], [110], 
[115], [116], [117]. Interestingly, the same cytokines and mediators involved in shock 
stimulate NO production, which is carried in the intestinal mucosa by enterocytes, vascular 
tissue, smooth muscle, neurons, fibroblasts and with cells [118], [119], [113], [120]. 
Different pathologies enclose different sequences of shock, however, the consequences 
that lead to death are very similar. A decrease of the organ perfusion, hypotension (low 
blood pressure), hemoconcentration (decrease of blood fluid and therefore increase of 
blood contents concentration), release of toxic substances and vasocongestion (increase of 
vascular blood leading to tissue swelling) are the main ones [121]. All of them occur 
irrespectively of the initiating cause of shock as a general inflammatory response. In this 
research we are going to study two major causes of shock caused by ischaemia after 
surgical intervention. 
1.3.2 Post-operative Ischaemia 
Anastomosis Leaks 
In a gastrointestinal surgical procedure, the two bowel segments transected are joined 
again; closing the bowel lumen, this technique is what is known as bowel anastomosis. 
Anastomosis in low rectal connection has a high risk factor of leakage and this can lead to 
more severe complications [122]. 
If the faeces transported through the lumen of the bowel escape from that anastomosis leak 
to the peritoneal cavity, there exist a high rate in the development of peritonitis and risk of 
mortality. At present, clinical leak rates are found in a range between 3 to 15 % [123]. When 
leak has developed, mortality rates are in a range of 6-40% [124]. 
There are several factors that contribute to anastomosis leak, preoperative variables, such 
weigh loss, malnutrition, cardivoascular disease, intraoperative difficult anastomosis or 
postoperative blood transfusions [125], [124]. Nevertheless, tension on the anastomosis, 
poor sealing technique and ischaemia of any of the joining segments are the main factors 
related to anastomosis leak [123], [125], [124], [126]. Furthermore, it has been observed 
that the performance of a low rectal anastomosis has a high impact in the development of 
anastomosis leak [122]. At present surgeons attempt to perform a tension free anastomosis 
and provide an adequate blood supply to the two ends of the anastomosis [123]. 
Delivery of an adequate oxygen tension to meet the metabolic demands of the healing 
process and avoid an early ischaemic event is crucial [127]. However, when the leak 
occurs, the possibility of an early diagnosis could improve outcomes rates.  
Currently clinical techniques for the diagnosis of leaks are radiology and CT scans. Overall, 
the physician has to complete a diagnosis based in the physical symptoms of the patient. 
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Hence, there exists a need of a fast and reliable technique to be used in a clinical 
environment. This is explored in this thesis in chapter 5. 
Abdominal Aortic Aneurysm  
Disease or weakness of the blood vessels causes the vessel wall to dilate with the 
continuous passage of blood, and this can form a protuberance filled with blood, an 
aneurysm. As the aneurysm increases, being fed by blood, the risk of rupture increases and 
this can produce severe haemorrhage leading to other complication and ultimately to death. 
The most common aneurysms occur in arteries at the base of the brain and in the aorta. 
Abdominal aortic aneurysm (AAA) refers to the aneurysm formed at the abdominal level of  
the aorta artery. The number of patients treated surgically of AAA has increased and 
postoperative management is important as the development of complication is often high  
[128]. 
The most common complication after abdominal aortic aneurysm surgery is ischemic colitis, 
or ischemia produced in the colon, which is the most common form of intestinal ischaemia 
[129]. Ischaemic colitis after AAA surgery ranges between 2 and 13% [130], however 
mortality rates are as high as 90% [131]. Hence, it has a high impact in total mortality rates 
postoperatively [132], [133], [134]. 
After emergency operation for a ruptured abdominal aortic aneurysm, the occurrence of 
ischaemic colitis increases to 60% [135]. Hence, the evaluation of an adequate perfusion 
through the colon after these surgeries is crucial for the reduction and prevention of 
postoperative morbidity and mortality. 
Intestinal ischaemia and gut barrier failure are the principal factors in the development of 
sepsis, systemic inflammatory syndrome and multiple organ failure (MOF) [136], [109]. 
Ischaemia is also known to be the principal factor for the development of anastomosis leak 
and has a high rate of recurrence after AAA repair. Currently research at the organ level is 
not as broad as at cellular and molecular level in relation to microcirculation and secretion 
during shock [137]. For this reason, the work of this thesis investigates the mechanism of 
ischaemia before shock and multiple organ failure begins, monitoring gut metabolism during 
gastrointestinal surgery (chapter 4), in anastomosis procedure in animal models (chapter 5) 
and postoperatively following the repair of abdominal aortic aneurysm (chapter 6).  
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1.4 Gut Metabolism 
Critically ill patients presenting splanchnic hypoperfusion generally have a poor outcome.  
Mucosa hypoperfusion in gastric, small intestine and colonic tissue develops sepsis despite 
presenting hyperdynamic systemic circulation [138]. Some studies describe the mucosa as 
one of the highest metabolically active tissues under conditions of sepsis [139], [140]. There 
is also evidence that gut blood flow and metabolic changes are heterogeneous [141], [142], 
[143], however, no clear association between those has been found [144]. Van de Meer et 
al. propose the increase of oxygen extraction as a mechanism of reaction for compromised 
mucosal tissue [145]. However, evidence exists of unavailability from the cells to use 
oxygen during sepsis, despite adequate oxygen delivery [146].  
Ischaemia increases intestinal permeability, provoking variation of intracellular biochemical 
markers. In general these biochemical markers are raised in the ischaemic bowel once the 
cause of injury is initiated, such as bowel strangulation, intestinal perforation or impaired 
blood flow [147]. Therefore, metabolic substances are presented as a useful measurement 
for the monitoring of intestinal ischaemia.  
Metabolic changes refer to all the chemical and energetic transformations occurring in the 
body. The principal product of carbohydrate digestion and the main circulating sugar is 
glucose. Glucose source is derived from digestion of polysaccharides and mobilisation of 
glycogen reserves. When glucose levels in blood are low, the hormone glucagon binds to 
the G-protein that activates the breakdown of glycogen reserves in the liver. On the other 
hand, when glucose levels are high, the Islets of Langerhans in the pancreas secrete the 
hormone insuline that initiates the storage of glucose as a glycogen by liver, muscle and fat 
tissue cells. Hence, once glucose enters the cell, it is phosphorylated, from which can then 
be polymerised into glycogen (glycogenesis) forming storage of glucose, or broken down 
into pyruvate and/or lactate (glycolysis) [148].  
Glycolysis occurs in the cytosol: glucose is converted into pyruvate in a pathway of trioses. 
This process does not need oxygen. Pyruvate is converted into acetyl-CoA and this enters 
the TCA cycle (tricarboxylic acid cycle) or what is also called the citric acid cycle or Krebs 
cycle. This occurs in the mitochondria in the presence of oxygen. This follows a sequence 
of seven reactions, where Acetyl-CoA is metabolised to CO2 and NADH molecules. Glucose 
is not the only source of NADH, fats and amino acids can also be metabolised, however 
NADH is usually the final product (Figure 1.7). 
Finally, the NADH molecules are used to make ATP in a process known as oxidative 
phosphorylation. Here the electrons stored in NADH are fed through a series of redox 
reactions that largely take place in the mitochondrial membrane ultimately terminating in the 
reduction of oxygen to water. The energy released at each stage is used to generate a 
proton gradient between the inner and outer mitochondrial membranes. This proton 
gradient is used to drive a molecular machine, ATP synthase, responsible for the 
generation of ATP (Figure 1.8). 
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In energetic terms, the anaerobic conversion of glucose to pyruvate has a net gain of 2 
molecules of ATP. However, 2 molecules of NAD+ are also consumed. In the absence of 
oxygen, glycolysis could stop due to lack of NAD+. However, pyruvate can accept a proton 
from NADH and form lactate and NAD+. In this way glucose metabolism and energy 
production can continue for a short period without O2. The lactate accumulated can be 
converted back into pyruvate once the O2 supply is restored. During aerobic metabolism of 
glucose, the net production of ATP is 19 times higher than anaerobically. Before the 
conversion to pyruvate, the 2 NADH produced, generate 6 mols of ATP. 6 mols of ATP are 
formed from the conversion of 2 pyruvate to 2 acetyl-CoA and 24 mols of ATP are formed 
during the two turns of TCA cycle. Hence the theoretical net production of ATP per mol of 
blood glucose during cellular respiration is 38. Experimentally, ATP is needed as energy to 
move pyruvate, phosphate and ADP to the mithocondria [149]. 
Ischaemia produces a change of metabolism to the tissue affected, from aerobic to 
anaerobic, decreasing glucose levels and increasing lactate levels. Glucose is no longer 
sustained by the splanchnic circulation, hence its tissue levels will fall. In addition, because 
of the lack of oxygen, pyruvate cannot enter the citric acid cycle and be metabolised, 
therefore it is accumulated in the tissue. To maintain glycolysis, pyruvate is converted to 
lactate, hence tissue lactate will rise.  
Monitoring the gut metabolic markers, such as glucose and lactate, will inform us on this 
variation from aerobic to anaerobic metabolism. The measurement of glucose and lactate 
will inform on the balance between oxygen supply and demand and therefore will present 
the ischaemic degree of that tissue. 
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Figure 1.7: Glucose metabolism. 
Glucose undergoes six conversions to produce 2 molecules of pyruvate during the glycolysis pathway before 
entering the citric acid cycle. Purple route indicates the glicolysis pathway and the red route th glycogenesis. 
Once in the mitochondria, pyruvate is converted into acetyl-CoA, each turn of the cycle provides 4 NADH and 1 
FADH2 via oxidative phosphorylation and one GTP that is converted to ATP. The numbers (3C,4C...) indicate 
the numbers of carbon atoms in each intermediate.  
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Figure 1.8: Oxidative phosphorilation. 
The electron transport chain: as electrons pass through each of the complexes, a proton is passed to the 
intermembrane space. The flow of protons back into the matrix is coupled to ATP synthesis. Modified from 
[149]. 
1.5 Monitoring Metabolism 
Inadequate blood flow is a characteristic of shock and the cause of ischaemia. The 
metabolic needs of the tissue are not met in these conditions and this can lead to tissue 
injury. Consequently, ensuring both perfusion pressure and blood flow, to maintain the 
necessary metabolic supply to meet the tissue metabolic demand, are highly important to 
avoid diseases [150]. Nevertheless, when blood flow has been partially compromised, an 
early diagnosis could prevent the injury developing further into organ dysfunction and 
death. 
In order to monitor these perfusion irregularities, several techniques have been used over 
the years. In humans, techniques such as tonometry, (a balloon introduced in the stomach 
measures intramucosal pCO2) [151], [152], laser Doppler flowmetry [41], reflectance 
spectrophotometry [153], near-infrared spectroscopy [154], orthogonal polarisation spectral 
imaging, [155], [156], indocyanine green clearance [157], and measurements of plasma 
D-lactate [158], have been used to study gastrointestinal perfusion. All these techniques 
measure different constituents of gastrointestinal perfusion and although they predict the 
outcome of patients with septic shock, they cannot be compared to each other [159]. 
Intestinal failure has been diagnosed through intestinal bleeding, and although bleeding is 
unquestionably an indication of organ damage, this failure cannot be quantified. Throughout 
research, absorption markers of increasing permeability are highly useful to assess gut 
function, however, currently they are not appropriate for clinical monitoring in the intensive 
care unit (ICU) as they are highly invasive and require extensive nursing time. At present, 
gastrointestinal tonometry, due to its simplicity, is the most commonly used technique. It 
provides adequate information of GI perfusion and it is highly suitable for use in ICU. 
However, this method depends on the technical operator, compromising its reproducibility. 
In addition, its sensitivity to changes in perfusion countercurrents in the GI tract are yet not 
known [160]. 
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Regardless of all advances in clinical technology, the monitoring of GI perfusion is still 
limited and in most surgical departments the diagnosis of intestinal ischaemia relies in 
clinical symptoms and examination [161]. Improvement of GI perfusion has failed to prevent 
mucosal failure [159]. Furthermore efforts to improve this perfusion could affect the 
metabolic rate and modify the oxygen supply and demand balance.  
In any case, the characteristics needed for a method that measure ischaemia are:  
• Non invasive 
• Reliable 
• Selective 
• Sensitive 
• Reproducible 
• Rapid and easy sampling 
• Long time recording 
In general the methods listed previously do not meet all these characteristics. Currently, 
other challenges are due to the possibility of localised biochemical changes in specific 
segments of the gut of the patient [162]. Monitoring function and metabolism could be the 
ultimate mode of measuring gut perfusion [160].  
Biosensors have been widely used to study tissue metabolism in animal models measuring 
glucose directly [163], [164], [165], meeting all the demands needed for the measurements. 
Reproducibility of the biosensors before implantation, calibration in vivo, biocompatibility, 
stability in vivo, sterilisability and immunoreactivity are issues that limit the biosensors use 
[166], [167], [168]. Studies of biosensors coated with polymer layers are being carried out 
with the purpose of overcoming immune-defensive reactions and toxicity produced by 
directly implantable biosensors in humans [169]. A final concern is that most biosensors for 
implantation use O2 rather than a synthetic mediator. During ischaemia tissue oxygen levels 
fall, potentially altering the sensitivity of the biosensor. Lowry et al. have shown that for 
glucose oxidase, oxygen levels can fall to levels without changing sensitivity. Lactate 
oxidase however is sensitive to changes on oxygen levels (Lowry personal communication).  
In the last 30 years, in parallel with the work on biosensors, a minimal invasive sampling 
method, Microdialysis, has been developed. It has been coupled to a wide range of 
detection technique including biosensors, and has been increasingly used providing a 
reliable measurement of human tissue metabolism [170], [171], [172], [173]. 
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Bowel Microdialysis 
Microdialysis is an extraction technique that was developed in the early seventies by 
Ungerstedt and Pycock [174] to measure interstitial substance in the brain without causing 
damage. During subsequent decades extensive reviews on microdialysis have been written 
[175], [176]. More recently, applications of this technique have broadened to the sampling 
of extracellular fluid of different human tissues including brain [177], [178], liver [179], heart 
[180] muscle [181] and bowel [182]. 
Microdialysis related to the bowel has been used to study intestinal ischemia in 
experimental models [183], [184], [185]. In general terms, microdialysis monitoring in the 
abdominal cavity has been done in the peritoneal cavity, [186], [187], intestinal lumen [188] 
or the intestinal wall in a single case [189].  
Sommer et al. compared results from microdialysis probe inserted in the bowel of a swine, 
in different sites, intraperitoneal, intramural and intraluminal [183]. Intraluminal could be a 
good approach, because the injury that occurred in the bowel causes a bigger damage to 
the mucosal than to the seromuscular layer, and therefore, biomarkers rose early during 
injury period into the lumen. However, the metabolites measured intraluminally were so low, 
probably due to the resting phase of the intestine at that moment and also due to the high 
volume of contents in the lumen, that these could not be monitored [183]. Most of the 
research found in the literature in bowel microdialysis in humans placed the microdialysis 
probe in the peritoneal cavity [183], [190], [186]. These studies claim that the metabolic 
markers of an impaired circulation are greater in the peritoneum than in blood, due probably 
to the high amount of intestinal anaerobic products metabolised by the liver [147]. 
Peritoneal and luminal microdialysis are less invasive. Some studies suggested that the 
introduction of microdiaysis probe in a tissue might provoke a surgical trauma, causing 
histological changes and affecting metabolism of the region for periods longer than 1 hour. 
However, these studies were done in the skin of human subjects [191] and in ratʼs liver 
[192]. It is increasingly recognised that such a model does not accurately reflect human 
tissue responses. On the other hand, one of the main disadvantages of the peritoneal 
microdialysis is that changes occurring in the region of the ischaemia insult are diluted by 
the metabolites from the non-ischaemic region and from the peritoneum supplied by the 
systemic circulation [182].  
We use for our research intramural microdialysis monitoring. We aimed to detect these 
metabolic changes faster than with the other methods listed above, due to the proximity of 
the probe to the damaged tissue and due to the lack of dilution artifacts. However, the 
insertion of the microdialysis probe into the bowel gut presents a difficult challenge that will 
need intensive training for the clinician. 
In general, most of the studies found in the literature used the commercially available 
analyser from CMA (CMA 600, CMA/Microdialysis, Stockholm, Sweden). This consists on a 
high pressure liquid chromatography (HPLC) system for separation of the components and 
a range of detection methods including absorbance and fluorescence. The dialysate 
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samples are collected in vials of 200 µl volume, which are then manually stored in the 
freezer or in ice, by generally the ward nurse. Since the average flow rate in these studies 
is 0.3-2 µl/min, the time necessary for the collection of 200 µl of sample is of 1.5 hours or 
more, generating a pool of dialysate for that period of time. The time burden for clinical 
staff, and the problem of misplaced samples are serious issues for ʻtraditionalʼ microdialysis 
[178]. 
The main features that characterise our research are the on-line measurement and the 
rapid detection of the dialysate. The dialysate is directed from the outlet of the microdialysis 
probe to our on-line rapid sampling microdialysis (rsMD) system for analysis. The system 
provides us with a fast, every 30 seconds, method that needs no extensive manipulation, 
running by itself during 24 hours up to 5 days. This system was previously employed in 
monitoring human brain trauma during and after the operation in Intensive Care Unit, 
measuring metabolic changes during brain ischaemia [193], [194]. 
1.6 On-line Rapid Sampling Microdialysis Monitoring   
The aim of this system is to assay glucose and lactate levels on-line at a time resolution of 
2 samples/minute. The components of this system can be summarised in 4 major elements:  
a) Microdialysis technique, extraction of the analytes from the tissue of interest.  
b) Flow injection analysis (FIA) system for the sampling of dialysate, and carried by an 
external buffer, which also contains the mediator molecule (see transduction). 
c) Biorecognition element, where the biological molecules (our analytes) are 
recognised. 
d) Transduction component, where the analytes are converted in another type of signal 
and detected. 
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A schematic overview of the parts of this intricate system is shown in figure 1.9:  
 
 
Figure 1.9: Scheme of the components of the on-line rapid sampling microdialysis system.  
Microdialysis is the technique for which the analytes are extracted from the bowel, the flow injection 
automatically injects the analytes into the flow stream, the biorecognition recognises biological molecules and 
the transduction is where these molecules are detected. 
a. Microdialysis 
The original concept for microdialysis was to mimic a blood capillary [175]. Microdialyisis is 
based on the passive diffusion of the molecules through a hollow fiber membrane [195]. 
The probe, consisting of a small segment of cylindrical membrane of 250 µm diameter, is 
implanted within the tissue of study. The membrane cut-off is approximately 20000 Daltons, 
which limits the size of the molecules diffusing through it, avoiding large molecules such as 
proteins and enzymes to diffuse and therefore increasing the selectivity of the technique. In 
the clinical situation this also has the consequence of preventing the passage of tissue born 
virus or prions into the dialysate.  
A solution matching the physiological ionic composition of the intercellular space is pumped 
through the probe by a microperfusion pump. Molecules present in the extracellular fluid 
(ECF) diffuse down a concentration gradient across the membrane to the dialysate, the flow 
then carries them out of the tissue. 
The clinical probe is a concentric tube, its wall acting as the semi-permeable membrane, as 
shown in the figure 1.10a. The saline solution (or perfusate) is perfused into the probe via 
an inner tube and an outer tube carries out the dialysate fluid for analysis.  
Chapter 1: Introduction 
 44 
 
Figure 1.10: Diffusion through the microdialysis membrane and uptake/release balance in the ECF. 
a) Diffusion of the analytes through the semi-permeable membrane to and from the tissue, this follows 
concentration gradient, b) The microdialysis probe resembles a blood capillary and extracts the balance of 
uptake and release of the cell from the ECF.   
Probe size: For all microdialysis probes the size is determined by the availability of suitable 
membrane, rather than by theoretical considerations of ideal probes sizes. From the first 
microdialysis probes, the cylindrical membrane required came from renal dialysis 
cartridges. There is evidence from the brain that the ideal diameter would be < 70 µm, the 
mean intercapillary distance, to avoid damage to local blood supply [196]. 
Membrane material: In early microdialysis work it was thought that the chemical 
composition of the membrane was important as this affected probe performance in vitro. 
Cellulose, Cuprophane and Hospal membranes were all tried. However, with a better 
understanding of in vivo recovery (see section 1.7), it is now clear that the main property 
the membrane has is that of molecular weight cut-off, based on the tortuous diffusion path 
through the membrane. The clinical probes use a supported polycrystalline, polyethylene 
terephthalate (PET) membrane and usually are 20 kDa but 1 MDa are available for 
macromolecules.  
Probe geometry: Original probes were U-shaped or linear. To simplify surgery in the brain 
these were replaced with a concentric design. With the application of clinical microdialysis 
to other tissues, other geometries are now being considered.  
b. FIA System 
Flow Injection Analysis is an analytical method where the sample is automatically injected 
into a moving liquid stream that is typically coupled to a detector.  
The dialysate fluid, sampled by the microdialysis probe, is carried through a low volume 
tube into the valve system. A 200 nl internal loop is used to sample the dialysate stream 
and inject it into two analysis streams. Each stream is accelerated through separate 
reactors containing the enzymes.  
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c. Biorecognition 
The biorecognition element of a biosensor is a protein with specific surface or interior 
recognition sites, necessary for the recognition of the desired analyte. The element imparts 
the required analyte selectivity to the transducer. Enzymes were chosen as a recognition 
element because of their high substrate specificity. 
d. Transduction  
Transduction is the conversion of enzyme turnover into a measured response. Biosensors 
can be divided in three categories:  
a) First generation of biosensors, the natural product of the reaction causes the electrical 
response due to its diffusion to the electrode. With glucose oxidase for example, the 
substrate is oxidised by the reaction with the enzyme in presence of oxygen, and this is 
reduced to H2O2. This is a cyclic process and requires a continuous supply of oxygen. The 
Clark electrode is an example of a 1st generation biosensor. It was used to detect the levels 
of oxygen [197]. The main problem with these biosensors is the detection of oxidisable 
interference species, such as ascorbic acid, due to the high potential required for H2O2 
oxidation.  
b) Second generation of biosensors, a synthetic mediator is chosen to carry the electrons 
from the enzyme to the electrode surface [198]. The mediator is chosen to have fast 
electrochemistry, a common use mediator is ferrocene monocarboxylate (Fc) that carries 
electrons from the substrate oxidase enzyme to the electrode. Such a biosensor avoids 
oxygen interference. This is the basis of the Abbott Industries blood glucose sensor that 
has 70% of the European diabetic testing market [199]. 
c) Third generation of biosensors measure the signal by direct oxidation/reduction of the 
enzyme. This method allows the minimization of interference by other substance. It also 
allows the lowest potentials to be used. However, it is usually restricted to small redox 
proteins or small enzymes such as HRP. Ferri et al. investigated the direct (unmediated) 
electrochemistry of HRP [200]. 
To make a flow through biosensor a two part biosensor was chosen to avoid interference 
from ascorbic acid. The substrate oxidase enzyme (SOx) recognises the analyte, it could be 
regenerated using Fc(III) [198], however, as Fc(III) is not stable enough to store in a flow 
buffer, the SOx is allowed to reduce oxygen into hydrogen peroxide. A second enzyme, 
Horseradish Peroxidase (HRP), selectively reacts with H2O2. Ferrocene (II) is used as a 
mediator to reduce the HRP enzyme [201]. The ferrocene (III) is reduced at a low potential. 
By applying a low voltage at the electrode the interfering reactions are reduced significantly, 
and background currents and noise levels are minimised.  
The two enzymes are trapped (chapter 2, section 2.5) inside an enzyme reactor (chapter 2, 
section 2.2.3). The substrate enters the reactors and the reaction to the products occurs as 
shown in figure 1.11. 
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Figure 1.11: Modified second generation biosensor using peroxidase.  
The substrate is oxidised when meets the first enzyme (SOx) and in the presence of oxygen, peroxidase is 
obtained. This is reduced by the second enzyme (HRP), which simultaneously oxidise the mediator (Fc). The 
reduction of Fc takes place on the surface of the electrode. 
The transduction in this system is formed by an electrochemical sensor, that measures, at 
constant potential, the current due to the electrons produced as a result of the enzyme 
turnover. These detectors are formed of 3 electrodes, working, reference and auxiliary 
electrodes.  
1.7 Microdialysis Calibration: Recovery 
Analytical chemistry techniques are mainly quantitative methods, thus a proper calibration 
method for each technique is of major importance to obtain a reliable measurement. 
Calibration of the microdialysis probe and the parameters that affect this calibration are 
essential for a better understanding of this technique.  
The recovery (R) of the probe affects the concentration of the outlet in microdialysis with 
respect of the concentration in the sample. Originally recovery was defined as the ratio 
between the concentration of the analyte in the dialysate (outlet) and the concentration of 
the analyte in the tissue extracellular fluid [202]. 
The diffusion coefficient, the temperature, the membrane area, geometry and weight cut-off, 
substance concentration and interaction, composition of the perfusion fluid, the time and the 
perfusion flow rate are factors that affect the recovery of the probe.   
1.7.1 In vitro Recovery 
In vitro recovery was the first method of microdialysis calibration used to compare the 
concentration of the outlet with the concentration of the tissue. The assumption made was 
that mass transfer resistance was bigger through the membrane than through the tissue 
[202]. 
In vitro recovery can be measured by placing the probe into a standard solution of the 
analyte. The percentage of substance that is diffused through the probe and therefore 
analysed is the relative recovery (R), a percentage of the real concentration.  
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€ 
Rinvitro =
Cout
Cm
                            (1.1) 
Cout is the substance concentration in the outflow and Cm is the substance concentration in 
the medium [175], [203].  
When discussing recovery two calculations can be done, relative recovery (R), as shown 
previously in equation 1.1 or absolute recovery. This is the number of moles per unit of time 
removed from the tissue and can be calculates as: 
€ 
AbsoluteR(%) = FlowRate×Cout                             (1.2) 
The in vitro recovery is constant for a given flow rate, temperature and probe type. 
Assuming that temperature and probe effects are constant, the variable that can be 
controlled to obtained a greater recovery is the flow rate. 
These two variables are compared in figure 1.12 with the data measured for glucose 
recovery (see chapter 3). 
Figure 1.12:  Scheme for relative and absolute recovery graph. 
Relative recovery (purple) decreases when flow rate increases while absolute recovery (orange) increases with 
increases of flow rate. Data taken from in vitro experiments.  
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1.7.2 In vivo Recovery 
In vivo the picture is further complicated. The recovery of the membrane might vary 
depending of the tissue where it is implanted. In moving from the brain to the gut an 
important variable is blood flow. It is known that the blood flow varies in each tissue, for 
example in the brain is 40 ml/100 g/min [204] while in the gut varies along the alimentary 
canal and increases with the activity, in the submucosa it is 20 ml/100 g/min at rest, in the 
longitudinal muscle it is 5 ml/100 g/min and the lymphatics it is 1 ml/100 g/min [205].  
Calibration and in vivo quantification methods of microdialysis data monitoring have always 
raised controversy. In vivo recovery depends on active effects, such as active uptake and 
release processes, and passive effects, such as excluded volume and tortuous diffusion 
path [206]. 
 
 
Figure 1.13:  Sketch of the diffusion path of the substances to the microdialysis probe.  
a) Tortuous path of the substances around the cells. b) Volume taken by the cells creates an excluded space for 
the substances.  
The cells present an obstacle for the substances that must diffuse along a tortuous path 
around them, and at the same time the volume taken by the cells does not contribute 
diffusing molecules. In addition, the effect of these two processes is to reduce the effective 
diffusion coefficient in vivo. Consequently, in vivo concentration gradients are not across 
the membrane (as in the ideal in vitro case, figure 1.14a) but across the tissue (Figure 
1.14b). The recovery in vivo is then lower than in vitro because the substances supplied to 
the probe are limited by the transport across the tissue. It is for this reason that the 
membrane material is not important and the in vivo recovery, unlike the in vitro, is not 
constant for a particular probe but dependent on the extracellular volume of the tissue.  
Finally if the molecule is actively removed from the ECF by uptake of enzymatic 
degradation, this has the effect of stepping the concentration gradient in vivo (Figure 1.14c) 
[207]. 
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Figure 1.14: Schematic profile of concentration diffused from solution/tissue to microdialysis probe. 
a) In vitro. b) In vivo for an exogenous compound, passively distributed. c) In vivo for an endogenous compound 
which is supplied, uptaken and metabolised by the tissue. Increasing steepness in the curves represents an 
increase by a factor of ten in the tissue handling rates [206]. 
Measurements of In-vivo Recovery  
As the in vitro performance at a probe simply gives an upper limit on the in vivo recovery, 
methods to measure recovery in vivo are required. 
No-Net Flux Method (NNF) 
The no-net flux (NNF) or zero-net flux (ZNF) in vivo calibration method involves perfusing 
the analyte of interest at different concentration (CIN) and measured them at the outlet of the 
probe (COUT) [208], [209]. Perfusion concentrations are chosen to match the expected 
concentration of the analyte in vivo (CEXT). The relation is expressed in equation 1.3.  
€ 
Cin −Cout = E Cin −Cext( ) (1.3)  
Where E is the extraction efficiency, a measure of the capability of the tissue to collect 
material from the probe. [206] A plot of CIN - COUT versus CIN produces a straight line (Figure 
1.15). The point of NNF across the membrane is the x intercept where CIN = COUT. The 
desire CEXT can be determine from this point because from equation 1.3, when CIN - COUT = 
0, then CIN = CEXT.  
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Figure 1.15: Scheme for the No-Net-Flux method. 
At lower concentrations than of that correspondent to the ECF, greater concentration diffuse from the tissue and 
at higher concentrations than of that correspondent to the ECF, lower concentration diffuse to the tissue. 
Concentration matching the ECF the point is where the line crosses with zero. Modified from [206]. 
The NNF method presents some complications that have been studied extensively in the 
literature. The contribution of error by the non-linearity effects of the tissue has been 
revoked by Chen et al.ʼs theoretical analysis, where it was shown that CEXT determined by 
NNF method is insensitive to non-linearity uptake or release [210]. However, a major 
obstacle in the NNF method is the assumption that R, the ability of the probe to collect from 
the extracellular space and E, the ability of the probe to deliver to the extracellular space, 
are the same. The method implies that COUT/CEXT = E when CIN = 0 and then covering E 
equivalent to R. 
Hence equation 1.3 should properly be written as:  
€ 
Cin −Cout = E Cin −
R
E
 
 
 
 
 
 Cext
 
 
 
 
 
  (1.4) 
Thus, from the equation above, CEXT cannot be estimated without knowing R and E [211], 
[212], [213]. 
Several studies combining microdialysis with fast scan cyclic voltammetry (FSCV) provided 
evidence that E and R differs. When uptake was inhibited E and R moved in opposite 
directions in the proximity of the probe [211]. However, other analysis demonstrated that R 
decreased with uptake inhibition, similar to E [214]. 
Theoretical studies concluded that the concentration estimated by NNF method is not 
affected by the difference between R and E, since this is not related to the presence of 
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isolated sites of release [215], [216]. However, if the tissue has been damaged by the probe 
implantation, the release of the layer around the probe would be impaired relative to the 
uptake, and then R and E would differ [216]. This would cause complication when 
measuring compounds with fast uptake rate, such as dopamine. It would be difficult to 
diffuse through the uptake region when released into the damaged area and therefore it 
would not be collected by the probe. This would result in low concentrations of dopamine in 
the dialysate. Monitoring glucose and lactate does not present such an impediment, as their 
diffusion lengths are longer, therefore we considered R=E to calculate CEXT. This has been 
tested by the measurements of brain glucose by No Net Flux method and microdialysis 
[217] and with biosensors [218]. Hence R = E in healthy tissue for glucose and lactate.  
Variable Flow Rate Method 
In this method the flow is varied and the concentration of analyte in the dialysate measured. 
The fundamental theory of this method postulates that when the probe has no flow or very 
little flow, the internal concentration will equilibrate with the extracellular concentration. 
Because of this, variable-flow-rate method uses low flow rates, where recovery increases 
when flow rate decreases, obtaining the condition where recovery is closed to 100%, such 
that Cout = Cext [219].  
€ 
Cout =Cext − Cext exp −
k0A
F
 
 
 
 
 
 
 
 
 
 
 
  (1.5)  
where, K0 = average mass transfer, A = area of the probe, F = flow rate [220].  
CECF can be obtained varying the flow rate through the microdialysis probe and performing 
a non-linear regression of the data. 
  
Figure 1.16: Scheme for the low flow rate method. 
At low flow rates the concentration of the dialysate resembles the concentration of the ECF and the 
extrapolation of the curve provides this measure. Data taken from in vivo monitoring in a patient in ICU in 
chapter 6. An extra value at low flow rates is added to show the effect at this flow rate.  
8
6
4
2
0
[G
lu
c
o
s
e
] 
/
 m
M
43210
Flow Rate (µl/min)
C
o
n
c
e
n
tr
a
ti
o
n
 /
 m
M
 Extrapolation 
CECF 
Chapter 1: Introduction 
 52 
Low flow rates values are important here since the extrapolation of the curve at zero flow 
rates would indicate the concentration of the ECF. When the flow rates are high, the 
extrapolation of the same curve would not be indicative of the extracellular concentration 
since the curve would rise to infinite values. However, very low flow methods suffer greatly 
from inaccuracy of collecting low volumes (nl) over hours and flow losses through the 
membrane due to slight osmotic differences [221]. 
1.8 Outline of Thesis 
This thesis describes the set up and adaptation of a novel on-line biosensor system for 
monitoring patients in vivo during gastrointestinal surgery and in an intensive care unit.  
Chapter 2 illustrates all the instrumentation necessary to build the FIA system, the 
specifications and methodology for its use in the lab and in a clinical environment.  
Chapter 3 describes the studies and modifications performed in the system for its 
adaptation to the gastrointestinal area. Clinical applications and experimental uses are 
exemplified in chapter 4, 5 and 6. 
Chapter 4 shows the use of the on-line assay system in the operative theatre of St. Maryʼs 
Hospital, Imperial College London in collaboration with Prof. George Hanna and Prof. Ara 
Darzi. This was used to monitor patients during bowel surgery and to observe the changes 
in metabolism when the specimen presented a partial or total deficit of blood supply. 
Chapter 5 applies the system experimentally in the surgical labs of the company Tyco 
Healthcare (now Covidien) in Elancourt, Paris. The entire system was shipped and 
constructed again there, and three days of single monitoring were carried out to understand 
the metabolism associated with ischaemia in the anastomosis constructed in the bowel of 
experimental models. 
Chapter 6 describes the application of the system in intensive care unit at St. Maryʼs 
Hospital, monitoring patients post-operatively for 48 hours after an aorta aneurism artery 
repair surgery. This permits us to study the metabolism of the tissue that is been perfused 
through collateral flow. 
Chapter 7 concludes the thesis and suggests future work.  
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Chapter 2: 
Common Materials and Methods 
 
 
 
A new variant of the rapid sampling on-line microdialysis system was developed for use in 
gastrointestinal surgery.  
The equipment and hardware are outlined first, summarising the instrumentation needed for 
the construction of the assay system. The disposition of each instrument on a clinical trolley 
is exposed to give a better understanding of the structure.  
The preparation of the buffer, the standards and any other solution required as well as the 
enzyme reactors are outlined here along with the experimental protocol. The clinical set up 
needed for the research and the necessary precaution are also described here. For 
example, the variations caused to the microdialysis probe to apply it on-line during surgical 
procedures. Finally the data analysis method is portrayed along with the presentation of 
data and the statistics used. 
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2.1 Introduction 
The rapid sampling microdialysis system consists of several techniques, which combine 
together, produce our biosensor assay, capable to detect ischaemia on-line.  
 
 
Figure 2.1: Biosensor assay system scheme. 
The microdialysis pump with the probe is attached to the tissue and connected to the valve. From here two 
reactors holding the enzymes are coupled to radial flow cell electrodes, which are electronically connected to 
potentiostats and powerlab. These are controlled by computer program and an external buffer is also pumped 
through the system. 
Figure 2.1 illustrates schematically the components of the assay system. A microdialysis 
pump, which perfuses a saline solution through the microdialysis probe, is attached to the 
tissue of study. The outlet of this microdialysis probe is then connected to a valve that 
alternately switches, injecting the dialysate to both reactors connected on each side, where 
the reaction occurs. The reactors are coupled to radial flow cell electrodes, formed of 3 
electrodes, working, reference and auxiliary electrode, following the principle of 
amperometry, hence, the electrical current is proportional to the concentration of analyte. 
These are held at a constant potential via the potentiostats and a powerlab that are 
controlled by the computer software. An external Ferrocene buffer is also pumped through 
the system, which contains the mediator molecule for transduction to occur (Chapter 1, 
section 1.6).  
Once the biochemical reaction occurs in the reactors, the electrochemistry takes place on 
the electrodes producing a peak-shape electrical current, proportional to the analyte 
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concentration, displayed on the computer screen. Overall we have the conversion of the 
concentration of substrate into a current in a specific biochemical reaction [222]. 
Each of these devices and solution are described more extensively through this chapter. 
2.2 Equipment 
This section describes all the equipment and hardware necessary to assemble the on-line 
system. 
2.2.1 Microdialysis system 
In the procedure, microdialysis is used as an extraction technique to sample the ECF from 
the tissue of interest. The metabolites of interest are exchanged from the tissue sampled to 
the saline through a High Performance Clinical Microdialysis Probe (CMA 62, CMA 
microdialysis, Stockholm, Sweden) with 20 kDa cut-off, outer diameter of 0.6 mm and 
length of 3 cm, for use in human. For animal models a Microdialysis probe MAB 7.11 
(Royem Scientific Limited, Bedfordshire, UK) with 15 kDa cut-off, outer diameter of 0.6 mm 
and 1 cm length were used. The implantation of the probe was done in the seromuscular 
layer of the bowel (Figure 2.2), between the serosa and the muscularis, tunnelled by hand 
by the clinician, using an 18-gauge catheter (Abbott Laboratories, Il, USA). The fixation of 
the probe became the focus of study due to several failures. Clinical probes are perfused 
using a CMA 400 microdialysis syringe pump (CMA/Microdialysis, Stockholm, Sweden). 
Using Hamilton Syringes (Hamilton, GR, Switzerland) with needles (22 gauge, 0.75 inches, 
Hamilton, GR, Switzerland). 
 
Figure 2.2: Placement of the Microdialysis probe in the intestine layer. 
The probe was tunnelled between the serosa and the muscle layer. Picture modified with consent from [19]. 
Probe location is verified during implatation by visual inspection of the surgeon. After 
implatation verification depends on the procedure: 
• Patient Surgery - Post-operatively: the clinician visually inspects the probe site to 
observe any perforation or damage and following the removal of the probe, the 
position of the implatation tunelling is verified. 
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• Animal Surgery: during the entire procedure the clinician can visually inspect and 
verify the probe implantation site. 
• Patient Intensive Care: unfortunately, there are not means for inspection of the 
probe site after implantation during intensive care treatment. An MRi scan could 
locate the probe using the gold marker in the probe tip. However, a scan was not 
routinely performed on this patient group. 
2.2.2 HPLC Pump 
The assay system uses a ferrocene buffer that accelerates the dialysate fluid coming from 
the microdialysis outlet through the valve into the enzymes reactors. In order to pump this 
buffer an HPLC pump (Flux Instruments, Rheos 2000, Reinach BL Switzerland) is used. A 
transparent PEEKTM tubing (Thames Restek, Buckinghamshire, UK) 1/8” external diameter 
is connected from the pump to a solvent filter, working on the principle of capillary, in the 
bottle. The bottle, being of specific shape, (Anachem Ltd, Bedfordshire, UK) encloses a lid 
with perforations to hold the filter with the tubing in. The connections between the valve and 
the pump are green PEEKTM tubing (Anachem Ltd, Bedfordshire, UK) 0.030 inch internal 
diameter and 1/16 inch external diameter, and 0.007 inch internal diameter yellow and 
0.005 inch internal diameter red PEEKTM tubing for the connections between the valve and 
the reactors and between the reactor and the electrodes, respectively, to reduce the dead 
volume. Fittings are Sealtight TM (Upchurch Scientific, WA, USA). 
The green tubing coming from the pump is divided in two streams before entering the valve. 
This is been usually a normal t-shape connector (Thames Restek, Buckinghamshire, UK). 
However, for this new assay system, Valco retailers provided us with a custom adjustable 
connector, previously discussed with them. This also consists of a t-shape union with flat 
bottom ports and flangeless fittings for a tight seal. The nut with a T (see figure 2.3) turns to 
right or left, leading the flow to the side that is turned and blocking the flow in the other 
direction. 
 
Figure 2.3: New T-connector from Valco.  
The connector splits the flow coming from the black ferrule to the green one on the left and the blue one on the 
right. Turning the nut with the T permit us to lead the flow stream to each side without disassembling the 
connections.  
This new connector will result in a highly helpful tool in the construction of the reactors (see 
section 2.5). 
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2.2.3 Faraday Box 
The Faraday box holds the valve connected to each enzyme reactors that then are coupled 
to the electrodes.  
Box 
The box (RS, Northans, UK) needed to be custom modified to place the injection valve, the 
enzyme reactors and the radial flow cell electrodes in one compartment and the motor and 
the automatic system of the valve in another. It was then ordered and delivered to a 
mechanic workshop at Kingʼs College Hospital.  
 
 
Figure 2.4: The Faraday Box. 
The valve, the reactors and the flow cell electrodes connected to the potentiostats are visible when the lid is 
open, while the motor of the valve is hidden behind. 
The lid that covers the box can be open showing only the valve and the reactors 
compartment. The box provides an excellent isolation as well as a perfect place to keep the 
electronics in order. 
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Injection Valve 
The dialysate liquid collected from the ECF is carried through a FEP tube (1.2 µl/10 cm, 
Thames-Restek, Buckinghamshire, UK) attached to the outlet of the probe and to a needle 
(22 gauge, 0.75 inches, Hamilton, GR, Switzerland) at the other end. This needle is 
connected into the port of a custom valve made for us by Valco Instruments (Schenkon, 
Switzerland USA) with a 0.2 µl dual internal loop (Figure 2.4). Standards for the calibration 
are injected also into the valve manually using a 1 ml Hamilton Syringe (Hamilton, GR, 
Switzerland).  
 
Figure 2.5: Injection Valve Scheme. 
The valve has two injecting positions, the dialysate is connected to the loading port, the valve then switches to 
direct the flow to the lactate reactor (left), returning to reload position to then inject to the glucose reactor (right). 
The custom valve consisted of 6 ports valve, one port where the collection of the dialysate 
is directed, with its respective waste. Two others are the inlets of the external buffer and the 
two remaining ports are the outlets to each respective reactor.  
Enzyme Reactors 
The reactors are used to hold a 6 mm disc membranes where the enzyme has been 
previously loaded.  
 
Figure 2.6: Reactor for the enzymatic recognition. 
The enzymatic reactors are made from in-line biocompatible filter components. It consists of a steel body and 
two end fittings where the enzyme membranes will be held. The arrow of the body helps orientating the reactor 
in the direction of the flow. 
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These are built from novel in-line biocompatible filters components (Anachem Ltd, 
Bedfordshire, UK) that consisted of three sections, a stainless steel body and two end 
fittings made of 100% PEEKTM. The reactors are settled between the valve, through which 
the sample is injected alternatively, and each respective electrode where the detection 
occurs. 
2.2.4 Radial Flow Cell 
The electrodes named above are two radial flow cells (BAS, IN, USA) one for glucose and 
one for lactate. These radial flow cells consist of a stainless steel jet auxiliary electrode 
through which the flow from the valve passes. It then hits the glassy carbon working 
electrode, embedded in the other part of the radial flow cell. The reference electrode 
Ag/AgCl covers a small area beside the 3 mm glassy carbon electrode of the flow cell. The 
working electrode is separated (16 µm) from the auxiliary electrode by a thin Teflon gasket. 
 
Figure 2.7: Radial flow cell electrode. 
The auxiliary electrode is the stainless steel jet, the working electrode can be seen in the other part as a 3 mm 
glassy carbon area and the reference electrode is the Ag/AgCl dot next to the working electrode. 
Working electrode 
The working electrode is positioned opposite to the auxiliary electrode and separated by a 
gasket a distance of 16 µm. 
 
Figure 2.8: Schematic radial flow cell gap between auxiliary and working electrodes. 
The possibility that a molecule of ferrocene that is oxidised on the working electrode, diffused to the auxiliary 
electrode and reduced there to then be oxidised again on the working electrode is depicted. 
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Hence, there is a possibility that a molecule of ferrocene (Fc), oxidised on the working 
electrode (Fc+), diffuses to the auxiliary electrode where it is reduced (Fc) and oxidised 
again on the working electrode.  
The velocity performance of the radial flow cell is calculated by Bohs et al. [223] as 
indicated in table 2.1. 
 
Electrode 
diameter  
(mm) 
Active volume 
above           
electrode (nl) 
(16µm gasket) 
Linear velocity 
(cm/sec)         
16µm Gasket        
10 µl/min 
Linear velocity 
(cm/sec)          
16µm Gasket           
100 µl/min 
Linear velocity 
(cm/sec)       
16µm Gasket 
1000 µl/min 
1 12.38 0.331 3.31 33.1 
2 50.27 0.165 1.65 16.5 
3 113.09 0.110 1.10 11.0 
Table 2.1: Linear velocities for the radial flow cell electrode of different diameters. 
The linear velocities of the radial flow cell were calculated at different flow rate over electrodes of different 
diameters [223]. 
Hence, at 100 µl/min, the typical flow rate used in the assay, the linear velocity at different 
distance from the jet can be observed in figure 2.9. 
 
Figure 2.9: Linear velocities at different distance from the jet centre at 100 µl/min. 
The different distance from the jet centre is related to the electrode diameter. The longer is the distance from 
the jet, the lower is the linear velocity of the flow cell. 
When fluid flows on the electrode, from a distance of 2 mm to 3 mm at 100 µl/min, the linear 
velocity is: ((1.65 + 1.1) / 2)) = 1.37 cm s-1 and the time needed to travel this distance (0.1 
cm) is 72.9 milliseconds.  
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The distance that a molecule diffuses in 1D is approximately given by: 
€ 
d = 2Dt  (2.1) 
d = distance travelled (cm); D = diffusion coefficient (cm2/s) for ferrocene species ≈ 7.7 x 
10-5 cm2/s [224]; t = time  
Hence in 72.9 milliseconds a ferrocene molecule will travel by diffusion 26.7 µm eliminating 
the possibility of a molecule travelling to the auxiliary electrode and back (32 µm) to the 
working electrode. 
Bohs et al. described the unijet detector as thin-layer cell with radial flow pattern over the 
working electrode, differing this from the original design of wall jet electrode [223]. 
 
Figure 2.10: Geometries of different electrodes. 
a) Wall-jet electrode, the jet is opposed to the electrode, the flow hits the electrode directing the flux in the 
opposite direction, b) thin-layer flow cell electrode, the flow is parallel to the electrode, c) radial flow cell 
electrode, the flow is opposite to the electrode, however, the electrode is found confined between walls, hence 
the flux cannot revert, and follows a linear flow like the thin-layer. 
The limiting current for the thin layer flow cell and the wall jet electrode are expressed in 
table 2.2. 
 
Thin Layer Flow Cell [225] Wall jet Electrode [226] 
€ 
Ilim =1.467nFAC∞
D
h
 
 
 
 
 
 
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3 Uv
d
 
 
 
 
 
 
1
3  
€ 
Ilim =1.59nFC∞D
2
3ν
−
5
12a−
1
2r
3
4U
3
4  
n=number electrons equivalents/mol n=number electrons equivalents/mol 
F=Faraday constant F=Faraday constant 
C∞=concentration of reactant in the bulk 
eluent (mol/cm3) 
C∞=concentration of reactant in the bulk 
eluent (mol/cm3) 
D=diffusion coefficient (cm2/s) D=diffusion coefficient (cm2/s) 
A=area of the electrode (cm2/s) a=distance between nozzle and 
substrate 
h=thickness of channel r=jet nozzle radius 
d=width of channel ν=kinematic viscosity 
U=volume flow rate (cm3/s) U=volume flow rate (cm3/s) 
Table 2.2: Limiting current for thin layer flow cell and walljet electrode. 
Limiting current equation for thin layer flow cell and wall jet electrode are displayed with their constants. 
A B C
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Since the geometry and the mathematics of the thin-layer radial flow cell are between the 
wall jet electrode and the thin-layer cell, and significantly complicated, the limiting current is 
not theoretically calculated. However, the radial flow pattern compared with the cross 
pattern confers a higher sensitivity to the detector. The experiments carried out by Bohs et 
al. showed this important increase of signal detection, a signal of 2 nA of noradrenaline with 
the cross flow cell gives a signal of 7.5 nA with the radial flow cell and in the case of 
dopamine the signal increases from 1 nA to 3 nA [223]. 
Reference Electrode 
The radial flow cell encloses a chloridised Ag wire in direct contact with the buffer to 
minimize dead volume. 
 “The UniJet reference electrode is a pseudo-Ag/AgCl reference electrode. The reference 
electrode potential is determined by the quantity of Cl– in the mobile phase. The higher the 
Cl– concentration, the closer the reference will become to a standard Ag/AgCl. We 
recommend using 10 mM NaCl in any mobile phase to increase the stability of the 
reference electrode and prevent alterations in the potential. The UniJet reference electrode 
is about 100 mV more positive than the standard RE-4 Ag/AgCl reference electrode. Thus, 
the potential set on the detector should be 100 mV less than was used with an RE-4” [227]. 
We became concerned that this adjustment was not correct. The stability of the pseudo 
Ag/AgCl reference potential was confirmed as shown below. 
For the half cell: 
€ 
AgCl(s) + e− ↔ Ag(s) + Cl−   (2.2) 
The potential is given by the Nerst equation: 
€ 
E =  E oAg/AgCl + 2.303RTF log
1
aCl −
 
 
  
 
 
   (2.3)                                                                   
Where a is the activity of the species,  
€ 
a = γ± C[ ]   (2.4) 
γ± is the activity coefficient of ion species; [c] is concentration of species  
For dilute solutions the Debye-Hückel limiting law can be used and γ, the activity coefficient, 
can be calculated as (Appendix I):  
€ 
log γ±( ) = −Az±2 I  (2.5) 
z± is the charge number of ion species; A is a constant that depends on the solvent, for 
water at 25°C, A ≅ 0.5; I is the ionic strength of the solution and can be calculated as, 
€ 
I = 12 cii
∑ zi  (2.6) 
Chapter 2: Common Materials and Methods 
 63 
For concentrated solutions the relationship is more complex and the activity coefficient (γ) 
has been determined by measurement. The activity coefficient of the NaCl as a single 
electrolyte at 3 M is 0.714 [228]. The Ag/AgCl electrode presents an electrode potential of 
0.22 V versus standard hydrogen electrode (SHE). Following the previous equations we 
can calculate the potential adjustment needed for different concentration of NaCl dissolved 
in the buffer that runs through our reference electrode as shown in the following scheme. 
 
 
Figure 2.11: Potential variation for the Ag/AgCl reference electrode with NaCl. 
Potential changes following the Nernst equation dependent on the activity of the electrolytes. Different 
concentrations of electrolyte are considered to measure the variation of potential. At 3 M of NaCl the potential 
decreases by 19.2 mV, at 150 mM it increases by 59.2 mV and at 10 mM by 119.3 mV. 
The potential to which the electrodes have been held is -100 mV for buffer containing 10 
mM of NaCl and 0 V for buffers containing 150 mM of NaCl (see chapter 3, section 3.6). A 
cyclic voltammetry (CV) of ferrocene was run to ensure we are in the diffusion limited 
potential range. The ferrocene buffer containing 150 mM of NaCl was set at a flow rate of 
100 µl/min through the radial flow cell electrode and CV was performed at scan rates of 5 
mV/s.  
Cyclic voltammetry of the ferrocene through a radial flow cell electrode with salinity 
concentration of 150 mM shows that at potential of 0 V we are in a safe zone, where there 
is mass transfer limiting current (figure 2.12). By analogy, at 10 mM of salinity, the curve will 
be switched +60 mV, hence at potential of -100 mV were are still in a safe zone.  
E°H2=0 
E°Ag/AgCl=0.22V 
150mM NaCl 10mM NaCl 3M NaCl 
-19.2mV 
+59.2mV 
+119.3mV 
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Figure 2.12: Cyclic voltammetry of Ferrocene. 
Ferrocene buffer containing 150 mM of NaCl was set at a flow rate of 100 µl/min through the radial flow cell 
electrode and CV performed at scan rates of 5 mV/s. 
2.2.5 Hardware/Software 
The reference, auxiliary and working electrodes are connected via electrical pin color coded 
wires to their correspondent clips on the potentiostat. Two potentiostats (ADInstruments, 
E.Sussex, UK) are used to control the flow cell electrodes. A Powerlab 8/SP A/D converter 
(ADInstruments, E.Sussex, UK), running ChartTM 5.5.6 software (ADInstruments) on an 
Apple computer (G4 powerbook) is used to display the data, control the valve switching and 
record comments. The computer also ran Virtual PC Windows 2000 Microsoft to control the 
HPLC pump with the software Janeiro™ via a Keyspan fast USB to serial adaptor. 
2.2.6 Clinical Trolley 
Due to the clinical nature of the research, patient monitoring was done in the surgical 
theatre and the intensive care unit, while the preparation of the microdialysis assay was in 
the lab. A clinical trolley was ordered in order to have a mobile unit from lab to clinical point 
of care. The clinical trolley (CTL medical, Essex, UK) was custom made to our 
requirements and to satisfy EU electrical safety regulations protocol for clinical equipment.  
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The modifications were the following:  
• Static free wheel of sufficient sizes to allow an easy transport.  
• Isolation transformer under the regulation of CE in accordance with the low voltage 
directive.  
• Safety plugs at the back of the trolley. 
• Uninterruptible power supply (UPS, apc, Berkshire, UK) to avoid system failure in 
case of interruption of the power. 
2.3 Set up 
All the equipment listed above were installed on the clinical trolley and connected. 
The microdialysis pump was placed on the bench of the trolley, near the bottles containing 
the buffer, the waste and the rinsing solutions in order to clean the system. This location for 
the microdialysis pump was key for its proximity to the patient and the box. 
The HPLC pump and the UPS were installed on the lower shelf, being both the heaviest 
instruments. The solvent from the bottles above travels down the transparent PEEK tubing 
named before by capillarity to the pump. Before use, all the tubes and the pump had to be 
purged to avoid air in the connections, and solvent had to be pumped through the pulse 
dampener. Once the pump was purged and all the connections attached then the green 
PEEK tubing was connected to the T-union custom made for us by Valco (Schenkon, 
Switzerland). This splits the flow into two streams that are then connected to the two inlet 
ports of the valve. 
The valve was fixed onto the faraday box and connected to two unions (Thames Restek, 
Buckinghamshire, UK) by specific HPLC nuts and ferrules that produce a good seal. These 
fittings were attached to the PEEK tubing, of smaller volume (yellow coding) that connects 
the union to each side port of the valve, where the reactors will be placed. The reactors 
were connected the same way to the radial flow cell through even smaller PEEK tubing (red 
coding). From the cells the flow is directed to the waste through the outlet tubing and the 
three electrodes connected to the potentiostats. 
The box was mounted onto an arm fixed in the trolley. The arm can be extended and lifted 
conferring a functional flexibility to the system. This is advantageous to keep the detection 
point close to the patient while the electronics are more distant. Moreover, it provides an 
excellent approach to ground the box.  
A laptop (powerbook, Mac) was used to control the powerlab, connected to the 
potentiostats, by the software program Chart TM provided by its ADInstruments hardware.  
To avoid having to unplug the entire system when transporting it, everything was plugged to 
the back sockets that are plugged to the UPS. Therefore, just one plug of the trolley needs 
to be connected to the mains supply.  
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Once mounted and checked, the system was transported to the lab of the Gastrointestinal 
Research Unit in St. Maryʼs Hospital, Paddington. 
 
 
Figure 2.13: On-line rapid sampling microdialysis system. 
All the components of the assay system were placed on a clinical trolley. The HPLC pump and the UPS on the 
bottom shelf, the valve and electrodes in the Faraday box, in the arm. The potentiostats and powerlab were 
placed below the computer and the CMA pump on top of the trolley next to the solvents and buffer. 
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In order to gain experience and confidence several lab experiments were done before trying 
in the operation theatre. Some in vitro experiments were also carried out and the electrical 
unit of the hospital checked the safety of the equipment. Once the ethics committee of the 
hospital approved the protocol, the system was declared ready for a whole set of in vivo 
experiments. 
2.4 Common Solutions and Standards  
In order to run the system, different buffers and solutions were necessary. A specific buffer 
was used to run the assay, the analytes were diffused to a particular saline solution through 
the microdialysis probe and the calibration of the system was carried out with several 
different standards.  
2.4.1 Solutions 
The solutions used in the system and their preparations are described below. 
Ferrocene Buffer 
In order to provide the right environment, biochemically and electrochemically, in the FIA 
assay systems, a ferrocene buffer was normally used. The solution needed to be fresh to 
avoid contamination, therefore 1 litre of ferrocene buffer solution was prepared frequently 
(at least weekly) and kept in the fridge between experiments. 
Sodium citrate (0.1 M, grade 99%, Sigma, Dorset UK) confers the right pH, Ferrocene 
monocarboxilic acid (1.5 mM, Fluka, Dorset UK) is used as a mediator for the 
electrochemistry reaction on the electrode, EDTA (1 mM, Fluka, Dorset UK) as a metal ion 
scavenger and Sodium chloride (10 mM or 150 mM, BDH laboratory supplies, Poole UK) to 
provide conductivity. All these chemicals are dissolved in 1000 ml of ultra pure water (18.1 
MΩ/cm, Millipore) and continuously stirred. The solution is pH adjusted to pH 7.0 with 1 M 
hydrochloric acid. 5-Chloro-2-methyl-4-isothiazoline-3-one (500 µl Kathon CG, Rohms & 
Hass, UK via Chesham Chemicals) is added as an antibacterial agent. The solution is 
filtered with membrane filters (0.1 µm / 0.02 µm, 47 mm, Anodisc, Whatman International 
Ltd, Maidstone UK) to avoid blockage of all the tubing.  
The ferrocene buffer runs through all the system, flowing also by the flow cells. The cells 
include what is so-called ʻthermodynamicʼ reference electrode, the Ag/AgCl electrode, 
which is in direct contact with the flow stream. To overcome the failure of the reference 
electrode by the dissociation of the specie AgCl, the flow buffer needs at least 10 mM 
chloride.  
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Dialysate Solution 
In order to follow the basis of the microdialysis diffusion, a dialysate solution is required. 
This saline solution perfused by the micropump through the microdialysis probe consists of 
a physiological saline solution which contains the following ionic concentrations: Na+: 147 
mmol/l, K+: 4 mmol/l, Ca2+: 2.3 mmol/l, Cl-: 156 mmol/l (Perfusion fluid T1, CMA 
microdialysis, Stockholm, Sweden). When monitoring patients this commercially available 
solution is used, as the sterile conditions are required. However, when in vitro or animal 
experiments were carried out, the dialysate solution was prepared. 
2.4.2 Standards 
Calibration of the system is necessary to correlate the amperometric signal with the 
metabolic concentration, therefore standards at different concentrations are required. 
Mixed Glucose / Lactate Standards 
D-(+)-glucose (0.5 M, Sigma, Aristar grade) and L-(+)-Lactic acid (0.5 M, Sigma, Aristar 
grade) are prepared in ionic saline solution from the hospital to resemble the dialysate. The 
solution was kept in the fridge overnight to allow mutarotation of glucose. D-(+)-glucose has 
two anomeric forms, α and β. Glucose Oxidase is specifically selective to the β-anomer, 
then it is β-(+)-glucose that reacts actively with the enzyme, and hence mutarotation is 
necessary to obtain additional sensitive results (see chapter 3) [229].  
Different solutions of glucose and lactate were made by serial dilutions to get concentration 
from 10 mM to 50 µM in 10 ml clean and dry flasks. Aliquots of these standards were stored 
at –18˚C. 
2.5 Enzyme Membranes and Reactors Assembly. 
All enzymes were purchased from Genzyme General Diagnostics (Genzyme Ltd.,Kent, 
UK). 
 
Enzyme Glucose oxidase Lactate oxidase 
(Recombinant) 
HorseRadish 
Peroxidase 
Source Aspergillus Niger Aerococcus 
viridans 
Horseradish 
Cat. code GLOX-70-6451 RELO-70-1381 PERO-70-6915 
Activity 180 U/mg protein 20-60 U/mg protein 180 U/mg protein 
Weight used 1 mg 2 mg 0.5 mg 
Table 2.3: Description of the three enzymes used to construct the reactors. 
The biological source of the enzyme, the catalogue code, the activity and the amount loaded in the cellulose 
membrane are described. 
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Each enzyme was stored in weighted aliquotes in eppendorfs at -20ºC to avoid 
denaturation of the enzymes. These aliquots were carefully and individually dissolved in 1 
ml of ferrocene buffer and filtered several times through a 25 mm filter holder (Swinnex, 
Millipore UK) where a mixed cellulose esters membrane (0.025 µm pore, 25 mm, Millipore 
UK) was placed. A ring placed in the filter holder did the seal. If the seal is not properly 
done the holder leaks and the enzymes do not pass through the membrane. When the 
filtering is successful, the membrane turns to a slightly yellow or brown colour dependent on 
the colour of the enzyme itself, as shown in figure 2.14. Otherwise, the membrane appears 
colourless due to leaks through the filter holder. 
 
Figure 2.14: Membranes loaded with GOx, HRP and blank solution.  
The membrane loaded with blank (only buffer) solution (right) shows a wet surface differenced of the dry one 
where the external ring appears whiter. The HRP (middle) shows a brown colour, while the GOx (left) shows a 
yellow colour. The LOx (not shown) is a paler yellow that can be differenced with naked eyes but not in the 
photography. 
Due to intensive filtering, the enzymes are adsorbed onto each membrane by this process. 
Each enzyme was thus separately trapped onto a membrane. Several membranes of 6 mm 
of diameter can be punched with a hole puncher of the same diameter out of the original 
membrane of 25 mm. To prevent the membranes from drying, they were placed separately 
in buffer. Two cellulose membranes, one with substrate oxidase and the other with 
peroxidase, were sandwiched onto the reactor. SOx has to be the first disc on the direction 
of the flow to ensure the biochemical reaction [177]. The membranes have to be placed in 
the centre of the reactor to avoid their damage and blockage. Each enzyme membranes 
can be stored in buffer at 4ºC and be ready for use. As the flow is splitted in two streams, to 
present an equal course, the reactors need to present the same pressure. Hence each 
reactor was individually fixed controlling the pressure in the pump software, Janeiro™. The 
new T-connector (Figure 2.3) provides the ability of turning the total flow to each stream to 
check the pressure for each reactor. 
The specific biochemical reaction of the enzymes has an overall conversion of the 
concentration of substrate into a current. This current (observed as a peak shape) under 
potenstiostatic control is measured at the electrode and can be related to the kinetics of the 
enzyme reaction that will be further described in chapter 3. 
GOx HRP blank 
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2.6 Gastrointestinal Microdialysis Probe 
The gastrointestinal microdialysis catheter is a commercially available CMA 62 probe, 
which mainly consists of a dialysis probe (30 mm of length and 0.6 mm of diameter), 
through which the diffusion takes place. The shaft (length of 180 mm and diameter of 0.9 
mm) is a concentric tube. The inlet tube, with a 600 mm length and 1 mm of diameter, 
carries the ionic solution into the probe. The outlet tube (220 mm long and diameter 1 mm) 
carries the dialysate out of the probe. The microvial and vial holder are mainly used for 
collection of the dialysate when the monitoring occurs off-line. This dialysate is analysed 
typically between 30-60 minutes.  
For our purpose, on-line monitoring, these two pieces were not necessary. In fact we need 
to join the outlet of the probe to a 1.5 m length FEP tubing that will carry the dialysate to the 
valve of the system. To modify the probe the vial holder was cut, leaving only 1 mm of tube, 
which it was joined to the FEP tubing using a “trumpet” connector (Royem Scientific 
Limited, Bedfordshire, UK). The other end of the vial holder was trimmed to leave the small 
needle that connects to the microvial available to join to the outlet tube of the microdialysis 
probe. The vial holder after this transformation acquired the form of a bell, naming this 
connector “bell connector”. 
 
Figure 2.15: Modification of the microdialysis probe CMA 62 for use with the on-line system. 
The microdialysis probe inlet is connected via an extension set to a sterile clinical syringe. The outlet is 
connected with a ʻbell-shapeʼ connector to a ʻtrumpetʼ connector to attach it to the FEP extension tubing.  
1.5 m FEP tubing 
MD probe 
‘Bell’ connector 
‘Trumpet’ 
MD membrane 
Low volume set  
extension with clamp 
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An extension set with clamp (Alaris medical system, Hampshire, UK, 150 cm, 0.4 ml) was 
connected to the lock connection of the inlet tubing of the probe through one end and the 
other end to a sterile syringe containing the ionic saline solution. A FEP tubing extension 
was used in this case for the outlet tubing, the end of which is connected to the on-line 
system. The perfusion fluid was delivered at a rate range from 2 to 4 µl/min, depending on 
the tissue to monitor and the distance added by the FEP tubing from the tissue to the 
assay. For longer distance, the time of dialysate to reach the analyser will be longer, and 
therefore higher flow rates were necessary. However, other parameters, like microdialysis 
recovery are of importance. This will be clarified further in chapter 3.  
2.7 Data Analysis 
Subsequent to the monitoring, the analysis of the peaks is required in order to plot the 
graphs and present the data. When needed de-rippling and de-noise signal processing was 
executed. [230]  
For the analysis of the peaks, Chart TM, the software used for the recording was employed. 
For the analysis of the calibration data, peaks were selected manually using the ʻPeak 
Parametersʼ extension. The peak amplitude, width, area and baseline were determined and 
stored in the data pad. 
 
a)
 
b)
 
Figure 2.16: Peak Parameters window and data pad from Chart TM 5.5.6 for Mac. 
a) Peak parameters window. Different options can be selected in the preferences of this window, which are 
displayed here and can be stored for further analysis, b) snapshot of data storage. Each column has been 
selected with a specific parameter that is stored when the peak is selected. 
Once the peaks were measured, the data was transferred to Excel and the analysis was 
completed. In this case the construction of the calibration curve was required in order to 
then fit the current peak results and obtain the concentration for glucose and lactate.  
Peak Parameters of "A.N.1.12.06"
-0.4
0
0.4
0.8
1.2
1.6
11:33:13.2 11:33:28.2 11:33:43.2 11:33:58.2
B=-0.354 µA
Apeak=1.719 µA
W50%=5.187!s
Area=10.4002µA.s
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The figure 2.17 shows the raw data for a routine calibration. 
 
 
Figure 2.17: Concentration calibration raw data.  
The height of the peaks in current (µA), glucose (red) and lactate (green), is correlated to concentration. Each 
concentration is injected 3 times and mean ± stdev is obtained. 
The peaks from the concentration calibration were measured and a graph of current versus 
concentration was plotted. A best fit was then performed in the calibration graph and the 
correlation was obtained. 
 
Figure 2.18: Current versus concentration graph. 
A linear regression can be fitted in both glucose and lactate calibration curve facilitating the correlation between 
current and concentration in future analysis. 
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After the calibration was obtained the analysis of every peak was performed with the ʻFindʼ 
option from Chart TM, a semi-automatic option that selects the peaks. The peak amplitude, 
width, area and baseline were determined and were stored also in the data pad. 
The appearance of the raw data while the recording is happening is shown in figure 2.19.  
 
 
Figure 2.19: Chart TM 5.5.6 for Mac screen snapshot of data collection. 
The Chart TM program appears in the computer screen divided in two channels, one for glucose (red) and one 
for lactate (green). The left hand side of the screen shows peaks every 30 seconds for over a period of 1 hour, 
while the right hand side shows the peaks occurring at that precise moment. 
A snapshot of the screen while the assay is running was taken to show the typical 
appearance of the raw data. The screen for the Chart TM program is divided in two. The right 
side shows the peaks that are being monitored at that instance and the left side shows the 
entire recording; having a scroll bar to observe changes on time. 
The raw data is corrected for the lag time between dialysate leaving the probe and the 
peak-current measured. When the surgeon inserted the microdialysis probe a mark was 
noted at that time in the monitoring. When the first measurement was observed the time lag 
could be measured, being the time between the probe implantation and the first peak 
observed. This time lag could be extracted at the end of the monitoring from the entire data.  
Once the raw data was analysed, glucose and lactate dialysate levels could be plotted 
versus time axis. The time lag due to the outlet tube extension had to be taken into 
consideration to place the marked events at the right time. A representative example of 
analysed data is presented in figure 2.20. 
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Figure 2.20: Human monitoring processed data. 
The calculated concentration is plotted versus time for glucose (red) and lactate (green). The vertical dotted 
lines indicate the events performed by the surgeon.  
Following the basic data analysis to present the results in concentration units, a three data 
points moving average was applied to the traces. To produce overlay curves for similar 
events the concentration versus time traces were time aligned, with the relevant events, 
usually the initiation of ischaemia, defined as zero. The changes in glucose and lactate 
levels relative to the baseline concentration values at t = 0 were calculated.  
The prefered method of analysis was to calculate the baseline subtracted area under the 
curve (AUC) for each time aligned trace. This was achieved using excel by suming the 
concentration values over the required time and multiplying the result by the inter sample 
time intervals in seconds to give units of “mM min”. If required these traces were averaged. 
Statistical tests 
Area under the curve: when possible the area under the curve of each trace was calculated 
and one sample 2-tailed student t-test was performed comparing the area under the curve 
to the null hypothesis of AUC = 0. 
Individual values: on occasions single time points were averaged between patients and 
single population 2-tailed t-test was performed comparing the estimated mean to the null 
hypothesis that this was zero.  
For comparison of individual data points, the standard deviation (STDEV) is used. As is 
costumary in biomedical publications when the traces are averaged the data points are 
given by mean ± standard error mean (SEM) for a given n value. 
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Chapter 3: 
Adaptation of the System for 
Gastrointestinal Monitoring  
 
 
 
This chapter describes the adaptation of rapid sampling microdialysis method, previously 
developed for brain monitoring of patients with head trauma intra and post-operatively, for 
intramural monitoring of the human bowel. 
Bowel ischaemia has been previously monitored using the off-line analyser commercially 
available. As monitoring of ischemic bowel with the on-line system was a new microdialysis 
target, it was necessary to optimise the microdialysis probe and the on-line assay for the 
new conditions. 
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3.1 Introduction 
The reactors used in this research (chapter 1) consist of a modified second generation 
biosensor [198], which utilise enzymes as the element of biorecognition.  
Enzymes are catalysts of biological systems, most of them are proteins and have the 
extraordinary characteristic of determining the pattern of chemical transformations. The 
active site of the enzyme is the responsible for its catalytic power and specifity [231]. 
Two types of enzymes have been used to construct the reactors. The first enzyme is a 
substrate oxidase (SOx), glucose oxidase and lactate oxidase for each reactor, 
respectively, and the second enzyme is horseradish peroxidase (HRP).  
Glucose Oxidase (GOx):  
Glucose oxidase, from Aspergillus niger, consists of two identical subunits (dimer) with two 
flavin adenine dinucleotides (FAD) co-enzymes non-covalently bound (Figure 3.1). It is a 
well-characterised glycoprotein and its structure at 1.9 Å [232] has been determined and 
published.  
 
a)
 
b)
 
Figure 3.1: Glucose oxidase structure.  
a) The two subunits are shown in dark and light blue, and the FAD coenzyme in pink, [233] b) 1.9 Å resolution 
structure of Aspergillus niger glucose oxidase subunit. β-D-glucose molecules are shown in the active site of 
glucose oxidase, stabilised by 12 hydrogen bonds and by hydrophobic contacts to three neighbouring aromatic 
residues and to flavin adenine dinucleotide [232]. 
The dimensions of the unit cell for GOx are: 6.75 x 6.75 x 21.54 (nm) and the molecular 
weight 65.69 kDa [232]. 
The coenzyme FAD acts as an electron carrier during catalysis [234], GOx catalyses the 
oxidation from D-glucose to D-gluconolactone: 
€ 
C6H12O6 +O2→C6H10O6 +H2O2 (3.1) 
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Nakamura et. al. propose the mechanism of glucose oxidase as [235], 
€ 
Eox + S⇔ EoxS→ Ered +P
Ered +O2→ Eox +H2O2
 (3.2) 
GOx is produced naturally in some fungi and insects where hydrogen peroxide, its catalytic 
product, acts as an anti-bacterial and anti-fungal agent. GOx is commonly considered safe 
and is been used widely in the industry as food preservative. This enzyme presents an 
excellent electrochemical activity, which makes it an essential constituent in glucose 
sensors and potentially in fuel cell applications [233].  
L-Lactate Oxidase (LOx): 
Lactate oxidase, from Aerococcus viridans, is a member of a family of homologous flavin 
mononucleotide (FMN)-dependent α-hydroxy acid-oxidising enzymes. At present the only 
large source of LOx is soybean flour, however, the result is a mixture of isoforms with 
different properties. Hence, the production of LOx as a recombinant enzyme in microbial 
host presents the advantage of being a single protein, free of other isoforms, cheaper and 
inexhaustible. Its crystal structure reveals that the active site residues are located around 
the FMN. The crystal structure of LOx complexed with D-lactate has been found at pH = 4.5 
and at 2.1 Å [236], [237]. 
 
Figure 3.2: Ribbon representation of Lactate Oxidase.  
LOx tetramer complexed with D-lactate. Each monomer is represented in a different color, with FMN (yellow), D-
lactate (light blue) and molecular oxygen (red spheres) [236]. 
The dimensions of the unit cell for LOx are: 11.73 x 13.47 x 18.56 (nm) and the molecular 
weight 330.99 kDa [236]. 
LOx catalyses the oxidation of lactate to pyruvate: 
€ 
C3H5O3 +O2→C3H3O3 +H2O2 (3.3) 
The enzymatic reaction mechanism is complicated and has been studied extensively. 
Maeda-Yorita et al. showed a ping-pong mechanism [238], where in the first half-reaction 
(the reductive), the α-hydroxy acid substrate is first oxidized by the enzyme to form a keto 
acid as the product, and the flavin is reduced to the hydroquinone. In the second half-
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reaction (the oxidative), the reduced flavin is re-oxidized by an electron acceptor, which is 
molecular oxygen (the second substrate) and leads to the formation of hydrogen peroxide.  
€ 
Eox + S⇔ EoxS⇔ EredP→ Ered +P
Ered +O2→ Eox +H2O2
 (3.4) 
LOx is been widely used in biosensors to measure concentrations in blood and other fluids 
[239]. 
Horseradish Peroxidase (HRP):  
Horseradish peroxidase is an important enzyme containing a heme group. It utilises 
hydrogen peroxide (H2O2) to oxidise a broad range of organic and inorganic compounds. 
Due to its commercial use in immunoassays the production of peroxidase from horseradish 
occurs in large scale. It has been studied for more than a century due to its essential 
application for immunoassays and clinical diagnosis [240]. However, not until recently, new 
technologies have made possible the study of its three-dimensional structure at 1.57 Å. 
 
Figure 3.3 : Three-dimensional structure of Horseradish Peroxidase. 
The relative position of the secondary structural element in HRP at 1.57 Å [241]. 
The dimensions of the unit cell for HRP are: 4.28 x 6.75 x 11.7 (nm) and the molecular 
weight 34.52 kDa [241]. 
Major understanding of the structure and function of HRP was achieved by the successful 
production of the recombinant enzyme [242]. Berglund et al. found the catalytic pathway for 
HRP at high time resolutions and demonstrated the five oxidation states of the enzyme 
[241]. 
HRP catalyses the oxidation of many substrates with H2O2 following the scheme [243]: 
€ 
H2O2 + Sred +2H + HRP →   2H2O+ Sox  (3.5) 
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Several studies have demonstrated the mechanism of the HRP reaction, where a first active 
compound is formed through a high-valent iron-oxo species, compound I (porphyrin radical 
cation) [243], [244]. 
 (3.6) 
The literature is extensive in articles tackling the complexity of HRP [245], [246], [247]. 
Recently, Sanz et al. clarified the HRP/H2O2 reaction mechanism in the absence of the 
external substrate [243]. The reduction step (reaction ii, equation 3.6) can take place in 
absence of substrate, by the proteic part of the same peroxidase, intermolecular (another 
HRP) or intramolecular (same HRP). 
 (3.7) 
Due to the first step being very fast, the HRP can react with H2O2 forming HRPI 
continuously, until the proteic part of the HRP is unable to transfer more electrons to the 
heme group. 
 
Figure 3.4: HRP mechanism and its intramolecular reaction. 
HRP reacts with H2O2 forming HRPI, this can react intramolecularly with another HRP and slow down the rest of 
the mechanism [243]. 
An increase of HRP, as illustrated by figure 3.4, could lead to a decrease in reaction 
activity, by subsequent reduction cycles of HRPI complex, which slows down the rate of 
reaction. In the same manner, an excess of H2O2 could lead to a decrease in sensitivity.  
Jones et al. showed the effect of salting HRP, which by increasing the ionic strength 
increased the bonds of the enzyme to the silica beads and therefore, the coupling 
efficiency. However, when both GOx and HRP were salted out, the results were non-linear, 
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showing an important increase at the start point of the calibration followed by decrease 
response when the concentration was increased. It was demonstrated that HRP undergoes 
substrate inhibition at H2O2 concentration above 1.5 mM. Hence, increase of GOx loading 
results in a higher conversion of substrate to H2O2, and this can lead the HRP into the 
region of substrate inhibition [177]. 
The interactions between HRP and GOx were also studied and it was demonstrated that 
GOx could act as a substrate of HRP [243]. All these features guided us to study the 
performance of the assay varying the concentration of all the enzymes used, and will be 
discuss further along this chapter.  
Enzyme Kinetics 
Enzymes act as a catalyst by lowering the activation energy (Ea or ΔG‡) of the reaction. 
A large number of the enzymes follow the Michaelis-Menten kinetics [231]. For an 
oxidoreductase this involves binding of the specific substrate, conversion of the bound 
substrate to bound product, followed by release of the bound product. Finally, a second 
reaction converts the enzyme back to its original form (equation 3.8). 
€ 
Eox + S⇔ EoxS[ ] K2 →  Ered S[ ]⇔ Ered +P
Ered O2 →  Eox
 (3.8) 
In equation 3.8 the reoxidation of the enzyme is assumed to be the fast step, i.e. not the 
limiting factor. The rate of an enzyme catalysed reaction is given by the equation 3.9 
(Appendix II). 
€ 
−d S[ ]
dt =
k2 E0[ ] S[ ]
KM + S[ ]
 (3.9) 
Where KM is the Michaelis-Menten constant and E0 the total enzyme concentration. 
Two extreme cases are normally considered and are shown in 3.10 and 3.11. 
€ 
KM >> S[ ]⇒
−d S[ ]
dt =
k2 E0[ ] S[ ]
KM
     (3.10) 
The rate of the reaction is proportional to [S]. 
€ 
S[ ] >> KM ⇒
−d S[ ]
dt = k2 E0[ ] =VMAX
  (3.11) 
The rate becomes equal to k2[Eo] and then it is independent of substrate concentration 
developing to maximum turn over rate (vmax ). 
The steady state current at an amperometric electrode under diffusion control is shown in 
equation 3.12 
€ 
Id = nFAJ  (3.12) 
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Where J is the flux of molecules in mol s–1 cm–2 to the electrode surface; n, the number of 
electrons passed per molecule and F, the faraday constant. 
For a given biosensor with enzyme on its surface operating under enzymatic control the 
equation is: 
€ 
JA = − d S[ ]dt
 
 
 
 
 
 
surf
 (3.13) 
Hence we can write 
€ 
I = IMAX S[ ]KM + S[ ]
 (3.14) 
Thus the current response of a biosensor is often represented by a Michaelis-Menten curve 
as shown in figure 3.5. 
 
Figure 3.5: Michaelis-Menten curve for an amperometric biosensor. 
The current of the reaction is plotted against the concentration of the substrate. The curve reaches a maximum 
(Imax) and the constant KM can be calculated by finding the [S] at Imax/2. At low [S] the response is linear.  
At low concentrations of substrate, the response is linear and the current increases rapidly 
and proportionally with the increase in the concentration. However, at high concentrations 
the current is constant, being limited by enzyme loading and the rate of the enzyme. 
Michaelis-Menten studied these characteristics of the enzymes through its kinetic reaction.  
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Different KM have been found in the literature for the free enzymes:  
 
KM GOx 
(Michaelis constant, with 
respect to glucose) 
KM LOx 
(Michaelis constant, with 
respect to lactate) 
KM HRP 
(Michaelis constant, with 
respect to H2O2) 
33 mM [248] 0.28 mM [249] 0.0334 mM, [250] 
41.8 mM [251] 0.94 mM [252] - 
Table 3.1: Literature values of the kinetic constants of GOx, LOx, and HRP. 
The free enzyme kinetics constants have been found in different publications among the literature and are listed 
here. 
However, the Km value of glucose oxidase when used in a biosensor has been reportedly 
lower (7.01 mM) than that of free enzyme [253]. 
In a FIA biosensor system such as used in this thesis, the empirical Hill equation can be 
used [254], 
€ 
I = IMAX
1+ KM
glucose[ ]α
 
 
 
 
 
 
 
 
 (3.15) 
where I is the measure of the rate of the enzymatic reaction and α is the measure of 
deviation from ideal Michaelis-Menten behaviour. 
In general, to reduce analytical errors in a biosensor signal, the linear range from the 
calibration curve is used. However, this implies a low sensitivity range available for the 
measurement. Mathematical expressions for biosensors calibration at different 
concentrations reduce the errors and quantify the length of the linear range. The Hill 
equation is widely used for approximations of the calibration curve in various biosensors. 
Nevertheless, this is an empirical equation and not the mechanistic basis of the reaction for 
the biosensing device [255].  
GOx and LOx kinetics appear to follow the Hill equation [254], hence, this expression will be 
used to fit the calibration curves of glucose and lactate biosensors. 
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3.2 Enzyme Concentration 
Each enzyme contains a specific protein that recognises a specific substrate [231], hence, 
the higher the concentration of enzyme the higher its sensitivity. This section describes the 
interaction of the enzymes and its behaviour at different concentrations.  
The membranes were loaded with different amount of enzymes as shown in table 3.2.  
 
HRP GOx LOx 
1 mg 1 mg 
2 mg 2 mg 0.5 mg 
5 mg 5 mg 
1 mg 1 mg 
2 mg - 1 mg 
5 mg - 
Table 3.2: Enzyme loads onto the membranes. 
Different amounts were used for each enzyme (GOx, LOx and HRP) to be loaded onto the membranes.  
The membranes were positioned in the reactors as explained before in chapter 2 and 
calibration was performed with a range of standards from 250 µM to 30 mM. Each standard 
was injected three times and the average was plotted in the calibration curve in figure 3.6, 
as mean ± stdev (standard deviation). 
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Figure 3.6a: Calibration test varying GOx loaded in the membrane and 0.5 mg of HRP. 
Results from FIA system with enzyme reactor membranes loaded with 1 ml of solution containing different 
amount of GOx (pink: 1 mg, blue: 2 mg, orange: 5 mg) on first membrane and HRP on second membrane. Hill 
equation fitting curves, respectively: I = (7.69 ± 0.62) / [1 + (10.45 ± 1.32 / x) 1.53 ± 0.20]; I = (8.26 ± 0.91) / [1 + 
(11.26 ± 1.91 / x) 1.53 ± 0.25]; I = (8.65 ± 1.4) / [1 + (16.13 ± 4.01 / x) 1.43 ± 0.23] 
 
 
Figure 3.6b: Calibration test varying GOx loaded in the membrane and 1 mg of HRP. 
Results from FIA system with enzyme reactor membranes loaded with 1 ml of solution containing different 
amount of GOx (pink: 1 mg, blue: 2 mg, orange: 5 mg) on first membrane and HRP on second membrane. Hill 
equation fitting curves, respectively: I = (11.57 ± 0.18) / [1 + (12.99 ± 1.92 / x) 1.47 ± 0.18]; I = (9.62 ± 0.52) / [1 + 
(8.52 ± 0.69 / x) 1.76 ± 0.21]; I = (10.45 ± 0.76) / [1 + (12.23 ± 1.51 / x) 1.31 ± 0.12] 
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GOx:HRP KM IMAX 
1:0.5 10.45 ± 1.32 7.69 ± 0.62 
2:0.5 11.26 ± 1.91 8.26 ± 0.91 
5:0.5 16.13 ± 4.01 8.65 ± 1.4 
1:1 12.99 ± 1.92 11.57 ± 0.18 
2:1 8.52 ± 0.69 9.62 ± 0.52 
5:1 12.23 ± 1.51 10.45 ± 0.76 
Table 3.3: Experimental kinetic constants for the reactor GOx:HRP. 
The enzymes immobilised on the membrane presented different KM and IMAX depending on the proportion of 
each enzyme. 
The difference in response for different GOx loading was negligible in both HRP loading 
cases. Taking 10 mM glucose as example to study closer the response:  
 
 
Figure 3.7: Response of membranes loaded with different GOx:HRP ratio. 
Data from previous experiment at 10 mM of glucose. Response current from enzyme reactor membranes 
loaded with 1 ml of solution containing 1, 2 and 5 mg of GOx. 0.5 mg of HRP purple spuares and 1 mg of HRP 
orange circles. 
Important increase of GOx loaded on the membrane from 1 mg to 2 mg and 5 mg did not 
present a significant increase in sensitivity. This confirms that the detection method is 
limited by mass transport and not from the kinetics of the enzymes. This mass transport 
limited rate provides some advantages; the possibility of depletion of oxygen in the buffer is 
essentially eliminated and enzyme losses through constant use do not affect significantly to 
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the reactor sensitivity. Therefore, the membranes were loaded with 1 mg of GOx and 0.5 
mg of HRP.  
Lactate Oxidase was loaded following the same rules as glucose, with different amounts of 
LOx and HRP as shown table 3.2. The reactors were constructed and calibration performed 
as before. The average of the three injected standards was plotted in the calibration curve 
in figure 3.8 as mean ± stdev. 
 
 
Figure 3.8: Calibration test varying LOx loaded in the membrane. 
Results from FIA system with enzyme reactor membranes loaded with 1 ml of solution containing different 
amount of LOx (pink: 1 mg, blue: 2 mg, orange: 5 mg), on first membrane and 0.5 mg HRP on second 
membrane. The Hill equation fitting curves, respectively are I = (9.65 ± 0.19) / [1 + (7.76 ± 0.25 / x) 1.63 ± 0.08]; I = 
(16.84 ± 0.26) / [1 + (6.01 ± 0.17 / x) 1.73 ± 0.09]; I = (13.08 ± 0.11) / [1 + (3.63 ± 0.09 / x) 1.59 ± 0.06]. And open pink 
circles 1:1 for LOx:HRP. I = (9.64 ± 0.14) / [1 + (5.82 ± 0.016 / x) 1.58 ± 0.07] 
 
LOx:HRP KM IMAX 
1:0.5 7.76 ± 0.25 9.65 ± 0.19 
2:0.5 6.01 ± 0.17 16.84 ± 0.26 
5:0.5 3.63 ± 0.09 13.08 ± 0.11 
1:1 5.82 ± 0.02 9.64 ± 0.14 
Table 3.4: Experimental kinetic constants for the reactor LOx:HRP. 
The enzymes immobilised on the membrane presented KM and IMAX that varies with the amount of LOx and 
HRP. 
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The difference in response for different LOx loading was negligible in both HRP loading 
cases. Taking 10 mM lactate as example to study closer the response:  
 
 
Figure 3.9: Response of membranes loaded with different LOx:HRP ratio. 
Data from previous experiment at 10 mM of lactate. Response current from enzyme reactor membranes loaded 
with 1 ml of solution containing 1, 2 and 5 mg of GOx. 0.5 mg of HRP blue squares and 1 mg of HRP pink circle. 
Figure 3.9 shows the membrane loaded with different amount of LOx and HRP. Alike the 
GOx loading, increase of LOx loaded on the membrane from 1 mg to 2 mg and 5 mg did 
not present a significant increase in sensitivity. This confirms again that the detection 
method is limited by mass transport and not from the kinetics of the enzymes.  
In this case, however, the increase in sensitivity when 2mg of LOx is loaded on the 
membrane compared with 1 mg persuade us to load the lactate reactor with an enzyme 
ratio of 2:0.5 for LOx:HRP. 
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3.3 Perfusate Flow Rate 
In optimising the system for a different tissue an important variable under our control was 
the dialysis perfusion flow rate as it affects probe in vivo recovery, and hence dialysate 
concentration of the analyte. A series of in vitro experiments were carried out where the 
perfusion flow rate was varied and the recovery, delayed time and fluid loss through the 
probe measured. 
Method: 
Glucose and Lactate mixed standards containing of 1 mM and 2 mM were prepared in 
volumes of 250 ml. The solutions were left overnight for the mutarotation of glucose. The 
solution was transferred in a flask with constant vigorous stirring, to create good mass 
transport. Depending on the stirring, the recovery may vary [202]. Therefore the stirring was 
set at maximum speed available, when a vortex was created and the magnetic stirred did 
not collide. A microdialysis probe was inserted into the solution, in the vortex wall (Figure 
3.10). The probe was fixed to the CMA pump that was set up at a fix flow rate.  
 
Figure 3.10: Microdialysis probe into the vortex of the stirring solution. 
The solution was stirred properly to assure mass transport and the probe was inserted in the wall of vortex, 
created by the fast stirring. 
By changing flow rate and interchanging the probe between 1 mM and 2 mM solutions and 
measuring the dialysate with the on-line system, the calculations of response time and 
percentage of sensitivity of the probe for each flow rate were obtained.  
MD probe 
Inlet 
Outlet 
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Results can be observed in figure 3.11. 
a) 
b)  
  
Figure 3.11: Variation of dialysate concentration with flow rate. 
Glucose (a) and lactate currents (b) are plotted versus time. Flow rates were changed from 3 to 10  µl/min and 
the MD probe was placed in a standard well-stirred solution of concentration 1 and 2 mM, at 20°C. 
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The graphs plotted in figure 3.11 show clearly the decrease of sensitivity with the increase 
of dialysate flow rate. The dotted lines added to the figures show when the changes of flow 
rate occur, varying from 3 to 10 µl/min. The shifts of concentration can be observed clearly, 
starting from 1 mM to 2 mM and back to 1 mM, repeatedly. From this experiment we can 
calculated the in vitro recovery and delay time of the microdialysis probe. 
3.3.1 In vitro Recovery 
In vitro the recovery of the probe is affected by different factors (chapter 1). Nevertheless, 
considering these variables constant, the main variability is produced by the perfusion flow 
rate and this can be controlled and measured. 
By injecting some samples of the bath of concentration 2 mM and 1 mM, before, during and 
after the experiment described before, the percentage of recovery at different flow rates by 
the probe could be calculated. The data obtained from this experiment, shown in the figure 
3.11, was analysed to produce figure 3.12.  
 
Figure 3.12: Glucose relative recovery versus dialysis flow rate in vitro. 
Percentage (%) of relative recovery changing with flow rate (µl min-1). Error bars indicate the standard deviation 
of the average value of the three measures. 
Figure 3.12 illustrates the inverse relationship between perfusion flow rate and relative 
recovery. At 1 µl/min a 78% of relative recovery can be observed, this is highly sensitive to 
dialysis flow rate, unlike the ideal value of 100% at which the recovery is no longer sensitive 
to flow rate or tissue conditions. At increasingly higher flow rates there is significantly less 
sensitivity to flow rate. In fact several studies with small animal probes suggest that in 
practice above 2.5 µl/min probe recovery is virtually insensitive to perfusion flow rates [256], 
[257]. 
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Another method to test the recovery of the probe is the calculation of absolute recovery 
(Chapter 1), where the measurement indicates the number of moles per unit of time 
removed from the tissue.  
The figure 3.13 shows the relative recovery and absolute recovery versus the perfusion flow 
rate. 
 
 
Figure 3.13: Glucose relative and absolute recovery versus flow rate. 
In vitro recovery of the solution surrounding the microdialysis probe. In purple the relative recovery in 
percentage (%), in orange the absolute recovery (µmol min-1)  
Figure 3.13 illustrates the inverse proportionality between relative and absolute recovery. At 
higher flow rates there is not enough time for molecules diffuse down the concentration 
gradient to come to equilibrium with the dialysate concentration. On the other hand at 
higher flow rates there are a higher number of molecules per unit of time (absolute 
recovery) leaving the outlet, this is because the lower dialysate concentration maximises 
the concentration gradient between tissue and the dialysate. Both relative and absolute 
recovery follow an exponential relationship with flow rate. Nevertheless, in this case that is 
not the best fitting. 
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Figure 3.14: Relative recovery fitting curve. 
Relative recovery at low flow rates fits the Jacobson model, but at higher flow rates the recovery is lower than 
the predicted values. 
At low flow rates it fits the Jacobson model, discussed in chapter 1, but at higher flow rates 
we see a fall away from the values predicted by this model. This is probably due to slight 
loss of perfusate through the membrane due to the built up of a positive hydrostatic 
pressure gradient across the membrane at higher flow rate. This has been very recently 
described by Bungay [221] and can lead to significant falls in relative recovery.  
From figure 3.14 it can be observed that at 5 µl/min, we are still in a safe zone where the 
curve fits the model. And therefore, using a longer probe we pushed the limit of recovery 
sensitivity till flow rates of 5 µl/min. 
In vitro recovery should not be used as a method of in vivo calibration, due to the 
complexity of the tissue environment [175], [207], [206], [178]. There are methods for 
measuring the probe recovery in vivo, these include extrapolation to zero flow [220] and 
zero net flux method [208], [209]. However, in vivo recovery was a more complicated option 
when monitoring human patients. In vivo recovery will also permit the study of the tissue 
disturbance by the dialysate flow rate, which might be significant in the bowel compared to 
the brain, due to its lower regional blood flow.  
The concentration of dialysate depends on many other factors, such as flow rate (f), 
membrane area (A), mass transfer coefficient (k) (see equation 1.5 in chapter 1). The 
product of kA and the concentration of analyte in the tissue can be obtained varying the 
flow rate through the microdialysis probe, however in vivo and in vitro measurement differ 
suggesting that active processes influence the recovery of the probe [202]. Further studies 
with animal models are carried out to study in vivo recovery (Chapter 5, section 5.4). 
Since the outlet tubing is extended from the probe to the analyser, the time lag was a 
parameter to be considered before concluding with an optimum flow rate.  
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3.3.2 Delay Time  
The length of the clinical probes varies for each clinical application. The distance between 
the patient and the system according to electrical safety protocol has to be at least of 0.5 m, 
however, longer extensions were more appropriate to give the surgeon more flexibility when 
manoeuvring the tissue, thus FEP tubing had to be added to the outlet of the catheter. This 
length adds a lag of time for the dialysate to exit the catheter.  
Data from the experiment described in section 3.3 is used to measure the time needed for 
the dialysate to be collected. When the flow rate or the concentration is changed the results 
appeared on the computer with some time of delay, due to the length of the tubing. When 
the change occurred, a mark is written on the chart, the elapsed time was calculated. This 
is plot below in figure 3.15 for each flow rate.  
 
Figure 3.15: Variation of the delay time with flow rate.  
1 m length of FEP tubing extension is added to the 600 mm outlet of the CMA probe. The time lag is measured 
for each flow rate and error bars (typically smaller than symbols) indicate the standard deviation of the average 
value of the two measures, for glucose and lactate monitoring. 
At higher flow rates the time lag between the probe and analyzer decreases exponentially. 
In the following flow rates the drop becomes less pronounced. This could be produced by 
the lack of a faster sampling time with faster flow rates. At higher flow rates, 30 seconds 
sampling was an inaccurate measure of the time delay, this explains the non-linearity in the 
decay. At higher flow rate, a lower delay time was found, however, as we saw in the 
previous section, higher flow rates also mean less time for exchange of molecules between 
the dialysate and the tissue fluid.  
After several monitoring sessions during gastrointestinal surgery and due to the 
manoeuvres of the surgeon with the tissue, more flexibility and space was essential. A 
longer FEP tubing extension was required, therefore the outlet tubing of the microdialysis 
probe was extended by 1.5 metres of FEP tubing, which was the length needed for surgery. 
This means that there was a longer delay in every measurement. However, a remaining 
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concern needs clarification previous to the use of higher flow rates. When working at high 
rates, the possibility of dialysate fluid loss through the membrane can represent a problem. 
This would be caused by the increased back-pressure from the outlet tubing, therefore, a 
series of dialysis loss experiments are conducted. 
3.3.3 Microdialysis Probe Fluid Loss 
The microdialysis probe was analysed for performance characterisation. The probe was 
designed for use with the commercially available off-line analyser. In order to apply the on-
line set up, the probe is tested for the fluid loss with different lengths of FEP tubing 
extensions. Studies suggest that the flow leakage through the microdialysis membrane can 
contribute to delay in the transport of analytes and consequently vary the response time. 
[258] The sampling delayed time and the recovery of the molecules in vitro through the 
microdilaysis membrane are also evaluated.  
Some studies report fluid loss trough the semi-permeable membrane [259], [260], although 
in general this fluid loss can be prevented by the use of slow perfusion flow rates [202]. A 
test is carried out with the purpose of experimentally measuring the loss of fluid through the 
probe.  
The dialysis syringe is filled with water. The dialysis pump is set to constant flow rate of 2 µl 
min-1, and the probe membrane immersed in pure water to prevent evaporative losses 
through the membrane. Once steady state had been obtained, pre-weighed Eppendorf vials 
are used to collect the dialysate liquid passed in a 30 minutes period: 
a) At the syringe outlet with no dialysis probe. 
b) At the exit of the probe 
c) At the end of 1 m FEP tubing 
d) At the end of 1.5 m FEP tubing 
The experiment is then repeated at 10 µl min-1 and the measurements are carried out using 
either a precision glass syringe (Hamilton 1000) or a sterile plastic syringe, as used 
clinically. The results are shown in the table 3.5. 
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 Glass Syringe Plastic Syringe 
Flow 
Rate 
(µl/min) 
Condition Vol (µl) Vol lost  
(µl) 
% lost Vol (µl) Vol lost  
(µl) 
% lost 
2 a 60   89   
 b 54 6 10 84 5 5.6 
 c 50 10 16.7 77 12 13.5 
 d 46 14 23.4 74 15 16.8 
10 a 300   444   
 b 276 30 9.8 390 54 12.2 
 c 225 81 26.5 158 286 64.4 
 d 214 92 30.1 147 297 66.9 
Table 3.5: Microdialysis probe fluid loss using different syringes. 
The table shows the volume release by the probe at different tube length, measured by difference of weight 
collected for 30 minutes and the calculation of probe losses: a) at the syringe outlet with no dialysis probe, b) at 
the exit of the probe, c) at the end of 1 m FEP tubing, d) at the end of 1.5 m FEP tubing. A density of 1000 mg 
µl-1 is used to calculate volumes. 
Glass Syringe: The most surprising result was that in experiment (b) with the probe but no 
FEP tubing. Here even at 2 µl min-1 (a recommended flow rate) volume was lost, 
presumably through the membrane. It is interesting to note that the volume actually 
delivered was in agreement with the digital reading on the pump, though in fact there was a 
6 µl (2 µl/min) and 30 µl (10 µl/min) loss through the membrane. The addition of 1 m or 1.5 
m FEP tubing gave rise to a small additional loss at 2 µl min-1.  At 10 µl min-1 the loss due to 
FEP tubing was substantial, being up to 30.1% of the infused volume.  
Plastic Syringe: The first feature (row a) to notice is that in 30 minutes the plastic syringe 
did not deliver the expected volume of 60 µl (2 µl min-1) or 300 µl (10 µl min-1), but 
consistently gave more volume than expected. This was checked with several syringes of 
different bore and was found to be consistent results. Due to the design of the experiment 
protocol, the dialysis probe results could still be processed by comparing the volume 
collected with that delivered in experiment (a). The loss of the plastic syringe is comparable 
to the Hamilton syringe at low flow rates, however, at higher flow rates the loss becomes 
more important. Since the probe and outlet tubing were the same as in the glass syringe we 
conclude that this increased loss was due to leakage of the plastic syringe plunger 
therefore 10 µl/min is not recommended for our monitoring.  
Summarising, when the flow rate was increased, the time necessary for the molecules to 
travel down the tube to the assay was reduced. Nevertheless, this faster perfusion through 
the probe tip represents less time for the molecules to exchange, producing a reduction in 
the signal due to the lower concentrations. In order to have a fast time of response, crucial 
for in vivo monitoring and a signal sufficiently above the assay detection limit for a correct 
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measurement, a compromise was needed. At 1 µl/min the percentage recovery was 78% 
and the delay time 18 minutes, while at 10 µl/min the percentage recovery was decreased 
to 20% and the time needed to respond to 3 minutes. This was also associated with liquid 
loss through the membrane when an outlet tube was connected and in turn would reduce 
recovery further [221]. 
Low flow rates (1 µl min-1) present high sensitivity to the dialysis flow rate coupled to long 
transit times, thus is not suitable flow rate choice. At high flow rates, 5-10 µl min-1 the 
sensitivity to flow rate is lower, nevertheless the transit time is greatly reduced. This 
represents poorer recovery magnitudes, however the higher levels of glucose and lactate in 
the bowel wall compare to the brain means that this can be tolerated without assay 
detection limits problems. At these high flow rates the fluid loss through the probe is 
substantially important and therefore not very recommendable for this study. In conclusion, 
for the assay to cover a fine relative recovery, short time lag and minimum fluid loss, the 
results suggest an optimum flow rate range between 2 - 5 µl min-1. 
3.4 Concentration Calibration 
For the brain use, the on-line system was routinely calibrated between 50 µM and 2-mM 
[194]. For the gastrointestinal research much greater concentrations were expected [261], 
therefore an extended calibration range was examined.  
 
 
Figure 3.16: Extended calibration curve for glucose and lactate. 
Glucose in red and lactate in green show a pseudo-linear response until approximately 15 mM and 10 mM 
respectively, where the enzymes saturate and the response plateu. Samples were 200 nl injection and are 
represented by mean ± stdev. Hill equation fitting curves: I = (8.76 ± 0.23) / [1 + (6.87 ± 0.37 / x) 2.84 ± 0.42]; I = 
(15.54 ± 0.13) / [1 + (5.18 ± 0.11 / x) 2.19 ± 0.09] 
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The nature of the enzyme is to be more reduced with more concentration of substrate, 
however at higher concentration other terms gain importance, in Michaelis-Menten equation 
(equation 3.14), a constant (KM) marks the limit of that linear relationship, and the enzymes 
saturate giving a plateau in the calibration graph. The KM of Glucose Oxidase and Lactate 
Oxidase are known to be 33 mM [248], 0.94 mM [252] respectively. Hence, while the mode 
of operation for glucose (Km of GOx in a biosensor was 7.01 mM [253]) is consistent with 
this being a limiting factor it seems that with lactate other features acquired importance. The 
KM of an enzyme represents the strength of the binding protein to the substrate. The lower 
the KM, the stronger is the bond of the enzyme with the substrate, thus being the limiting 
step of the kinetic reaction. Georganopoulou et al. found in early version of the system that 
the response was limited above 0.2 mM of glucose concentration by HRP enzyme kinetics 
and enzyme loading [254]. 
 
Enzyme  KM literature (mM) KM experimental (mM) 
GOx 33 [248]  6.87 ± 0.37 
LOx 0.94 [252] 5.18 ± 0.11 
Table 3.6: Comparison of KM values from the literature and experimentally. 
KM values found in the literature for the free enzyme GOx and LOx are compared with those one found 
experimentally when the enzymes were immobilised onto the membrane. 
Since the volume of the injecting sample is been reduced to 200 nl, the loading of enzyme 
in the membrane increased to 2 mg and having lower recovery by the use of higher flow 
rates, the lower KM of the LOx enzyme was overcome. The LOx enzyme was never 
deficient of active sites to oxidase the substrate, evading the saturation of the enzyme.  
Figure 3.16 shows glucose response being lower than lactate response. Glucose has 
therefore a lower sensitivity, however, this effect is due to the nature of this sugar. Glucose 
is the stereo isomer D-(+)-glucose, which is itself a mixture of 2 anomers α-Glucose and β-
Glucose, being the proportion 40% and 60%, respectively (section 3.6). The anomers are 
interconverted at low rates in solution. The enzyme GOx is a selective enzyme, detecting 
only the β form of the sugar, thus the response of glucose is only a 60%. 
Monitoring glucose and lactate concentrations in tissue.  
In order to establish the required levels of glucose and lactate to be detected, pilot 
experiments are carried out in cadaveric tissue. Tissue from a surgical procedure of colon 
resection was monitored. The microdialysis probe was inserted in this tissue 30 minutes 
after resection, low concentration of glucose and high concentration of lactate are expected, 
as there is no blood perfusion. 
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Figure 3.17: Human resected tissue monitoring. 
Concentration changes of glucose (red) and lactate (green) in a cadaveric tissue. Probe is implanted in a 
section of bowel resected during an operation 30 minutes before. Metabolites levels are constant during the first  
half an hour to then change in opposite directions spontaneously indicating that the tissue is ischaemic.  
Figure 3.17 represents the changes in metabolites for a healthy bowel tissue reaching 
ischaemic values. Glucose decreased from a concentration of 300 - 400 µM to 15 µM and 
Lactate increased from 40 µM to approximately 6 mM, having a sharp transition half an 
hour after the beginning of the monitoring. The superior concentration range was hence 
confirmed by monitoring a resected bowel tissue sample.  
From these results we might conclude for a calibration method with standards from 50 µM 
to 6 mM, thus establishing the detection limits of the biosensor reactors. However, 50 µM 
standard might be excessively small for the purpose, knowing that the tissue was resected 
1 hour before the first measurement was read, at this stage the tissue is already ischemic 
[190]. Hence, to save time a better range is from 250 µM to 6 mM. A calibration curve over 
this range is carried out to confirm the appropriate correlation current - concentration. 
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Figure 3.18: Calibration curve at low concentration range.  
Current signal comes from 3 repeat injections of 200 nl concentration standard at 100 µl/min flow rate for each 
assay. Data symbols are mean ± sem. Hill equation fitting curves for glucose (red) and lactate (green), 
respectively: I = (19.23 ± 8.75) / [1 + (12.11 ± 5.5 / x) 1.53 ± 0.14]; I = (29.05 ± 14.6) / [1 + (11.94 ± 6.7 / x) 1.41 ± 0.16] 
Figure 3.18 illustrates the current for a range 0.25-6 mM of metabolites. From the 
experiments in human resected tissue we learnt that this was an adequate range, and we 
overcame the limiting factor of the theoretical KM for LOx with this new variant of the on-line 
rapid sampling microdialysis system. Therefore, for gastrointestinal monitoring, wider 
concentration range could be monitored unlike the lower series between 50 µM and 2 mM 
with the brain microdialysis. 
3.5 Effect of Temperature 
The enzymes show a different response at different temperatures, in fact the main 
constituent is a protein and so enzymes usually present their optimum response at 36.5°C 
(the body temperature). Due to the range of temperatures that the system is exposed to, 
experiments at different temperatures were carried out.  
As catalysts, enzymes increase the rate of specific chemical reactions, which is determined 
by the transition state that the molecules need to pass. For that, molecules require an 
additional standard free energy of activation, ΔG0 (Figure 3.19). 
For a reaction , 
 and  (3.17) 
Together these equations also give the thermodynamic result: 
 (3.18) 
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Equations from k1 and k-1 give rise to the important result that reaction rates are 
exponentially dependent on absolute temperature. The activation energy can, if needed, be 
estimated using Arrhenius or Eyring equations. 
 
 
Figure 3.19: Transition state for a chemical equilibrium.  
Free energy for the chemical reaction shows the conversion from the reactants to the products through the 
transition state.   
This exponential dependency with temperature is explained by the higher energetic 
collisions (more molecules per unit of time will reach activation energy) and by the increase 
in number of collisions (more enzyme molecules will collide with substrate molecules). 
However, the increase in temperature has another effects in the enzymatic reaction. The 
increase in temperature will increase the internal energy of the molecules. This can cause 
molecular vibrations that irreversible modify the shape of the protein structure 
(denaturation) and therefore inactivation of the enzymes protein. Furthermore, it can 
decrease the solubility of dissolved gasses. This would be important for enzymes, such as 
the oxidase enzymes, that use oxygen as a co-reagent. 
Usually the experiments are carried out at room temperature, however, when the monitoring 
is in vivo, the range of temperature changes importantly from one environment to the other. 
This may indicate a possible error route for the assay. The ferrocene buffer is kept in the 
fridge. Previous to the monitoring, the buffer is warmed up, mainly to remove dissolved gas 
and to reach temperatures that range between 20 and 30°C. Dialysate leaves the bowel at 
37°C and passes down the FEP tubing to the assay, which is at the temperature of the 
operating theatres (typically cooled at 12°C). This is in contrast to the laboratory at St. 
Maryʼs, which is typically kept at 20°C. 
Different experiments were carried out to check the optimum temperature for the best signal 
sensitivity. The buffer solution was kept in a thermostat bath at constant temperature, 
checking the temperature in the bath and in the buffer to ensure the accuracy of the data.  
Both in glucose and lactate graphs, in figure 3.20, the higher temperature showed a lower 
sensitivity at high substrate concentrations. Nevertheless, at low concentration not a great 
variation of temperature can be observed.  
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Figure 3.20a: Variation of temperature during calibration test for glucose. 
Change of sensitivity at the temperature of 20°C (orange), 26°C (blue), 30.5°C (purple). Each point is the mean 
of three measurements. Error bars are the standard deviation of the mean of three standard injections, typically 
less than the size of the symbol. Hill equation fitting curves; 20°C: I = (9.05 ± 0.67) / [1 + (7.18 ± 0.65 / x) 2.19 ± 
0.41];- 26°C: I = (8.68 ± 0.64) / [1 + (7.17 ± 0.65 / x) 2.15 ± 0.39]; 30.5°C: I = (8.10 ± 0.55) / [1 + (7.16 ± 0.61 / x) 2.0 7± 
0.34]. 
 
 
Figure 3.20b: Variation of temperature during calibration test for lactate 
Change of sensitivity at the temperature of 20°C (orange), 26°C (blue), 30.5°C (purple). Each point is the mean 
of three measurements. Error bars are the standard deviation of the mean of three standard injections, typically 
less than the size of the symbol. Hill equation fitting curves; 20°C: I = (12.61 ± 0.39) / [1 + (5.68 ± 0.24 / x)1.74 ± 
0.13]; 26°C :I = (12.48 ± 0.45) / [1 + (5.56 ± 0.28 / x)1.65 ± 0.14]; 30.5°C: I = (11.85 ± 0.03) / [1 + (5.48 ± 0.22 / x)1.69 ± 
0.12] 
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The higher concentration of substrate obtained for ischemic tissue was 6 mM of lactate 
(section 3.4), therefore this range was studied closer.  
 
Figure 3.21: Variation of temperature at low concentration of glucose. 
Current sensitivity at lower concentrations of substrate for: glucose at the temperature of 20°C: y = -0.15 ± 0.05 
+ 0.67 ± 0.02x; 26°C (blue): y= -0.08 ± 0.02 + 0.63 ± 0.01x; 30.5°C (purple): y = -0.09 ± 0.02 + 0.59 ± 0.01x. 
Data symbols presented as mean ± stdev, error bars are typically less than the size of the symbol. 
Lactate plot at low concentrations is not shown (presenting similar appearance as glucose 
plot) but the regression line equation was computed: at 20°C y = -0.02 ± 0.03 + 1.16 ± 
0.01x, at 26°C y= 0.09 ± 0.06 + 1.15 ± 0.02x, at 30.5°C y= 0.04 ± 0.01 + 1.10 ± 0.02x. Data 
for glucose and lactate is summarised in table 3.7.  
 
Temperature Glucose Lactate 
 Slope 
(µA/mM) 
p-values Slope 
(µA/mM) 
p-values 
20°C 0.67 ± 0.02 P = 2.58x10-5 1.16 ± 0.01 P = 1.26x10-6 
26°C 0.63 ± 0.01 P = 1.96x10-6 1.15 ± 0.02 P = 1.00x10-5 
30.5°C 0.59 ± 0.01 P = 2.73x10-6 1.10 ± 0.02 P = 1.22x10-5 
Table 3.7: Slope of the calibration curve at different temperatures. 
Slope of the calibration of 5 low concentration data points at different temperatures as mean ± stdev. Linear 
regression analysis was applied and p-values obtained. These indicate the significance of the linearity. p < 0.05 
is 95% significantly linear, p < 0.01 is 99% significantly linear and p < 0.001 is 99.9% significantly linear. 
The current at low concentration of substrate is a linear function of concentration. 
Statistically, the linear regressions were significant. However, to test whether the three 
linear regressions were different, the slopes for glucose and lactate were plotted versus 
temperature and a regression was applied to observe their significance. 
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f=0.28 
 
a)         b) 
 
 
Figure 3.22: Linear regression of the slopes of temperature calibration. 
Glucose (a) and lactate (b) slopes of the temperature calibration at different concentrations are plotted versus 
temperature. 
Glucose slope regression (f = 0.05) is significant, presenting a negative linear relationship 
with temperature. However, lactate slope regression (f = 0.28) is not significant; the null 
hypothesis, temperature variation presenting an effect in reactor sensitivity, can be 
disproved.  
A modest variation in the protocol was introduced, that involved a calibration standard at 
the end of the clinical monitoring period when the assay was cooled to the maximum 
degree, to quantify the maximum extent of this error. In practice such measurements 
agreed with initial calculations within the margin of error. 
Calibration before and after the operation was carried out.  
 
Figure 3.23: Glucose calibration of the assay before and after surgical operation.  
Glucose standards of (0.125, 0.25, 0.5, 1 and 2 mM) were injected before and after the operation to obtain the 
calibration. The temperature of the buffer was also checked with a standard thermometer. 
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In this case the temperature increased over the time of operation, probably due to the heat 
released by the equipment of the theatre. In any case, the sensitivity decreased with the 
temperature as shown in previous experiments. However, to check if the drop was caused 
by the increase of temperature or also by the prolong use of the reactors, a few calculations 
were carried out. 
 
 
Figure 3.24: Glucose calibration linear regression before and after surgical operation.  
Before the operation at 21ºC the linear regression is showed in blue and after the operation at 24ºC linear 
regression is showed in pink, the data points are mean ± stdev of the three samples recorded for each 
calibration. 
Sensitivity of glucose temperature was -0.007±0.001 (µA/mM)/ºC, hence to convert it in 
temperature units, it was divided by the slope of current versus concentration at 20ºC (0.67 
± 0.02 µA/mM).  
The response slope of the calibration at 21ºC is 0.36 ± 0.01 µA/mM and for 24ºC is 0.22 ± 
0.01 µA/mM, hence the predicted slope drop explainable by temperature sensitivity is -
0.012 ± 0.001 µA/mM. 
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(3.19)  
Hence, the slope of the calibration at 24 ºC, after the operation had finished should be 0.35 
± 0.01 µA/mM. However, the drop is larger, concluding that the constant use of the reactor 
through the operation period caused a larger loss of sensitivity.  
In any case, with the post-operative calibration this type of error routes could be corrected.   
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3.6 Optimisation of the assay 
3.6.1 Effect of the buffer 
The buffer as mentioned before (Chapter 2) consists:  
• Citrate buffer, to ensure the solution remains at pH = 7, the pH of maximum activity 
of the enzymes. 
• Ferrocene monocarboxylic acid, an electrochemically reversible compound used as 
a mediator. 
• EDTA which helps with the complexation of any divalent metal arriving from the 
dialysate 
• NaCl, to give a defined potential to the reference electrode and to make the solution 
conductive, avoiding migration effects. 
NaCl was added in low concentrations (10 mM), due to the nature of the reference 
(Ag/AgCl) electrode and following the electrode manual instructions (see chapter 2).  
Higher concentrations of this salt might increase the sensitivity and stability of the assay. In 
general, higher concentrations of salt provide higher conductivity. Furthermore, typically 
physiological saline solutions contain a high concentration of salts to match the body 
salinity. Therefore, matching the concentration of salt of the dialysate with the external 
buffer could lead to an improvement of signal background noise. Nevertheless, lower 
concentrations provide higher stability for the reference electrode. Due to the nature of our 
reference electrode, higher concentration of salts will increase the solubility of the electrode. 
In order to check the effect of higher salinity solutions, the following experiment was carried 
out. A buffer with 10 mM of NaCl and another with 150 mM were prepared in the same 
manner. The reactors were calibrated first with 10 mM NaCl, then with 150 mM NaCl and 
repeated to 10 mM NaCl, to ensure the validity of the results. A single variable was 
modified during the experiment, the potential at what the electrode was held, accordingly for 
the reference electrode scale. The Ag/AgCl electrode presents a standard electrode 
potential of 0.22 V vs standard hydrogen electrode (SHE). When modifying the 
concentration to 10 mM the potential needed to be held at -0.1 V vs Ag/AgCl, when the 
concentration was then 150 mM, the potential needed was 0 V.  
Chapter 3: Adaptation of the System for Gastrointestinal Monitoring 
 106 
The results for this experiment are shown in figure 3.25. 
 
Figure 3.25: Variation of sensitivity with the salinity of the buffer. 
Current data was obtained with the means ± stdev of three standards of the same concentration. In purple the 
first calibration at 10 mM NaCl, in blue at 150 mM and in pink a second calibration at 10 mM. Hill equation fitting 
curves, respectively: I = (3.35) / [1 + (11.68 / x) 1.08]; I = (1.20) / [1 + (2.05 / x) 1.92]; I = (1.59) / [1 + (4.10 / x) 1.75] 
The results observed in the graph verify the fact that at higher salinity the sensitivity of the 
assay is enhanced. At higher concentrations the increase in current can be observed 
clearly, however it is at small concentrations were this improvement of response gains 
importance. At low concentration the current peak is dissipated for the background noise, 
therefore any amplification of the response denotes an improvement in the assay. 
We resumed operating at 0 V with a salinity concentration of 150 mM of NaCl. However, 
regular examination of the reference electrode had to be carried out to evade dissolving of 
silver chloride. This examination is simple, since once open the radial flow cell, the 
reference electrode state can be seen from the difference of colour (Figure 3.26).  
 
Figure 3.26: Difference of the reference electrode (Ag/AgCl) plating of silver. 
The grey area is the Ag/AgCl reference electrode. Electrode of the left is in its correct form, while the electrode 
of the right shows a whiter colour due to the plating of silver in its surface. 
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When the specie AgCl is dissolved, the solid silver remains on the surface of the reference 
electrode showing a white colour. To counteract this, a strong oxidant agent (potassium 
dichromate solution (BAS, USA)) can be applied to the reference electrode, this 
regenerates the layer giving a dark lead colour. 
With continual usage, the AgCl layer can dissolve in the buffer due to the potential solubility 
of AgCl: 
€ 
AgCl(s)↔ Ag+ +Cl−   (3.20)                                                                                              
The specie AgCl is reasonably insoluble, therefore this equation lies strongly to the left. 
However AgCl is inevitably dissolved with the continual passage of the buffer. This is 
commonly solved, in conventional reference electrodes, by saturating the solution with 
AgCl. In our case the cell also contains the working electrode held at -100 mV (vs Ag/AgCl), 
therefore the buffer saturated of AgCl flowing through would contribute to the gradual 
plating of silver. 
It was observed that with the salinity of the buffer increased to 150 mM, the reference 
electrode was dissolved after a week of constant used of the system, while previously with 
10 mM of NaCl could last up to one month. In any case, when the reference electrode has 
been dissolved, the background signal will present the pattern shown in figure 3.27, 
warning us to check and rechloridise it. 
 
 
Figure 3.27: Background signal pattern of dissolved reference electrode.  
The signal is very unstable when the reference electrode has been dissolved, warming us of any problem. Once 
is rechloridised, the signal comes back to zero µA and presents a steady current. 
To avoid errors and background signal problems, the protocol was modified, reoxidising the 
reference electrode every week. 
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3.6.2 Mutarotase 
Glucose is a monosaccharide (sugar), the most common carbohydrate and classified as a 
hexose. Two steroisomers are found, but only one (D-glucose) is biologically active.   
Glucose cycles from its open form in two ring structures. These two structures (anomers) 
differ in the position of the hydroxyl group linked to C1. When the hydroxyl group is 
positioned in trans (axial) relative to the CH2OH in C5, the anomer is called α-glucose, 
when positioning in cis (equatorial) is called β-glucose. The two anomers intercorvert 
(mutarotate) in aqueous solution to a stable ratio of α:β 40:60 
 
Figure 3.28: Glucose mutarotation. 
D-(+)-Glucose presents two anomers in equilibrium. The conversion of these requires ring-opening to the 
aldehyde intermediate. The rotative power of the plane-polarised light change whether is the α anomer or the β 
anomer. 
Glucose has been a focus of research for more than 100 years. It is known that the 
mutarotation of glucose is catalysed by acid and bases, as well as by water, but neutral 
salts like sodium chloride, do not significantly affect it [262]. In any case the mutarotation of 
glucose is a slow process that requires hours. Lowry suggested in 1903 that the conversion 
between α- and β- glucose occurs by intermediate conversion of the aldehyde form [263]. 
The fact that mutarotation follows a unimolecular law can be interpreted by assuming that 
the change from α- to β-form to the aldehyde form is slow compared with the change from 
aldehyde form to either of the others [264]. Lewis et. al. confirmed using isotope studies 
that the bending mode force constants for CH bond of H3 and H5 are smaller in β- than in 
α- glucose, due to the equilibrium reaction of intramolecular crowding in α-glucose by the 
axial O1-C1 bond that is equatorial in β- glucose, which makes the latter energetically more 
stable and could be the reason for a higher percentage in equilibrium [265]. 
Mutarotase, an enzyme which catalyses the mutarotation of certain sugars was first 
discovered in 1949 [266]. Later, Keston studied the kinetics of different mutarotases and the 
relation to the transport of sugars [267]. 
Glucose mutarotase dimension were not found, however, galactose mutarotase is a good 
model to be considered for a general overview of the enzyme. Recently, the structure of 
galactose mutarotase has been observed at 1.80 Å. 
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Figure 3.29: Galactose mutarotase structure. 
Galactose mutarotase bonded to glucose. Since glucose cannot react, it crystallises and it can be observed in 
the structure [268]. 
The dimension of the unit cell for galactose mutarotase are: 4.42 x 7.56 x 20.95 (nm) and 
the molecular weight 77.63 kDa [268]. 
Mutarotase catalyses the interconversion of α- to β- glucose. In order to check the effect 
catalytic of mutarotase in our glucose oxidase reactor, 0.75 ml of Mutarotase (MUR1F, 
bioenzyme, UK) was dissolved in 1 ml of Ferrocene buffer. The solution was pumped 
several times through a membrane, in the same way as per glucose and lactate oxidase 
membranes (Chapter 2, section 2.5).  
 
Figure 3.30: α- and β-glucose equilibrium and reaction with GOx.  
The equilibrium α- and β-glucose is accelerated by mutarotase. And β-glucose is the anomer that reacts with 
the enzyme glucose oxidase to produce glucone lactone. 
One reactor was constructed with a GOx and HRP membrane as usual. A second reactor 
was sandwiched with Mutarotase and GOx in the same membrane and a second HRP 
membrane. A third reactor consisting of two consecutive membranes of Mutarotase and 
GOx and a third membrane with HRP was also assessed. The reactors were tested using a 
bench system, in the Imperial Collegeʼs lab, which was set up with a valve with an external 
loop of 20 µl rather than the usual 200 nl internal loop. This would be the cause of a higher 
response, however, the nature of this experiment was to compare the three reactors with 
the same system. The results are shown in figure 3.31. 
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Figure 3.31: Effect of mutarotase to the GOx reactor. 
The first calibration (orange) is from a GOx/HRP reactor only. Second reactor, GOx-Mutarotase/HRP (blue), 
contains GOx and Mutarotase in the same membrane. The pink calibration curve belongs to the first GOx/HRP 
reactor (orange) calibrated again to check the reproducibility of the system. Finally, a reactor containing two 
consecutive membranes of GOx with mutarotase and a third one of HRP, was calibrated (green). Data are 
mean ± stdev of three measurements. This valve consisted of a 20 µl loop hence the currents are much higher. 
T = 21ºC for all experiments. 
The addition of mutarotase in the same membrane of GOx caused a decreased in 
sensitivity. This decrease can be caused by: 
1) Glucose is not in equilibrium. Hence the mutarotase will accelerate the equilibrium 
and could decrease the proportion of β-glucose. The 24 hours mutarotation period 
for the glucose standards (Chapter 2) eliminates this hypothesis.  
2) Mutarotase competes with GOx for membrane sites. Therefore, a second 
membrane with Mutarotase and GOx was placed previous to the HRP membrane.   
3) Mutarotase scavenges H2O2. 
The addition of a second membrane (Mut/GOx) resulted in a further decrease of sensitivity. 
This could be due to the effect of having third membrane, which increases the resistance to 
the fluid flowing through the reactor. However, if that was the case the peaks would be 
wider and this was not observed. Hence, it could be conclude that the hypothesis of 
mutarotase acting as a scavenging agent of H2O2 was correct. However, to ensure this 
conclusion a second experiment was carried out. 
Early experiments with a polarimeter (Perkin-Elmer, model 343, serial 7408) were carried 
out, 1 M D-(+)-glucose solution was place in the polarimeter cell and the optical rotation 
was measured. The polarimeter was standardised by measuring the optical rotation of any 
impurity that could be present in H2O (α = 11.14) and taring the instrument.  
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    (3.21) 
[α], specific rotation; t, temperature (20ºC); D, wavelength of light (589 nm); l, path length 
(1 dm); c, concentration of solution (g/100ml).  
The rotatory angle of D-(+)-glucose at equilibrium is 53 º, as stated by Sigma. The optical 
rotation recorded when 100% of α-glucose was present was 119º and when 100% of β-
glucose was present was 12º. Initially, when dissolved, a solution of 0.1 M D-(+)-glucose in 
water presented a rotatory angle of 85º, showing that there was more α than β in the 
solution. Hence, increasing the rate of mutarotation will improve the response of the 
glucose reactor. In water, the mutarotation equilibrium presented a rate of 0.0156 s-1 and 
took over 200 minutes to reach the equilibrium. In sodium citrate the rate of mutarotation 
was almost double being 0.0291 s-1 and equilibrium was reached within 1 hour. This rules 
out the hypothesis that glucose was not in equilibrium before the reactor since we leave the 
D-(+)-glucose solution at room temperature over an hour and in the fridge for 24 hours.  
Since mutarotation was allowed for 24 hours, we were confident to place a membrane only 
with mutarotase before the GOx enzyme membrane. If the mutarotase is placed before the 
H2O2 is formed, then it cannot act as scavenger. Different amounts of mutarotase were 
loaded in the membrane to observe the effect of concentration of the enzyme with the 
response of the GOx reactor. 
 
Figure 3.32: Effect of the concentration of mutarotase to the sensitivity of the GOx reactor. 
The first reactor (0) only contains GOx/HRP, second reactor and succesives contain three membranes, the first 
one loaded with mutarotase, followed by GOx and HRP membranes. The numbers found to the right of each 
calibration curve indicates the amount (mg of mutarotase in 1ml of ferrocene buffer) loaded in the membrane. 
Data are mean ± stdev of three measurements.  
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The line marked zero has 3 membranes 0 mg Mut/GOx/HRP. Compared to data in figure 
3.31 this enzyme reactor has lower sensitivity, this is predominantly because the loop size 
is 200 nl compared to 20 µl. As the loading of mutarotase of the first membrane increases, 
the response drops consistently. This result is surprising because as the mutarotase 
membrane is upstream it cannot be scavenging H2O2, and nor can it be competing for 
membranes site on membrane two, where glucose oxidase is loaded. Finally, since we 
know that the glucose standards are completely mutarotated to equilibrium, we must 
conclude that there is a different mechanism by which mutarotase decreases the assay 
reactor sensitivity. Li and coworkers contradicted the controversial possibility of the 
inhibition of the mutarotase by its own substrate, glucose [269]. Hence, the possibility that 
we can hypothesise is that higher loading of mutarotase into the membrane confers more 
resistance to the molecules of glucose that have to travel through the tortuous path of the 
cellulose fibers to reach the GOx membrane. Since this is a loss of activity we did not 
investigate this further. 
3.7 Conclusion 
The system was adjusted to achieve the best conditions for running in the gastrointestinal 
monitoring cases.  
The membrane enzyme loading was studied to obtain the optimum sensitivity of the assay. 
An increase of GOx loaded in the membrane did not show an important increase in 
sensitivity. Lactate oxidase sensitive was not greater alike glucose with higher loading, 
however, it was observed a small difference between 1 mg and 2 mg. In the case of HRP, 
higher loading increased the response, but this did not have a considerable improvement 
respect to the cost of the enzyme. Hence the membrane was loaded in the case of Glucose 
Oxidase with the ratio 1:0.5 mg (GOx /HRP) and 2:0.5 mg (LOx /HRP) for Lactate Oxidase. 
After studying the in vitro recovery, time lag and probe fluid loss a dialysis flow rate range 
was proposed from 2 to 5 µl min-1, depending on the procedure. The recovery decreased 
with the flow rate, however due to the high levels of metabolites in the human bowel, the 
monitoring will still be successful. The time lag also decreased with flow rate and this was 
an important variable during intra-operative monitoring where the feedback during the 
surgery depends on the time scale of the results. The fluid loss at higher flow rates 
established the limits of this, not pushing the dialysis flow rate higher than 5 µl min-1. 
The final calibration setting was fixed to a concentration calibration from 250 µM to 6 mM, 
which appeared to be the right range for the human bowel monitoring. 
Lactate sensitivity was increased by increasing the enzyme loaded on the membrane, 
increasing the flow rate, hence lowering the recovery and reducing loop size. This solves 
the detection limit of LOx with low KM. However, the detection of glucose, presenting only 
60% response, was pushed to the limit. To counteract this effect several studies were done 
to increase the sensitivity of the system in general, such the temperature of the assay and 
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the salinity of the buffer. The sensitivity of glucose was studied in particular, such as the 
effect of mutarotase.  
Temperature variation caused a small difference of the assay response. In any case, an 
increase of temperature provoked a decrease of response and hence we concluded 
operating the assay at room temperature. However, the protocol was changed to include a 
calibration standard at the end of the clinical monitoring period to act as a test for 
temperature effects or sensitivity drift. 
The change of the salinity to a concentration of 150 mM of NaCl and operating at 0 V did 
show an increase of sensitivity of the assay. However, to evade dissolving the reference 
electrode regular examination is required.  
The addition of mutarotase to the GOx membrane did not show any improvement of 
sensitivity, in fact, the response decreased. Since glucose standards are completely 
mutarotated to equilibrium that effect could be discarded. The addition of a second 
membrane with GOx/mutarotase, discarded the option of the enzymes competing for site of 
the membrane. To avoid mutarotase acting as scavenger H2O2, the enzyme was place 
upstream, however, the response of the glucose reactor did still decrease. Therefore, we 
concluded that there is a different mechanism by which mutarotase decreases the assay 
reactor sensitivity and we did not use mutarotase for any purpose. 
With all these variables and characteristics the system was ready for in vivo monitoring of 
human gastrointestinal surgery. 
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Chapter 4: 
Microdialysis Monitoring of Ischaemia in 
Humans during Gastrointestinal Surgery 
 
 
 
This chapter describes the use of rapid sampling on-line microdialysis to monitor bowel 
surgery when a clinical microdialysis probe is placed intramurally in the bowel wall.  
Initial stabilisation times are reported in healthy human tissue. Changes in dialysate glucose 
and lactate are shown following the repeated clipping of arteries feeding the tissue aimed 
for resection.  
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4.1 Introduction 
Intestinal ischaemia is a major complication factor after common gastrointestinal procedure. 
Clinical methods for the determination of intestinal ischemia are at present rudimentary and 
require the skills of the clinician to make a decision base on the appearance and texture of 
the tissue. Currently, clinical process such laser Doppler [270], tonometry [151], 
fluorescence [157], non-invasive imaging methods [312] and blood measurement [158] can 
detect poor blood perfusion of the tissue, but doing so they do not reveal the signature of 
ischaemia.  
Microdialysis offers the possibility of metabolic monitoring of tissue governed by a 
satisfactory perfusion [174]. Bowel microdialysis has been used, to date, for animal studies 
[184], [183], [271] and for intraperitoneal (extramural) monitoring in humans [190], [261]. 
Whilst some evidence of ischemia were found, the poor time resolution of the assay 
coupled to the large volume of the intraperitoneal cavity prevented this method from being 
useful during human bowel surgery. Furthermore, the intraperitoneal monitoring required a 
second intraperitoneal control probe placed away from the bowel to take account of 
systemic effects on intraperitoneal levels [186]. 
We have, for the first time, implanted a microdialysis probe intramural into the gut wall. 
Most microdialysis studies are conducted with the commercial available off-line 
microdialysis assay, which requires manual collection of samples, leading to a delay in the 
detection of key events. This represents a time consuming process for the nurses or 
specialist in charge. Our approach has been to study ischaemia in vivo, intra-operatively, 
intramural and continuously with our on-line rapid sampling microdialysis system (Chapter 
1). 
The method consists of the implantation of the microdialysis probe into the bowel wall in 
order to study the transient to ischaemia in a healthy tissue. The study was done in 
collaboration with clinicians from the Biosurgery Department in St. Maryʼs Hospital, Imperial 
College. The patients were recruited from the planned surgeries undergoing with the 
permission of the patient and the consent of the surgeon. The microdialysis probe was 
implanted and fixed into the wall of the bowel section that was due to be resected.   
This chapter outlines the surgical and microdialysis procedures and describes the results of 
a preliminary study and the intra-operative application of the on-line rapid sampling 
microdialysis system during gastrointestinal surgery.  
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4.2 Patient and Procedures  
This section outlines the methods and the patient recruitment process and permission. 
4.2.1 Surgical Procedure  
In order to study in vivo intestinal ischaemia in human during gastrointestinal surgery a 
specific type of operation was selected. The first approach was to implant the probe in the 
wall of the stomach in patients due to have a gastrectomy (stomach resection). This 
operation was chosen because it permitted us to see the response of the tissue when the 
surgeon was transecting the arteries of the stomach one by one. The stomach resection 
surgeries were led by the specialist surgeon Mr. George Hanna who permitted us to carry 
the study while the operation was proceeding. The optimisation of the system used in the 
theatre environment was achieved from these surgeries. Mr. Samer Deeba, the clinician in 
collaboration for the entire research, ensured the technique of inserting the microdialysis 
probe (CMA 62 probe, 30 mm of length and 0.6 mm of diameter), and established the 
adequate fixation method.  
A second surgical group for intestinal ischaemia monitoring was mainly colectomies. The 
surgeon in charge Mr. Paraskeve Pareskevas was actively involved in the research 
facilitating the monitoring. The probes were implanted and fixed in the bowel wall after the 
bowel segment was mobilised and before the transection of the feeding artery.  
All the operations were performed through a midline laparotomy. This is the incision of the 
abdomen to gain access into the abdominal cavity. The anaesthesiology team induced 
anaesthesia following the standard protocol and using propofol, fentanyl and midazolam 
together with atracurium muscle relaxation. Patient demographic data, disease, operative 
details and hemodynamic data such as plasma glucose were recorded during the 
monitoring. 
4.2.2 Patient Recruitment  
Following ethical approval (number 06/Q0403/21 from St. Maryʼs Hospital regional ethics 
committee), obtained from St Maryʼs Hospital Local Regional Ethics Committee, an 
explanatory consent form was produced to inform all participants. Patient consent was 
received the night before the surgery when the patient entered in the hospital. 
Twenty-five patients, undergoing radical gastrectomy (removal of entire stomach), 
oesophagectomy (removal of oesophagus) and colectomies (removal of colon), were 
recruited (Table 4.1).  
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Number of patient Type of operation Successful monitoring 
8 Gastrectomy 2 
1 Oesophagectomy 0 
16 Colectomies 7 
Table 4.1: Patients recruited for monitoring during surgery. 
The patients recruited and the final successful monitoring for each operation are numbered. 
Table 4.1 shows that only two gastrectomies succeed. These provided the understanding of 
the in vivo microdialysis gastrointestinal monitoring and were resolved as pilot runs. From 
the sixteen colectomies, six were abandoned for different reasons: a laparoscopy was 
performed (small incision where a instrument can be introduce to perform the surgery), 
patients present a metastasis or the tissue was highly vascular. Thus the implantation of 
microdialysis probe was impracticable. One colectomy was unsuccessful due to technical 
problems with the assay and in three cases the probe kinked before the end of the 
monitoring. The overall result was seven successful colectomies where the microdialysis 
probe was implanted and tissue metabolism recorded until the end of the procedure when 
the specimen was resected and placed outside the surgical area. 
4.2.3 Microdialysis Procedure  
All the surgeries were planned, however patient consent was only received before the 
surgery. Therefore, the enzymes reactors were prepared (Chapter 2, section 2.5) the day 
previous to the surgery. The assay system was transported to the theatre while the patient 
was being sedated. Calibration of the system was performed (see chapter 2) and the scrub 
research clinician sterilised the probe connections on a disinfected trolley. The connections 
were submerged for 20 minutes in a sterilising solution containing 5% hexidine. The 
consultant surgeon initiated the operation with the mobilisation of the gastrointestinal tract. 
Prior to transection of any feeding vessel, the clinical microdialysis probe was tunnelled in 
the seromuscular layer of the viscus by hand using an 18 gauge catheter (Abbott 
Laboratories, Il, USA) and then fixed in place with seromuscular sutures in a looped-shape 
to avoid kinking or breaking (Figure 4.1).  
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a)  
 
b) 
 
Figure 4.1: Insertion and fixation of the probe in the bowel wall. 
a) The probe was tunnelled in the seromuscular layer and sutured to ensure fixation, b) the probe remains 
tunnelled while the surgeon is moving the tissue to perform the operation. 
Once the microdialysis (MD) probe was inserted and fixed, the outlet was connected to the 
valve of the on-line rapid sampling microdialysis (rsMD) system. Before continuing with the 
surgical operation, a delay of 15 - 20 minutes was necessary for the dialysate to flow 
through the outlet tube. The GI probe has an outlet length of 220 mm and inlet 600 mm with 
a diameter of 1 mm. For electrical safety, the outlet could have been 0.5-metres long, but in 
practice 1.5 metres were used to provide the surgeon with the flexibility of manipulating the 
tissue. Following this time, the surgeon proceeded with the operation transecting the veins 
and arteries feeding that part of the colon. Glucose and lactate dialysate levels were 
recorded continuously every 30 seconds during the resection. When the surgeon performed 
any event, such as clamping of major vessels, these were marked with the recording to 
match the time of the event with the metabolic response. Monitoring was terminated when 
the specimen was completely resected and delivered outside the surgical field.  
Figure 4.2 shows the set up of the on-line rsMD system in the operation theatre, positioned 
next to the patient bed and behind the surgeon. The extension tubes and sterilising utensils 
are illustrated here. 
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Figure 4.2: Set up of the microdialysis system in the operation theatre during surgery. 
The system is place next to the patient bed, behind the surgeon. The dotted lines are the extended connection - 
from the system to the patient and back – for electrical safety and manipulation of tissue flexibility.   
 
  Assay Calibration Time 
Operation 
Surgeon Microdialysis 
Surgeon 
        Calibration 0 Anesthesia  
      Move to Theater ≈1 h Opening of Abdomen  
 ≈ 2 h Mobilisation of GI tract  
Time=0 for stabilisation ≈ 3 h  MD implantation 
  Baseline stabilisation ≈ 3.20 h Wait  
  Time=0 for analysis ≈ 3.40 h Artery resection   
 ≈ 4 h Segment removed  
 ≈ 4.30 h  Probe removed 
       Move to lab ≈ 4.45 h Specimen to histology  
        Calibration ≈ 5 h   
Table 4.2: Time - line for the surgery monitoring. 
The surgeon, the clinician in charge of inserting the microdialysis probe, and the on-line rapid sampling 
microdialysis system performance during the surgical operation is shown in the same time line to facilitate the 
comprehension of the entire procedure. 
CMA pump 
inlet 
outlet 
STERILE 
BARRIER 
Sterile 
trolley 
rsMD on-line System 
Chapter 4: Microdialysis Monitoring of Ischaemia in Human during GastroIntestinal Surgery 
 120 
4.2.4 Data Analysis  
All times were corrected for the lag time between the probe tip and sample assay. Chart 
was used for data analysis. 
In theatre, judgments were made by looking at raw data peaks. In post-operative analysis, 
calibration curves were used to produce traces of dialysis concentrations versus time 
(Chapter 2, section 2.7). In general, a three weighed points moving average was applied to 
the concentration data to smooth the curves. For baseline periods, relationship between 
dialysate and plasma levels was studied. Linear regression analysis was applied to obtain 
statistical coefficients for this correlation. 
To quantify the effects of ischaemia caused by the main feeding artery transection, this 
event was set to zero as a common reference for all the monitorings. The seven patients 
were averaged using this normalisation. The values were presented as mean ± standard 
error (sem). Baseline levels were obtained by difference from the pre-resection and 
resection (t = 0) concentrations, and the difference between resection and post-resection 
was also calculated to illustrate the changes. The increments of glucose and lactate 
obtained were plotted in a common axis of time. Single population student T-tests was 
performed, at 10 minutes and 17 minutes post artery transection and on the mean of the 
last 5 minutes of data recorded, on baseline subtracted data to test the null hypothesis that 
values were different than zero. P-values at the 0.05 level, (p < 0.05) are considered 
significant.  
4.3 Results 
4.3.1 Pilot Study: Gastrectomies 
Two gastrectomies were monitored, where the removal of the entire stomach was 
performed. The probe was placed in this case in the same layer of the stomach wall, 
between the serosa and the muscularis. In order to remove the stomach the surgeon 
transected a larger number of arteries. This represents a highly complicating surgery and in 
most cases the probe was displaced due to the manoeuvres of the surgeon. This was the 
main reason that the microdialysis probe was sutured to the bowel.  
Gastrectomies Stabil isation Period 
After the insertion of the probe, a waiting period was required for the dialysate to reach the 
assay and for the tissue surrounding the probe to stabilise. This period of time was typically 
15 minutes for a length of 1.5 metres of tubing at a flow rate of 4 µl/min. The time due to 
flow stabilisation was only 3 minutes and the rest was for tissue stabilisation. The surgeon 
allowed that time after the insertion of the probe and although initially it was not expected to 
be a study of stabilisation period, this was also examined. The baseline of the 
gastrectomies resections was then plotted as shown in figure 4.3. 
Chapter 4: Microdialysis Monitoring of Ischaemia in Human during GastroIntestinal Surgery 
 121 
a) 
 
b) 
 
Figure 4.3: Baseline levels after microdialysis probe insertion in the stomach. 
Dialysate concentrations of glucose (a) and lactate (b) for two patients, undergoing gastrectomies, over a period 
of 15 minutes from probe implantation. Patient 1 is represented by red and green traces and patient 2 with pink 
and blue for glucose and lactate, respectively. 
Figure 4.3 presents the stabilisation period for both metabolites after probe implantation, 
which is performed at time zero in the graph. After 8 minutes in glucose and 5 minutes in 
lactate, the baseline levels were stable. At 10 minutes, the baseline was stable for both 
metabolites, but missing further results, it was decided to wait 15 minutes minimum to reach 
stabilisation. The dialysate levels for the two gastrectomies were 3.63 ± 0.04 mM and 0.81 
± 0.04 mM for glucose and lactate, respectively, after 10 minutes of probe implantation. 
These values give important information about the perfusion of the tissue. Since the 
averaged blood glucose for both patients was 7.15 ± 0.21 mM, the recovery of the 
microdialysis probe was considered to be adequate.  
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A 62 year old male patient (T.J., 29/06/06) presenting a stomach cancer was operated. A 
single gastrectomy monitoring is shown in figure 4.4. 
 
Figure 4.4: On-line monitoring of a gastrectomy. 
Concentration of glucose (red) and lactate (green) are plotted in this graph versus the time of the day. The 
levels of metabolites were monitored while the surgeon was clamping the arteries to resect the specimen. 
Dotted lines illustrate the different clamping and events: (1) gastroepiploic vein, (2) 2nd branch of gastroepiploic 
vein, (3) gastroepiploic artery, (4) probe kinked, (5) right gastric artery.  
Figure 4.4 shows the dialysate levels of glucose and lactate for a human stomach 
resection. The surgeon continues the surgical operation 20 minutes after the microdialysis 
probe had been inserted, when the metabolites levels were stable (Figure 4.5). At this point 
the levels of the metabolites were 3.78 and 0.87 mM for glucose and lactate, respectively. 
Clamping of the major veins and arteries were recorded. The clamp of the gastroepiploic 
vein (event 1 in figure 4.4) at 12 pm caused a surprising increase in glucose (5.52 mM) and 
decrease in lactate (0.71 mM). This event can be caused due to a profound collateral flow 
occurring from the other veins and arteries. The clamp of the second branch of the same 
vein (event 2 in figure 4.4) produced a decrease in glucose and increase in lactate, 
returning to the original steady-state levels 3.97 mM and 0.93 mM, respectively. The 
gastroepiploic artery transection (event 3 in figure 4.4) did not cause any immediate 
changes. However, in the following 5 minutes the probe kinked (event 4 in figure 4.4), 
probably caused by the manipulation of the tissue by the surgeon. This effect can be seen 
as an artifact peak in figure 4.6. The recording continued with the maintenance of 1 cm of 
probe in the tissue. This suggests that in this case 1 cm membrane was enough for 100% 
recovery. The transection of the right gastric artery (event 5 in figure 4.4) resulted in a 
constant rise in lactate to 1.12 mM, while glucose levels maintained at 3.67 mM.  
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Monitoring could not continue until the specimen was completely removed, due to total 
displacement of the probe. However, the failure response of the blood supply was 
successfully observed with the on-line system. 
  
Figure 4.5: Baseline on-line monitoring of a gastrectomy. 
The microdialysis probe is implanted, the time lag is corrected and levels for both metabolites, glucose (red) and 
lactate (green), stabilise after a period of time. 
Figure 4.5 illustrates a closer view of the baseline from figure 4.4. After probe implantation, 
the levels of glucose and lactate reached 6.45 mM and 0.96 mM, respectively. The blood 
glucose for this patient was 7 mM, which suggests that the probe is sampling blood glucose 
(probably due to the damage that the probe caused when tunnelling into the tissue). Seven 
minutes post-probe insertion, the baseline levels stabilise to 4.16 mM for glucose and 0.85 
mM for lactate and remain there for a further 13 minutes. This stabilisation period suggests 
that the tissue surrounding the probe is stable shortly after implantation and that surgical 
operation can continue. Furthermore, it ensures changes in metabolism are not caused by 
baseline changes. 
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Figure 4.6: Artifact in the monitoring caused by probe displacement.  
The displacement of the probe caused a drop in both glucose (red) and lactate (green), that recovered after the 
clinician pushed it in back.  
The displacement of the probe caused a rapid fall for both signals, which is more clearly 
show in figure 4.6, to 1.43 mM in glucose, and 0.46 mM in lactate. The clinician 
repositioned the probe and ensured that at least 1 cm was inside the tissue. The parallel 
change of both metabolites in the same direction was recognised as the characteristic 
signature of an artifact. 
Both cases of stomach resection allowed the optimum insertion and fixation of the probe 
firmly on the wall. The arrangement of the system in the theatre environment was also 
mastered. Gastrectomies were a complicating surgery, where the surgeon extensive 
manipulation of the tissue increased the risk of probe displacement. Hence, stomach 
operations were not further monitored. 
4.3.2 General Study: Colectomies 
Seven patients undergoing colectomy (removal of colon) via open abdomen surgery 
(laparotomy) participated in this study. Seven colectomies were performed. These involved 
three sigmoid colons, two descending colons, one right colon and one subtotal (transverse, 
descending and sigmoid) colon. Figure 4.7 illustrates the different parts of the colon named 
above. 
The inferior mesentery artery supplies the sigmoid, descending and the subtotal 
colectomies. Hence, all of these can be considered as left colectomies. In these cases a 
microdialysis probe was tunnelled in the anti-mesenteric border of the sigmoid colon at 
about 10-15 cm from the rectosigmoid junction in the distribution of the inferior mesenteric 
artery. In the case of a right colectomy, a microdialysis probe was implanted in the region 
supplied by the ileocolic artery (see figure 4.7).  
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Figure 4.7: Feeding arteries and parts of the colon. 
The superior mesenteric artery supplies the ascending (right in humans, left in the picture) colon. This artery 
branches into the right colic, the ileocolic arteries and the middle colic artery that feeds also the transverse 
(upper) colon. The inferior mesenteric supplies the descending (left in humans, right in the picture) colon. This 
artery branches into the left colic, the sigmoid that supplies the sigmoid colon and the superior rectal that feeds 
the rectum. The marginal artery feeds the entire colon and is an important collateral flow supply when there is a 
failure. The MD probe is positioned right or left depending on the side to be operated. Picture modified from 
[272]. 
 
Figure 4.8: The MRI of a cancer colon.  
The colon wall presented a tumour of 9.1 mm and indicated with the white line. The bladder and hipbones are 
labelled for the better understanding of the location of the colon wall in the scan. 
Figure 4.8 above illustrates the Magnetic Resonance Image (MRI) of a patient revealed the 
affected area of the colon. The colon in figure 4.8 is the black circle surrounded by the 
tumour of 9.1 mm marked with a white line. The surgeon will perform the resection of this 
area of colon.  
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Colectomies Stabil isation Period  
In this study the required period of time for the dialysate to reach the assay and for the 
tissue surrounding the probe to stabilise was also considered. The baseline of the seven 
colectomy patients monitored for both metabolites is shown below in figure 4.9. 
a) 
 
b) 
 
Figure 4.9: Baseline for glucose and lactate for the seven colectomies monitoring. 
The levels of glucose (a) and lactate (b) monitored between the insertion of the probe and the beginning of the 
resection are plotted versus time for the seven colectomies. The lag time was corrected for all the cases and 
time = 0 was set when probe was implanted.  
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After seven minutes, in the case of glucose and nine minutes in the case of lactate, the 
metabolites levels for all patients were stable. However, due to the lack of further 
recordings and as described before with the gastrectomies stabilisation baseline, a 15 
minutes stabilisation times were recorded before continuing surgery. The monitoring period 
between the probe implantation and the first surgical event was averaged for glucose and 
lactate for all seven cases as shown in figure 4.10. 
a) 
 
b) 
 
Figure 4.10: Glucose and lactate averaged baseline levels during colon surgeries. 
Seven patients dialysate concentrations of glucose (a) and lactate (b) were averaged for a period of 15 minutes 
from probe implantation. Data points are presented as mean ± sem, n = 7.  
Figure 4.10 illustrates the averaged response for glucose and lactate in the period between 
probe implantation and the first vein clamping. After 10 minutes of probe implantation 
steady-states values were observed. Stabilisation periods for the dialysate levels of glucose 
and lactate with the on-line rapid sampling microdialysis system were 10 ± 2 minutes at a 
perfusion flow rate of 4 µl/min. The dialysate levels were then recorded using the same 
perfusate, 2.51 ± 0.06 mM and 0.79 ± 0.02 mM (n = 7) for glucose and lactate, respectively, 
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in a healthy human bowel. This provided a reference for subsequent ischaemia values and 
ensured that changes occurring were real and due to arteries and veins clamping.  
Blood glucose levels in all patients were measured between 5-8 mM. Only one of the 
patients was diabetic, however the glucose plasma of this patient (6.2 mM) did not differ 
from the other patientsʼ glucose plasma values. To observe the tendency of the dialysate 
levels in relationship with the plasma glucose, dialysate glucose, lactate and lactate/glucose 
(L/G) ratio were plotted versus plasma glucose (figure 4.11). 
 
Figure 4.11a: Correlation between glucose dialysate levels and plasma glucose in theatre.  
The data points are shown as bars, where half of the bar is the mean value of every patient dialysate glucose 
measured over 10 minutes of baseline data. The height of the bars indicates the standard deviation and the 
error bars are the standard error. 
It is tempting to discard the point at plasma glucose of 8.01 mM and to see a linear 
correlation between dialysate glucose and plasma glucose with a slope of 1.21 ± 0.76. 
However, this regression is not significant (p = 0.188, df = 4) probably due to the lack of 
data points and the slope itself is not significantly different from zero (p = 0.20, df = 3). 
Furthermore, there is not a valid reason to drop the point. The resulting regression slope 
with all points is 0.131 (p = 0.851, df = 5, ns), again not significantly different from zero (p = 
0.86, df = 4).  
Dialysate lactate did not show correlation with plasma glucose (Figure 4.11b), and in this 
case the last point was not recognised as an outliner. The linear regression was not 
observed to be significant producing a slope of 0.11 ± 0.22 (p = 0.65, df = 5) that was not 
significantly different from zero (p = 0.65, df = 4). Hence, plasma levels cannot be 
considered as an indication of an ischaemic event.  
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Figure 4.11b: Correlation between lactate dialysate levels and plasma glucose. 
 
Figure 4.11c: Correlation between lactate/glucose ratio dialysate levels and plasma glucose. 
Lactate/glucose (L/G) ratio levels remained moderately constant in relation to plasma 
glucose. The linear regression was not observed to be significant with a slope of 0.09 ± 
0.08 (p = 0.31, df = 5) and this was not significantly different from zero (p = 0.066, df = 4). 
This suggests, since we are plotting basal levels and stable values are obtained, that L/G 
ratio would be an important parameter to detect reliable ischaemic effects. L/G values 
higher than a certain levels could mark the transition from healthy to ischaemic tissue.  
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This supports the view that the L/G ratio is a useful parameter but is not only invariant with 
changes of in vivo recovery, but seems invariant with changes in plasma glucose.  
Monitoring Induced Ischaemia  
In general terms, a partial colectomy consists of the transection of the arteries that feed that 
specific side of the colon so that the part of the colon that is affected can be partly removed. 
In the ascending colon the superior mesentery artery (SMA) is the main feeding artery. This 
branches into the right colic and ileocolic artery. In the descending colon, the main feeding 
artery is the inferior mesentery artery (IMA). The marginal artery is a branched artery that 
feeds the entire colon. The superior rectal artery feeds the rectum (see figure 4.7). Once the 
appropriate arteries were transected, that part of the colon could be removed. 
During a left colectomy, the IMA was transected firstly. The marginal artery followed by the 
transection of the rectal artery freed that part of the colon and full removal could be 
performed.  
A 71 years old male patient (A.N., 1/12/06) presented a diverticulitis in the left colon; this 
condition presents diverticula (ʻsacketsʼ) coming out of the mucosa and submucosa due to 
the weakening of muscle layers in the colon wall. Diverticulitis is most common in the 
sigmoid colon due to its increased pressure. A single left colectomy monitoring is shown in 
figure 4.12. 
Figure 4.12: A single case monitoring of a left colectomy surgery.  
Glucose concentration (red diamonds) and lactate concentration (green circles) are monitored. After 
microdialysis probe implantation and a short period of stabilisation the surgeon performances are marked as 
events: (1) inferior mesentery artery cut, (2) transection of marginal artery, (3) rectal artery transected and (4) 
removal of the specimen outside the surgical field.   
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The microdialysis probe was implanted in this patient and 15 minutes stabilisation period 
was allowed before the surgeon proceeded with the operation. This produced a baseline of 
2.34 ± 0.14 mM for glucose and 0.661 ± 0.004 mM lactate, results obtained as a mean ± 
stdev of a three consecutives data points. In the case of glucose levels an increase to 2.80 
± 0.09 mM was recorded when the surgeon performed the transection of the inferior 
mesentery artery (event 1). Glucose recovered past 5 minutes, while lactate remained 
constant. During marginal artery transection (event 2), dialysate levels were initially 
constant but changed 5 minutes after the rectal artery was transected (event 3). An 
important change in both levels was observed once the specimen was entirely removed 
(event 4), where glucose decreased to 0.32 ± 0.04 mM and lactate increased to 2.87 ± 0.31 
mM. 
During a right colectomy, the right colic and ileocolic arteries are the main feeding arteries 
and were the first transections performed. However, the surgeon found an extra branch of 
the superior mesenteric artery (SMA). The middle colic artery was the last artery transected 
before the specimen was removed.  
A 74 years old male patient (T.M., 1/09/06) presented cancer in the right colon. A single 
right colectomy monitoring is shown in figure 4.13. 
 
Figure 4.13: A single case monitoring of a right colectomy surgery.  
Glucose concentration (red) and lactate concentration (green) are monitored with time. The surgical clamps are 
marked as events, (1) right colic vein, (2) right colic artery, (3) ileocolic artery, (4) another branch of superior 
mesentery artery, (5) middle colic artery, (6) MD displaced, (7) MD in resected specimen.  
The monitoring depicted in figure 4.13 shows a 20 minutes period after the implantation of 
the microdialysis probe, where the levels of glucose and lactate were 3.71 ± 0.01 and 0.88 
± 0.02 mM, respectively. The surgeon performed three successive clamping events: the 
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right colic vein (event 1), the right colic artery (event 2) and the ilecolic artery (event 3). 
During the first two events, changes in metabolism could not be observed. Glucose and 
lactate rose to 5.78 ± 0.08 mM and 1.27 ± 0.08 mM, respectively, with the third event, 
before returning to previous levels. As both glucose and lactate changed in parallel, with a 
percentage change of 156% for glucose and 144% for lactate, this metabolic event cannot 
be distinguished from an artifact due to a transient change in microdialysis recovery, 
perhaps caused by the extensive tissue mobilisation through this procedure. 
In general, the ilecocolic artery is the main feeding artery of the right colon, however, in this 
particular case another artery was found, which branched from the SMA (event 4). 
Following transection of this last artery, glucose levels decreased slightly to 2.78 ± 0.04 mM 
and lactate increased to 1.38 ± 0.02 mM. A more pronounce change was observed after the 
middle colic artery transection (event 5) with levels of 1.82 ± 0.03 mM for glucose and 1.52 
± 0.06 mM for lactate recorded. At this point the microdialysis probe was displaced for a few 
minutes (event 6), nevertheless monitoring could continued once the probe was reinserted. 
When the recording was restarted, the metabolites were returning to previous levels, 
probably caused by a supply of blood flow from the collateral of the marginal artery. Blood 
flow failed completely once the specimen was outside the surgical field (event 7). The 
values at the end of the recording for glucose were 0.28 ± 0.05 mM and for lactate 2.24 ± 
0.01 mM.  
When taking a closer look at the parallel event (event 3 in figure 4.13), we can observe that 
glucose levels increased greater than lactate. To study this increase in glucose, the smaller 
increase in lactate was subtracted from the larger increase in glucose. Calculations were 
done with percentage of the change respect to basal value. Hence, percentage change in 
lactate was subtracted from percentage change in glucose. Glucose trace can be observed 
after the elimination of baseline shift in figure 4.14b. 
 
a)
 
b)
 
Figure 4.14: Study of glucose performance during glucose and lactate parallel event. 
a) Change in probe recovery or plasma levels caused a shift in glucose and lactate concentration levels, b) 
lactate concentration in percentage was subtracted from glucose concentration percentage, glucose is plotted 
after the subtraction. 
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Figure 4.14a shows the baseline shift for glucose and lactate traces. In figure 4.14b, the 
absolute change of lactate has been subtracted from the glucose trace, obtaining a real 
change in dialysate glucose. After this data processing it can be observed that glucose 
changes are due to the transection of the ileocolic artery (event 3 in figure 4.13). This 
suggests that the transection of the ileocolic artery (which is the main feeding artery) 
produces the same pattern as the transection of the IMA (event 1 in figure 4.12), where 
glucose increases initially but then decrease momentarily.  
Seven patients were successfully monitored in the same manner.  
 
Patient Age Gender Disease Operation Blood Glc 
6/7/06 I.T 63 Male Diverticulitis  Left colectomy 7.3 mM 
1/9/06 T.M 74 Male Cancer Right colectomy 6.3 mM* 
1/12/06 A.N 71 Male Diverticulitis  Left colectomy 6.6 mM 
16/2/07 M.B 85 Female Cancer Subtotal colectomy 7.41 mM 
20/2/07 D.F 68 Female Cancer Left colectomy 8.01 mM 
23/2/07 A.B 61 Male Cancer Left colectomy 6.2 mM 
30/3/07 J.V 69 Male Cancer Left colectomy 5.91 mM 
Table 4.3: Patients demographic data. 
The patient age, gender, disease, specimen resected and blood glucose levels are listed. * refers to a diabetic 
patient, however the blood glucose levels were found in the normal range.  
The data recorded from these monitoring were analysed and grouped. The time was 
aligned for all the procedures, setting the transection of the main feeding artery as time 
zero.  Levels of the metabolites at time zero were subtracted from the levels throughout the 
entire procedure, obtaining changes from baseline. These changes in glucose (∆[glucose]) 
and lactate (∆[lactate]) when time aligned are shown in figure 4.15. 
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Figure 4.15: Increment of glucose and lactate changes for the monitoring of seven colectomies.  
Glucose traces are displayed below and lactate traces above to follow the direction of the changes from 
baseline. The transection of the main feeding artery was aligned at t = 0 for the seven patients monitored intra-
operatively. The numbers indicate data from the seven patients. 
The glucose and lactate data, each seems to fall into two groups: one changing rapid after 
20 minutes, the other changing slowly. However, closer examination, using patientsʼ 
numbers, shows no clear relationship between fast and slow glucose and lactate traces. 
And patient blood glucose, in order of patient number (Figure 4.11a) did not show any 
tendency. Hence we can rule out probe recovery changes as a cause and differences in 
plasma levels and conclude that the changes represent a limited sample of a broad 
distribution. As the tissue is an active environment various kinetics processes can occur 
altering the tissue reaction. Pharmacological interaction such as metabolic inhibition and 
vasodilatation could also show tissue alterations [202]. 
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Statistical analysis of patient studies are often difficult due to the broad distribution and 
dispersion of data, moreover patients differences in age, conditions and treatment can 
cause the results to diverge greatly. In this case, since all the glucose traces decrease and 
all the lactate traces increased and considering the monitoring of a specific tissue we 
resumed to average the traces.  
Considering the error route, glucose traces and lactate traces were averaged for the seven 
monitorings only to apply statistical analysis.  
 
Figure 4.16: Averaged data from microdialysis monitoring of seven patients colectomies. 
Glucose (red) and lactate (green) changes are average for seven colectomies. The transection of the main 
feeding artery is normalised at zero. Levels after t = 0 represent the changes in the metabolites due to the 
deprivation of blood supply. Data shown as mean ± sem (n = 7) versus an axis of time.  
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Figure 4.16 shows the data averaged for 7 patients. Stabilisation levels for glucose and 
lactate before the transection of the main feeding artery at negative times (t= -20 – 0 min). 
Following arterial transection glucose levels are significantly decreased at 10 minutes to 
recover to previous levels by ≈17 minutes. It is past the 20 minutes time scale that glucose 
levels show a dramatic decrease maintained to the end of the recording. Lactate levels do 
not show any difference from baseline until ≈17 minutes, whereby lactate begins to 
increase constantly to the end of the monitoring. The large error bars in glucose and lactate 
values after 20 minutes reflects the variation in the length of time that levels are maintained 
before changing, that is evident in the raw data traces showed in figure 4.15. 
The purpose of this study was to verify the capability of the rsMD system to measure 
ischaemia in human bowel. Due to the difference in patient time recording an area under 
the curve analysis could not be performed. Therefore, in order to apply statistical methods, 
the mean ± sem values of glucose and lactate concentration at different times following 
arterial transection are plotted as a bars graph as shown in figure 4.17. 
 
 
Figure 4.17: Glucose and lactate mean values of the colon after feeding artery transection.  
Raw data current values were converted to concentration. From patients individual traces, 5 minutes of data 
points for glucose and lactate were averaged at 10 and 17 minutes after the main feeding artery of the colon 
was transected and at the end of the recording where the ischaemia had completely set in. The values were 
averaged for seven patients and plotted as bars, representing mean ± sem (n = 7). A 2-tailed single group t-test 
was performed comparing the data with values at t = 0 to calculate the significance. * = 95% significant, ** = 
99% significant, ns = no significant. 
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Increment of glucose levels at 10 minutes after artery transection were -0.26 ± 0.08 mM (p 
= 0.02, n = 7) and recovered by 17 minutes to 0.06 ± 0.23 mM (p = 0.79, n = 7) to then 
decrease again to -1.89 ± 0.39 mM (p = 0.01, n = 6) when ischaemia was considered total 
with the specimen completely resected. Increment of lactate levels at 10 minutes after 
artery transection were -0.07 ± 0.11 mM (p = 0.55, n = 7) to then increased in a constant 
manner to reach the value of 1.47 ± 0.53 mM (p = 0.03, n = 7). P-values are calculated by 
comparing the mean ± stdev with zero.  
Recently in microdialysis literature, the data has been shown as a lactate/glucose ratio, for 
further consistent results [273]. It has also been demonstrated to predict adverse outcomes 
in patients with traumatic brain injury [274]. This is a more general and functional manner to 
present and compare the data, and as shown in figure 4.11c is more reliable. The 
lactate/glucose ratio was plotted and can be observed in figure 4.18. 
 
 
Figure 4.18: Lactate/glucose ratio for the averaged colectomies.  
The ratio was calculated as lactate over glucose, averaged for the seven patients and plotted with the same 
time axis. Negative times indicate baseline ratio values,  t = 0 is designated as the transection of the main 
feeding artery, positive times show the ratio levels after artery transection. Values are presented as mean ± sem 
(n = 7). 
This plot reveals the reliability of this proportionality from the implantation of the probe till 20 
minutes after transection. The ratio was observed to be constant at 10 and 17 minutes at 
0.45 ± 0.08 and 0.47 ± 0.08 respectively but then increased significantly to 8.05 ± 0.96 at 
the end of the procedure (p < 0.001, n = 7).  
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4.4 Discussion  
The transition from healthy to ischaemic tissue was monitored in patients with the on-line 
rapid sampling microdialysis system during abdominal surgery. Intestinal ischaemia after 
artery transection was successfully detected and we demonstrated that the system is 
practicable to use in the clinical setting. 
Traditional indicators of perfusion may erroneously reflect an increase in aerobic glycolysis 
in patients with injury or sepsis. The correlation of systemic markers, such as leukocyte 
count, acid-base status, serum electrolyte disturbance and serum lactate with perfusion 
frequently produced invalid results [275]. Currently in the clinical settings, bowel ischaemia 
is diagnosed on the ward through imaging techniques such as laser flow Doppler [270] 
tonometry [151], injection of intravenous fluorescein [157], computerized tomography or 
magnetic resonance angiography [312]. Bowel perfusion and status is analysed via 
photograph, but changes in tissue appearance and systemic markers occur at a later stage 
where the damage caused by ischaemia is often irreversible.  
The sensitivity of our assay allows us to detect the transient decrease of tissue glucose 
after the transection of individual feeding arteries. During surgical procedures bowel 
peristalsis is minimal, although surgeon motions could affect to the recovery of the probe, 
which would appear as a parallel alteration in both glucose and lactate dialysate 
concentrations [178]. 
Two gastrectomies were used as a pilot study to optimise the arrangement of the biosensor 
system in the operation theatre, where changes in the tissue metabolism were observed 
due to transection of individual arteries. The capacity of the system to detect glucose and 
lactate changes in stomach tissue was confirmed. 
The stabilisation period was established at 10 ± 2 minutes, as we shall see in chapter 6 this 
was also confirmed in the intensive care unit (ICU) monitoring. We also established the 
normal levels of glucose (2.51 ± 0.06 mM) and lactate (0.79 ± 0.02 mM) in a healthy colon 
at a perfusion rate of 4 µl/min with our on-line system. On the other hand, baseline dialysate 
levels for gastrectomies were 3.63 ± 0.02 and 0.81 ± 0.03 mM for glucose and lactate, 
which suggests higher levels of metabolites in the stomach than in the colon. When 
comparing the stabilitation times for both groups, colon and stomach monitoring, we 
observed the same response (Figure 4.19). 
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a) 
 
b) 
 
Figure 4.19: Baseline for glucose and lactate for the nine patients monitoring. 
The levels of glucose (a) and lactate (b) monitored between the insertion of the probe and the beginning of the 
resection are plotted versus time for the nine surgeries. The lag time was corrected for all the cases and time = 
0 was set when probe was implanted. Traces numbered 1 and 2 are the glucose and lactate baseline traces for 
the gastrectomies; the rest are all colectomies. 
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a) 
 
b) 
 
Figure 4.20: Averaged baseline levels for 9 monitoring after microdialysis probe insertion. 
Baseline dialysate concentrations of glucose (a) and lactate (b) over a period of 15 minutes from probe 
implantation were averaged for nine patients (stomachs and colon surgeries). Data points are presented as 
mean ± sem, n = 9.  
When all baseline levels were averaged together a stabilisation time of 10 minutes was 
evident with values of 2.77 ± 0.57 and 0.77 ± 0.17 mM for glucose and lactate, respectively 
for healthy gastrointestinal tissue.  
Since glucose and lactate dialysate levels did not present a clear and marked tendency 
either to increase or decrease in relation to glucose plasma, the response was considered 
constant, suggesting that it was not dependent of plasma variations. 
Two single colectomy cases have been shown to illustrate the difference in the metabolites 
changes dependent on the artery transected relative to the probe position and the 
possibility of flow collateralisation. The left colectomy showed a constant value through all 
the arteries transections, only to change when the specimen is outside the surgical field, 
then the ischaemic signature was observed. In the right colectomy, the transection of the 
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ilecolic artery caused an increase in both glucose and lactate. This parallel event was 
processed, and the final observation was a momentary increase in glucose typically of the 
transection of the main feeding artery. From these single observations we question whether 
the order of the transection of the different arteries affect the outcome of that organ. This is 
an interesting field that requires further study. 
From the seven colectomies two tendencies were observed in the decrease of glucose and 
increase of lactate following arterial transection. However, no clear relationship was 
observed between glucose and lactate traces of the same patient. The hypothesis of a 
change in probe recovery was ruled out and it was concluded that the changes represent a 
limited sample of a broad distribution. 
Following the transection of the main feeding artery it was observed a momentary increase, 
followed by the expected decrease in glucose. However, levels returned to baseline values 
and maintained for an average of 17 minutes to then fall continuously. From the surgical 
perspective, these constant levels of glucose and lactate during those 17 minutes suggest a 
therapeutic window where the surgeon could still perform other actions without 
compromising the tissue. This could also represent a highly important period for the 
surgeon during the transplantation of organs or highly risky surgical operations. From a 
metabolic prospect, this glucose rebound levels suggest a supplementary source of glucose 
to the tissue or equally a decrease in metabolic rate. We hypothesise an additional supply 
by collateral flow that explains the momentary increase in glucose following the transection 
of the main feeding artery. This collateral supply ended approximately 5 minutes later, when 
the last artery had been transected. However, levels maintained during another 12 minutes. 
Furthermore, lactate/glucose ratio was constant until times past 20 minutes from the main 
feeding artery transection. Ceppa et al. suggested that the villus tip, due the countercurrent 
mechanism where oxygen diffuse rapidly from arteriole to venule, is more susceptible to 
ischaemia. [106] We hypothesized that the bowel reacts to ischaemia mobilising all the 
reservoirs of glucose before collapsing completely. 
Some studies attribute this increase in blood supply to local arteriolar vasodilatation that 
mediates compensatory autoregulatory responses [276], [277]. Two mechanisms that 
govern these compensatory responses were found in the literature: 1) Myogenic response 
is a spontaneous effect of blood vessels in response to a decrease in blood pressure. The 
smooth muscle of the blood vessels reacts to any changes depending on the endothelial 
generation of nitric oxide, which causes intestinal dilatation [278], [279]. 2) Metabolic 
response reacts by increasing the levels of adenosine, a powerful mesenteric vasodilator, 
when there is decrease of pH and oxygen tension [280]. 
When the ischemic event continues, the super-regulation of intestinal flow is no more due to 
myogenic response and the primary mechanism to maintain intestinal oxygenation is by 
increasing oxygen and nutrient extraction [281]. This is assisted by the relaxation of 
precapillary sphincters, which provide an augmentation in blood flow [282]. 
As microdialysis levels reflect the balance between supply and utilisation, an increase in 
collateral flow is seen as a returning glucose levels to pre-transection values. The results 
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also showed the maintained levels of lactate, once again demonstrating the survival 
response of the tissue to early ischaemia via the collateral circulation, before increasing. 
Therefore, these variations in intestinal lactate level cannot be a feature of a systemic 
hyperlactatemia as indicated by Tenhunen et al. [184]. 
Other microdialysis studies have been done in the bowel, mostly in animal models and in 
the peritoneal cavity [184], [183], [271], [190], [261], [186]. Although we claim that the 
intramural microdialysis has a faster onset in the detection of ischaemia, due to the 
proximity of the probe to the highly metabolic tissue, the novelty of our research is the rapid 
on-line monitoring. We obtain metabolic values every 30 seconds, which permit us to 
measure ischaemic changes as soon as they occur. Although other studies claim to monitor 
ichaemia on-line, the fastest measurements were obtained every 30 minutes. Therefore, 
these methods are not viable for surgical operation due to the need of rapid feedback. With 
a 30 minutes sampling period, the stabilisation time minimum required is 1 hour and the 
therapeutic window could have not been observed.  
Several studies have been done to evaluate tissue blood perfusion as stated previously. 
However, none of these techniques can measure rapid metabolic responses. Furthermore, 
traditional indicators of perfusion may erroneously reflect an increase in aerobic glycolysis 
in patients with injury or sepsis. Our microdialysis system can measure rapid metabolic 
changes. However, a parallel technique to assess tissue blood flow would have been a 
good addition to this study. Nevertheless, techniques such as laser Doppler present 
difficulties in the operative theatre, particularly since flow artifacts are caused by sudden 
movements.  
Ungersted et al. highlighted that lactate alone is not a good marker of ischemia because an 
increase in lactate may be the result of ischemia as well as hypermetabolism [186]. Hence, 
many current studies use the lactate/pyruvate ratio as a main marker of ischaemia. Jasson 
et al. considered normal levels in human bowel between 7.1-21.7 for lactate/pyruvate ratio 
and between 4.5-14.3 mM for glucose, measured in the intraperitoneal area and at 
perfusion flow rate of 0.3 µl/min. It claims ischaemic values for lactate/pyruvate ratio higher 
than 50 and glucose levels undetectable [190]. Our assay system does not detect pyruvate 
levels, however increase in lactate and decrease in glucose is considered a valid method 
for detection of ischaemia [178]. Zauner et al. experiments in brain models presented data 
showing that a lactate/glucose ratio higher than 4 is related to hypoxic events. [283] While 
our data in figure 4.18 is consistent with this, we suggest that lactate/glucose ratios 
measured intramural in the bowel with on-line rapid sampling microdialysis can detect the 
onset of ischaemia at much lower lactate/glucose values.  
The current study demonstrated the feasibility of using the microdialysis system in clinical 
practice and the reproducibility of the measurements in 7 patients with consistent results. 
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Chapter 5:  
Microdialysis Monitoring of Ischaemia 
of Bowel Anastomosis in Animal Models  
 
 
 
The previous chapter concluded with the success of the rapid on-line microdialysis system 
monitoring of ischaemia intraoperatively. This chapter describes the use of a porcine model 
of human bowel surgery. In this model rapid sampling microdilaysis is used to examine the 
effect of ischaemia on an anastomosis site, to assess if this site can be monitored and to 
learn how ischaemia is presented in the anastomosis compared with healthy human tissue.  
The effect of ischaemia/reperfusion, hypoxia, and hypothermia in the animal bowel 
physiology was also investigated. Finally, no-net-flux microdialysis is used to determine the 
extracellular levels of glucose and lactate in the bowel of the pig.  
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5.1 Introduction 
Bowel anastomosis is the surgical connection of two intestinal loops. Anastomosis leak is 
one of the most common complications after a gastrointestinal surgical procedure. The 
bowel becomes ischaemic if perfusion near the site of the join fails. Ischaemia causes cells 
death and tissue necrosis, hence there is loss of tissue leading to perforation in the 
intestinal wall. This in turn contaminates the abdominal cavity with intestinal contents, 
developing in major sepsis and increasing the risk of mortality. 
Anastomosis leak leads to a significant elongation of hospital stay, a major increase in 
mortality and a risk of repeated local cancer [284]. Bruce et al. composed a systematic 
review for the definition and measurement of anastomotic leak after gastrointestinal surgery 
[123]. The reported clinical leakage after anterior resection varies between 3% and 21%. 
Furthermore, postoperative mortality associated with anastomotic complication ranges from 
6% to 22% and accounts for approximately one third of all deaths following colorectal 
cancer [284]. Several risk factors have been identified for anatomosis leakage, primarily 
patient related causes and technical issues [125], [285]. 
Currently, clinical diagnosis of anastomotic leaks is due to the present of physical signs 
such as fever, onset of pelvic pain, extended ileus, renal failure and leukocytosis [286]. The 
diagnosis is complemented using CT scanning or contrast enemas. However, the diagnosis 
of ischemia in the anastomosis site of the bowel relies on the physicianʼs ability to 
recognise any visible symptoms. The anastomotic leak is conventionally treated, with iv 
antibiotics. If the leak is large a preliminary percutaneous drainage is mandatory under 
radiologic guidance, followed by surgical operation [287]. 
In general, anastomotic leaks are been assessed using clinical radiology via CT methods, 
which are considered superiors to standard radiography [288], [289]. However, information 
regarding biochemical changes at the anastomotic site is still deficient, and ischaemia is 
considered to be a highly related factor to anastomosis leakage [290]. Furthermore, at the 
time of the diagnosis of the leakage, infection and sepsis in the patient is far developed. 
The symptoms are observed on median postoperative day 7 to 11 and the non-specificity of 
the physicianʼs measurements adds complications to the diagnosis [291], [292]. A rapid 
detection of ischaemia with a method that diagnoses the leak before its clinical 
consequences is necessary in order to manage a compromised bowel anastomosis and 
decrease the morbidity and mortality associated with these leaks.  
Matthienssen et al. has studied anastomosis leaks by intraperitoneal microdialysis, 
inserting the probe free in the intra-abdominal cavity in the peri-anastomotic area to monitor 
leaks in patients [290]. The study showed a rise in dialysate lactate and a fall in dialysate 
glucose concentrations, within 24-48 hours postoperative. However, the use of off-line 
analyser every 3-4 hours can miss events due to the time frame and to dilution cause by 
the pooled sample. Unlike other studies, the microdialysis probe was implanted intramurally 
to overcome the limitations of intra abdominal and luminal microdialysis (Chapter 1). 
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The on-line rapid sampling microdialysis system was proved to be a feasible technique to 
monitor the metabolic changes that take place in a segment of human colon during and 
after resection in the clinical environment. The ischaemia monitored in the previous chapter 
was induced, therefore the tissue was expected to present biochemical changes [193]. Our 
next approach is to demonstrate the capability of ischaemia prediction. The main aim of the 
animal experiments presented here was to learn the effect of ischaemia on stapled bowel 
anastomosis in pigs prior to carry out similar study in humans.  
The physiology and pathology of human bowel is very similar to that of the pig [293]. 
Moreover, the pig has a large length of bowel (12 metres), where the practicality of several 
anastomosis was favorable, consequently porcine models were used for these 
experiments. A total of three pigs were monitored, one per day, over a period of 9 hours. In 
the case of two pigs, several anastomoses were constructed along the bowel and 
ischaemia was induced clamping the artery feeding that anastomosis. In the third pig, 
physiological variables were monitored. 
The study with animal models also gave the opportunity to carry out in vivo recovery 
experiments, using the no-net-flux method. Tissue metabolic changes were monitored with 
the on-line rapid sampling microdialysis system. The baseline period was also examined 
here. The experiments were accomplished in the facilities of Tyco Healthcare (now 
Covidien) in Elancourt, Paris. 
5.2 Methodology 
The system with all the components was shipped to Tyco Healthcare centre, in Paris and 
set up in the surgery lab. Solutions and standards were prepared previous to the monitoring 
(Chapter 2). 
All animal preparation and maintenance of anaesthesia was carried out by veterinary staff 
employed by Tyco. All measurements were carried out within the limitations of the facilities 
available within the operating theatre at Tyco. All procedures were licensed by the French 
government by the “Ministère de lʼAgriculture, de la pêche et de lʼalimentation” (Licence 
number A-78760 « Licence dʼagrément dʼun établissement dʼexpérimentation animale, 
décret number 87-848 du 19/10/1987 »).  
On-line microdialysis was used for in vivo measurements of glucose and lactate 
concentrations from dialysates of a microdialysis probe (Microbiotech MAB 7.11, 1 cm 
length, 0.6 mm diameter, 15 kDa cut-off) tunnelled intramurally in the pig bowel wall.  
Experiments were conducted on 6 months old male large white strain piglets weighing 
between 25-30 kg. They were fed regular standard diet and fasted 36 hours before surgical 
procedures. They were premedicated with intramuscular injection of ketamine 20 mg/kg 
and acepromazine 0.5 mg/kg. When sedation set in, the marginal ear vein was canulated 
and anesthesia was induced by intravenous injection of Pentobarbital 6 mg/kg and 
endotracheal intubation was carried out. The tracheal tube was connected to the Servo 
900®ventilator (Siemens, Elma-Schonander, Sweden) and ventilation was set at a rate of 
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15 breaths per minute and 20 cm H2O positive pressure. Isoflurane was titrated according 
to the pigʼs heart rate to keep the animal anesthetised. 
For physiological variable monitoring, a microdialysis probe was tunnelled in the 
seromuscular layer of the bowel. For the ichaemic anastomosis monitoring a midline 
incision was performed. Two segments of sigmoid colon were aligned together with fixation 
sutures and two colotomies performed. The GIA 80 (Covidien Healthcare, city, USA) was 
deployed across the segments through the colectomies. 
 
 
Figure 5.1: Anatomosis stapler 
Anastomosis stapler used in the colon of porcine models [294].  
The microdialysis probe (Microbiotech MAB 7.11) for animal models was tunnelled on the 
rail of the stapling device to ensure constant distance from the anastomosis (2-3 mm) to the 
sampling area (Figure 5.2a). The device was then fired to construct the anastomosis and 
the colotomies closed using a running 3/0 vicryl suture.  
The feeding mesentery artery of both segments of the anastomosis was clamped to 
simulate ischaemia. Several anastomoses were constructed and monitored for physiologic 
versus ischaemic conditions.  
For all cases an independent microdialysis probe was tunnelled in a separate segment of 
the bowel, 2 metres away from the changes provoked, (Figure 5.2b) and control 
concentrations of glucose and lactate measured off-line.  
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a)  
 
b) 
 
Figure 5.2: Microdialysis probe in the pigʼs bowel. 
a) Anastomosis construction: two segments of the colon (A and B) are joined together with the stapler, the 
microdialysis probe (yellow dotted line) is tunnelled relative to the anastomosis site (black dotted line), b) control 
and experimental probes were tunnelled in distal segments of the pig bowel and fixed with the butterfly holders. 
The microdialysis set up was prepared as explained before in chapter 2. The probe was 
connected to the CMA 400 pump in the inflow tube and run at 4 μl/min with a FEP tubing 
extension of 0.5 metres. Two additional microdialysis probes were implanted away from the 
area of interest, one being Microbiotech MAB 7.11 and the other CMA 62. These were 
inserted in order to study the in vivo recovery of both probes and will be described in 
section 5.6 of this chapter. 
All data is corrected for the time lag between dialysate leaving the probe and analysis 
(Chapter 2). All concentrations reported are dialysis levels.  
5.3 Monitoring Anastomosis 
Due to the significant and not uncommon complication after surgery in the anastomotic site, 
it is of relevant importance to know the metabolic changes occurring in the tissue after an 
anastomosis procedure. Experiments were carried out to study the effects of ischaemia in 
the stapled anastomosis. Several anastomoses were constructed along the intestines of 
pig 1 and subsequent ischaemia was induced to monitor the outcome. Two pigs were used 
for this study, however, one of them died pig 2, as consequence the effect of ischaemia in 
the anastomosis site was conducted only in one animal model. The end result was five 
anatomoses fully monitored. 
The microdialysis probe was tunnelled next to the anastomosis tool, as explained in section 
5.2, and the two segments clamped. Initially the tissue was monitored for 15 minutes to 
achieve stable physiologic values. Following steady state, the feeding mesentery artery of 
both segments of the anastomosis was clamped for 30 minutes to simulate ischaemia. 
Glucose and lactate, sampled every 30 seconds, were monitored during the entire 
procedure, pre- and post-clamping of the feeding artery. 
A 
B 
Anastomosis 
MD Probe 
Anastomosis 
stapler 
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When monitoring in the vicinity of the anastomosis similar traces as ischaemic events 
before (rise in lactate and fall in glucose) were observed. The clamping of the major feeding 
artery of the anastomosis site was set to time zero. The current peaks were converted to 
dialysate concentration and the difference between the concentration at a given time and 
time zero was calculated. The changes of concentration for five anastomoses were plotted 
versus time. 
 
Figure 5.3: Individual traces of ischaemia for anastomosis clamp. 
Five individual anastomoses constructions are plotted. Lactate traces are shown in the graph above and 
glucose traces in the graph below. Zero on the time axes indicates the clamping of the mesentery artery feeding 
the anastomosis. The concentration changes are given in mM. The traces are numbered to correlate glucose 
with lactate traces. 
Since the traces were normalised at time zero when the clamping of the feeding artery was 
performed and the changes are given as increment of concentrations the five traces can be 
averaged and plotted given the graph in figure 5.4.  
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Figure 5.4: Average of the 5 traces for the anastomosis clamp. 
Concentration increments for glucose (red) and lactate (green) are plotted versus time. Times before zero are 
stabilisation periods and zero marks the clamping of the anastomosis feeding artery. Values are presented as 
mean ± sem. 
Figure 5.4 shows the dialysate changes for glucose and lactate after clamping the feeding 
artery of the anastomosis. Following anastomosis construction, the microdialysis probe was 
implanted and stabilisation time was accomplished. These baseline values for glucose and 
lactate were 0.04 ± 0.01 mM (n = 5) and 0.28 ± 0.05 mM (n = 5), respectively. Values 
presented as mean ± standard error. 
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Thirty minutes following arterial clamp glucose levels showed a fall of 0.040 ± 0.005 mM (n 
= 5). Lactate levels instead increased during 17 minutes following arterial clamping, by 0.39 
± 0.14 mM to then decrease to 0.14 ± 0.04 mM at the end of the recording. Area under the 
curve (AUC) was calculated between time zero and 30 minutes (Figure 5.5b). For the 
statistical analysis, the area was compared to a null hypothesis of zero using an excellent 
one sample student T-test. P values less than 0.05 were considered significantly different.  
These results were compared with the control probe implanted in another segment of the 
pig bowel. The two values anastomosis-control are shown in figure 5.5a as a bar graph. A 
paired T-test was performed between the ischemia values of the anastomoses from the on-
line probe and the control values from the off-line probes.  
 
a) b) 
 
Figure 5.5: Statistics bar graphs for the anastomosis monitoring. 
a) On-line anastomosis probe versus off-line control probe. Off-line metabolites increment levels from a control 
probe are compared with on-line levels from the anastomosis probe, b) area under the curve of the ischaemia 
traces for glucose and lactate averaged for the 5 anastomoses. 
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Figure 5.5a illustrates the metabolite changes during the monitoring for the control probe 
(off-line) and the experimental probe tunnelled in the anastomosis site (on-line). For the 
control probe the values were -0.004 ± 0.002 mM and -0.01 ± 0.01 mM (n=5) for glucose 
and lactate, respectively. For the on-line monitoring probe in the anastomosis the changes 
were -0.052 ± 0.009 mM, n = 5, p = 0.005 for glucose and 0.43 ± 0.11 mM, n = 5, p = 0.02 
for lactate. The two metabolite changes were significantly different from the control level 
changes. Figure 5.5b shows the AUC analysis for glucose (-0.90 ± 0.23 mM/min, n = 5, p = 
0.001) and for lactate was 4.65 ± 1.14 mM/min (n = 5, p = 0.009). Glucose and lactate 
changes respect baseline levels are very significant. 
The lactate/glucose ratio has been observed to be a relevant indicator of ischaemia 
(Chapter 4).  
 
Figure 5.6: Lactate/glucose ratio for the averaged anastomoses data. 
The ratio was calculated as lactate divided by glucose, averaged for the five anastomoses and plotted with the 
same time axis, where zero is the transection of the main feeding artery. Values are presented as mean ± sem. 
Figure 5.6 illustrates lactate/glucose ratio averaged for five anastomoses over the same 
time axis as that shown in figure 5.4. The ratio was observed to be constant during baseline 
periods 2.96 ± 0.48, n = 5. After clamping the anastomosis feeding artery the ratio begins to 
rise and reaches a maximum at 17 minutes with value of 23.64 ± 8.33, n = 5. The ratio 
decreases again to 15.35 ± 3.18 (p = 0.004, n = 5). A paired T-test was carried out between 
5 minutes mean value from baseline and at the end of recording to obtain the p values, 
which are considered significant when less than 0.05. 
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From these results it was observed that the tissue reacted to ischaemia 5 minutes after the 
anastomosis had been constructed. This reaction time can be detected in the individual 
traces graph (Figure 5.3), in the averaged graph (Figure 5.4) and in the L/G ratio graph 
(Figure 5.6). This rapid onset of ischaemia suggested that once the tissue is being 
damaged and repaired, such in the case of resecting and connecting the tissue, a further 
damage (ischaemia) will cause a traumatic effect to the tissue.  
5.4 Comparison with Human Data 
Data from the animal model in compromised tissue due to anastomosis construction was 
compared with data from patients undergoing surgical procedures in healthy bowel. 
However, due to the difference in concentration and time scale, the percentage of the 
metabolites concentration change was calculated. The time was scaled following the 
common factor of considering zero the time when the main feeding artery was clamped. At 
this time, the concentration for glucose and lactate was considered the initial concentration, 
from which the percentage was determined. The two traces, healthy human and 
compromised animal bowel, for glucose and lactate are superimposed in the same graph 
(Figure 5.7) to illustrate the similitude or differentiation. 
While healthy human bowel, as seen in chapter 4, relied on collateral flow to cope with the 
ischemic event produced by the clamping, the animal monitoring shows a rapid change in 
metabolism immediately after clamping. Hence, the 20 minutes therapeutic window 
observed during the human monitoring was not present in the anastomotic tissue.  
Before concluding with the hypothesis that healthy tissue survived ischaemia through 
collateral flow, unlike the compromise anastomosis tissue. Two other options have to be 
considered:  
1) Phisiology of the pig bowel might be different than human bowel 
2) Probe membrane length was different, being 3 cm (CMA microdialysis probe) for 
humans and 1 cm (Microbiotech micordialysis probe) for pigs. 
Chapter 5: Microdialysis Monitoring of Anastomosis Bowel of Animal Models 
 153 
 
Figure 5.7: Healthy human data versus compromised pig data. 
Percentage of glucose and lactate is plotted versus same time axis for both monitorings: MD probe (3 cm, CMA) 
implanted in human healthy bowel wall during surgery (Chapter 4) and MD probe (1 cm, Microbiotech) 
implanted in the anastomosis site of porcine bowel wall models. The time zero is considered when the main 
feeding artery of the human colon and the anastomosis site was clamped. Data is presented as mean ± sem, 
the traces for human bowel are in red for glucose and green for lactate and for animal monitoring in orange for 
glucose and blue for lactate. 
The levels of metabolites previous to the clamping were similar in percentage (100%) for 
both scenarios. Following the transection of the feeding artery both tissues, healthy and 
compromised, diverged in response. Nevertheless, the difference could be due to the 
porcine physiology, and not due to the difference between healthy and compromised tissue 
and it is studied next. Finally, the effect of probe membrane length on in vivo recovery was 
studied in section 5.6.  
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5.5 Dialysate Sensitivity to Key Physiological Variables. 
A series of experiments modifying physiological variables were carried out to check any 
other possible difference between human and porcine models in pig 3. The physiological 
variables of blood flow, blood oxygenation and temperature have a significant impact in the 
metabolism of any tissue. Changes in these variables were induced in the animal and 
metabolic markers were monitored with the on-line rapid sampling system. 
Ischaemia was induced by clamping the mesentery artery feeding a segment of healthy 
colon, followed by reperfusion with the unclamping of the artery. Pressure of oxygen was 
then decreased to monitor hypoxia in the bowel. Finally the effect of the temperature was 
studied. 
5.5.1 Ischaemia/Reperfusion (I/R) 
A single case of ischaemia/reperfusion (I/R) was studied. The implantation of both 
experimental and control microdialysis probes were performed as described before. Data 
from healthy colon was monitored for 80 minutes.  
 
Figure 5.8: Dialysate raw Ischaemia/Reperfusion baseline after microdialysis probe implantation.  
Glucose (red) and lactate (green) raw data peaks show the pattern of baseline levels during 1 hour after probe 
implantation. Dotted vertical line indicates time of the first clamping. Probe: Microbiotech 7.11, flow rate: 4 
µl/min. The MD probe was implanted at time zero. 
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Five minutes after probe implantation the first readings were obtained from the 
microdialysis probe. This determines the lag time for this probe. The baseline was 
considered to be stable 15 minutes after the first readings. However, glucose and lactate 
levels showed a later increase in the peak amplitude, reaching values double than those 
obtained at the beginning of monitoring. This rise occurred in parallel in both metabolites, 
which could imply a change of probe recovery, or an increase in plasma levels. 
Unfortunately, measuring blood glucose and lactate was not available in the facilities of the 
laboratories. Due to the lack of this measurement, the organisation of the experiments (one 
animal was used for the physiological data recording and two for the anastomosis 
recording), and the high cost of the models, it was necessary to proceed with the study. 
Nevertheless, a lactate/glucose ratio analysis was applied during this period of time to have 
a better understanding of this event. 
 
Figure 5.9: Lactate/Glucose ratio for the Ischaemia/Reperfusion baseline. 
L/G ratio trace was obtained from data set between 5 and 65 minutes in figure 5.8. 
Fifteen minutes following probe implantation the baseline was considered stable. Even 
though there was an increase of L/G ratio at 40 minutes, affirming a change in baseline 
levels, this returns to previous levels, and suggests a temporal change of either recovery or 
plasma levels. 
The rapid increase followed by a decrease observed in both glucose and lactate at 55 
minute in figure 5.8 appears in figure 5.9 as a relatively stable lactate/glucose ratio. This is 
potentially an artifact due to a change in probe recovery (change of metabolites 
concentration in the dialysate) or mechanical effect from surgeon maneouvre or it could 
represent a parallel change in glucose and lactate of metabolic origin. Without additional 
evidences these causes could not be distinguished, consequently, in line with good 
microdialysis practice, such parallel changes were excluded from analysis. [178]. 
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The vertical dotted line in figure 5.8 indicates clamping of the artery feeding the part of the 
colon containing the microdialysis probe. The baseline will be considered 5 minutes before 
the clamping, the concentration at this point is 0.63 ± 0.15 mM for glucose and 1.25 ± 0.01 
mM for lactate. 
The feeding artery was occluded for 30 minutes using a clip. Subsequently the artery was 
unclamped, allowing reperfusion of the colon and data was collected for a further 35 
minutes. The results are shown below in figure 5.10. 
 
Figure 5.10: Monitoring Ischaemia/Reperfusion. 
Glucose (red) and lactate (green) current levels are plotted versus time and the markers for the clamping and 
unclamping of the artery indicated with vertical dotted lines. The horizontal dotted lines illustrate the baseline 
levels before the clamping. Time is scaled to zero at the beginning of the graph. 
Figure 5.10 shows the trace from the ischemia reperfusion monitoring. The time is scaled to 
zero at the beginning of the graph, where 8 minutes of baseline can be observed. Mean ± 
stdev of three data points were calculated. Levels of metabolites are illustrated in units of 
current as raw data. Glucose oxidation reached a baseline of 0.20 ± 0.02 μA. After 
clamping the mesentery artery the current rose to 0.26 ± 0.04 μA acutely but then 
decreased to 0.15 ± 0.03 μA after 11 minutes. This level seemed to slowly recover, 
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probably due to collateral flow, however a more pronounce increase was observed with the 
unclamping where the current returns to its baseline.  
Lactate on the other hand, presented a baseline current of 0.60 ± 0.05 μA and it remained 
constant even 10 minutes after clamping. Once the artery was clamped lactate increased to 
1.10 ± 0.11 μA. This value was constant during unclamping and 15 minutes later dropped 
down to a value of 0.80 ± 0.09 μA, but did not return to the baseline value of 0.60 ± 0.05 
μA.  
 
Figure 5.11: Ischaemia/Reperfusion concentration plot. 
Glucose (red diamonds) and lactate (green circles) concentration levels are plotted versus time and the markers 
for the clamping and unclamping of the artery indicated with vertical dotted lines. Area in grey from 30 to 33 
minutes indicates an artifact event. 
Figure 5.11 collects the information of ischaemia/reperfusion in concentration levels. Mean 
± stdev of three data points were calculated. Before the clamping glucose levels were 0.74 
± 0.12 mM and lactate 1.21 ± 0.05 mM. Following the clamping both metabolites increased 
initially, glucose then decreased to a minimum of 0.47 ± 0.09 mM and lactate increased to 
1.59 ± 0.13 mM. Further increase in lactate occurred, reaching a value of 2.0 ± 0.07 mM, 
however, glucose levels resisted the ischaemic insult, returning to previous levels of 0.6 ± 
0.11 mM. Once the clamp was retired, glucose levels recovered faster to reach values of 
0.77 ± 0.15 mM and lactate decreased to 1.53 ± 0.09 mM. The area marked with a grey 
rectangle refers to an artifact, identified due to the parallel change of levels for both glucose 
and lactate. From these results it can be observed the lower glucose and higher lactate 
values compared with human data (2.51 ± 0.06 mM for glucose and 0.79 ± 0.02 mM (n = 7) 
for lactate, chapter 4). 
1 
1.5 
2 
2.5 
0.4 
0.6 
0.8 
1 
0 10 20 30 40 50 60 70 80 
[L
ac
ta
te
 ] 
/ m
M
 
[G
lu
co
se
] /
 m
M
 
Time / min 
clamp unclamp 
Chapter 5: Microdialysis Monitoring of Anastomosis Bowel of Animal Models 
 158 
After 50 minutes the clamping was repeated in the same artery and this time, no 
reperfusion was followed. The data was recorded on-line for 10 minutes and then switched 
to off-line, recording for a further 2 hours.  
 
 
Figure 5.12: Total clamp after Ischaemia/Reperfusion monitoring 
The artery was clamped again, this time permanently, and the metabolites changes were monitored on-line for 
10 minutes and off-line every 15-20 minutes, as a mean of three samples. Glucose (diamonds, red) and lactate 
(circles, green), off-line stdev typically smaller than symbols. 
Figure 5.12 shows the changes in concentration for the second and permanent clamp 
performed in the artery feeding a part of the pig bowel. Time axis were plotted as a 
continuation of figure 5.11, starting at minute 80. Off-line samples were collected every 15-
20 minutes into small vials and measured at the end of the day, taking the mean of three 
samples. 
The results were analysed and control probe data was compared to experimental probe 
data (values during baseline, partial ischaemia, reperfusion and total ischaemia). 
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Figure 5.13: Control and test probe bar graph. 
Comparison of ischaemia/reperfusion values from control and test probes for clamping, reperfusion and total 
ischaemia at the same probe site. Data is shown as mean ± sem (n = 3) of three measurement at each case. P-
values for the test probe are calculated (ns= no-significance, *= 95% significant, **= 99% significant) compared 
to control probe values measured off-line and in parallel over the entire experiment. Values for test probe are 
mean of 3 samples five minutes before clamping for baseline values, 20 min after first clamping, 30 min after 
unclamping and 1 h and 30 min after permanent clamping. 
The data from these experiments are summarised in figure 5.13. It shows the dialysate 
levels for glucose and lactate for the control probe being these 0.71 ± 0.09 mM and 1.35 ± 
0.02 mM, respectively. The baseline values for the experimental probe were 0.73 ± 0.23 
mM, p = 0.85 for glucose and 1.25 ± 0.01 mM, p = 0.59 for lactate and show a non-
significant difference. When artery was temporary clamped, glucose levels decreased to 
0.471 ± 0.004 mM, p = 0.05 and lactate increased to 2.03 ± 0.01 mM, p = 0.02 with a 
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significant difference of 95%. And the unclamping event showed the levels recovered to the 
values of 0.792 ± 0.001 mM, p = 0.24 for glucose and 1.38 ± 0.01 mM, p = 0.55 for lactate, 
again showing not significant difference versus control probe. Following 150 minutes from 
total clamping the levels of glucose and lactate were 0.009 ± 0.001 mM, p = 0.005 and 1.87 
± 0.01 mM, p = 0.04, respectively and suggest a total ischaemia, with a significant 
difference of 99% versus control levels in the case of glucose. 
The single run experiment to monitor ischaemia in the colon of animal models showed the 
decrease of glucose and increasing of lactate after arterial clamping. The levels of 
metabolites recovered after the unclamping of the artery, however the concentrations did 
not normalise completely after reperfusion. This reveals that tissue after a period of 
ischaemia appears damaged and it does not totally recover as expected following 
reperfusion. Furthermore, during the first occlusion, glucose levels showed first an increase, 
followed by a decrease 10 minutes after the artery was clamped. Lactate did not show any 
change 15 minutes after the occlusion. This result present similarities with the human data 
in chapter 4. On the repeated occlusion, glucose concentration does not increase, but 
immediately decreases following clamping. Lactate decrease after clamping and increases 
20 minutes later (anastomosis data). 
Physiological variable changes were monitored once the ichaemia-reperfusion test was 
completed in a healthy part of the pig bowel, to prevent the risk of interference with the 
habitual physiology of the pig. 
5.5.2 Reducing tissue pO2 
A pilot study reducing oxygen pressure supplied to the tissue was carried out and results 
were compared with ischaemic outcome, studied previously.  
An additional microdialysis probe was implanted in another piece of bowel from the same 
pig. The animal was ventilated via an endotracheal tube with the Servo 900®ventilator. 
Partial hypoxia was induced decreasing the administration of oxygen to the animal. The 
ventilation valve was closed, the flow from the ventilator dropped from 400 to 50 cc/min. 
The saturation pressure of oxygen (spO2) decreased gradually, from 100% till 50%. The 
heart rate was controlled during the decrease of spO2. Once the spO2 dropped to 50% the 
ventilation was switched on again and the spO2 rapidly returned to 100%. The laboratory 
lacked an accurate arterial blood gas sampling probe that would provide the facility to 
monitor the saturation pressure of oxygen. Instead this was monitored via a marginal ear 
saturation probe and its effects on metabolism recorded with the on-line system. (Figure 
5.14)  
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Figure 5.14: Effect of hypoxia on metabolites levels.  
Hypoxia was produced by stopping animal ventilation and glucose (red, diamonds) and lactate (green, circles) 
levels were recorded from the MD probe tunelled in animal bowel site. Saturated pressure of oxygen in blood 
and heart rate were simultaneously measured. Levels from control probe implanted also in the bowel wall of the 
pig but 2 metres appart from the experimental probe are also plotted (pink for glucose and blue for lactate), 
where the negative x-error bars indicate the time from the off-line collection, and y-error bars the stdev. 
Figure 5.14 shows the effect of reduced spO2 on glucose and lactate concentrations. 
Glucose showed a rapid decrease immediately after ventilation was shut down. Also 
observed was a decreased in lactate, however, the change was slower than glucose. While 
glucose levels decrease due to the lack of oxygen, lactate should have increased. Faster 
pumping of the heart, will give enough glucose to the cells to form lactate in anaerobic 
conditions. However, the capability of pumping of the heart, even at high rates, is not 
understood here. Lack of blood flow measurement facilities within the laboratory made this 
result difficult to interpret. 
The lowest dialysate levels were obtained when the spO2 was at 50%. After restoring the 
ventilation and returning to 100% spO2, values returned to steady state, however, glucose 
and lactate values did not recover immediately. The control levels illustrated in the figure 
also show the decrease for both glucose and lactate after ventilation was stopped.  
It was observed that dialysate baseline levels were lower than in the case of 
ischaemia/reperfusion. This is probably due to the alteration of the metabolic rate of the 
animal, confirmed by the similar lower levels in the control probe.  
A certain period was given for the baseline to return to previous levels, 0.213 ± 0.007 mM 
for glucose and 0.646 ± 0.012 mM for lactate before another physiological test on the pig 
tissue was studied.  
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5.5.3 Hypothermia – effect of temperature 
Hypothermia or low body temperature reduces the metabolism rate. We aimed to study this 
effect in our animal model with the on-line microdialysis system by decreasing the local 
temperature of the bowel tissue.  
In this case, since the temperature of the whole abdomen was changed, the control probe 
was used as the experimental probe. The temperature of the animal bowel before the 
hypothermia experiment began was 35.4°C, this was measured regularly with a digital 
thermometer, placing the tip on the bowel wall. Hypothermia was induced filling the animal 
abdomen with saline solution kept in the fridge. This saline was removed by suction from 
the abdomen and successive solutions at different temperatures were added. The abdomen 
temperature was cooled down twice and successively warmed up by a saline solution at 
room temperature, and changes marked in parallel with the recording (Figure 5.15).  
 
Figure 5.15: Effect of temperature  
The bars illustrating the temperature are colour-coded, red is the warmest down to blue, the coldest. The arrows 
pointing down indicate the addition of warm (red) or cold (blue) saline to the pig abdomen to either warm up or 
cool down, and the arrows pointing up indicate the removal of that saline. The black dotted lines indicate when 
the temperature was measured with a digital thermometer on the pig bowel. 
Figure 5.15 shows the changes of glucose and lactate concentration when the abdomen of 
the pig was cooled down with cold saline solution. The decrease in temperature produced a 
slightly decrease in metabolite levels. However, it was observed a larger increase in 
metabolic rates when the abdomen of the pig was warmed up. 
It can be observed that local hypothermia caused a slight decrease in glucose and lactate 
levels. A simple drop in metabolic rate for glucose with maintained blood supply would be 
seen as an increase in glucose in the extracellular tissue. The fact that we see glucose 
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decreasing slowly implies that if metabolic rate of glucose decreases then blood flow 
decreases also but to a slightly greater extent. The more interesting result is the increase in 
local temperature on each occasion, where by removal of cooling solution, or active 
warming, a sharp rise in glucose and lactate are seen. This is consistent with a rapid 
hyperemia in excess of any change in metabolic rate. 
5.5.4 Animal Death 
Following the recording of all physiological variables, an injection of ethanol with 1 mg/kg 
fentanyl was infused through the ear vein canula. The animal was monitored during that 
period to obtain a substantial hypoxic set of data (Figure 5.16).  
 
Figure 5.16: Metabolism monitoring during induced death. 
Glucose (red diamonds) and lactate (green circles) levels are recorded for 10 minutes before and one hour after 
euthanasia was provoked. An injection of ethanol with 1 mg/kg of fentanyl was infused through the ear vein 
canula. 
Figure 5.16 shows the effect of the euthanasia in the animal. Baseline levels were seen 
before the injection of fentanyl, 0.33 mM for glucose and 0.73 mM for lactate. When the 
fentanyl was injected glucose levels spiked to 0.53 mM to then decrease almost 
immediately to 0.006 mM. Lactate levels in the other hand increased slowly over the period 
of 50 minutes, to then increase rapidly to 2.20 mM, approximately and disappeared to 
levels of 0.080 mM. The standard deviation of the data showed an interesting detail. In 
glucose trend, the standard deviation decreased from 0.034 mM to 0.021 mM, and finally to 
0.0008 mM. This extremely steady state at the end of the recording, suggests once more 
the death of the tissue.  
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The second day of experiments, another animal (pig 2) was prepared to construct 
anastomosis and monitor ischaemia; however, the animal died unexpectedly, hence 
another set of hypoxia was obtained from that monitoring (Figure 5.17).  
 
Figure 5.17: Metabolism monitoring during death. 
Glucose (red diamonds) and lactate (green circles) levels recorded when the animal became hypoxic and 
unexpectedly died. Levels from control probe implanted further away from the experimental probe (pink for 
glucose and blue for lactate) are also plotted, where the negative x-error bars indicate the time from the off-line 
collection, and y-error bars, typically smaller than symbol, are the stdev. 15 µg/kg of atropine was injected 
through the ear vein canula to increase heart rate. 
Figure 5.17 shows the effect of hypoxia in the levels of metabolites. The probe was 
implanted next to an anastomosis just performed and the levels of glucose and lactate 
rapidly decreased. The first levels recorded were aproximately 0.88 mM for glucose and 
2.08 mM for lactate. However, these rapidly decreased, and the clinician realised by this 
pattern that the pig was in hypoxic attack and started to perform external cardiac massage. 
The levels decreased dramatically to 0.024 mM in glucose and to 1.64 mM in lactate. The 
veterinary injected a bolus of 15 µg/kg of atropine through the ear vein canula to increase 
the heart rate and this caused a significant increase to lactate levels (3.48 mM), without 
significant changes in glucose (0.08 mM). However, the increase in lactate was an 
indication of the lack of oxygen and temporal supply of glucose by the heartʼs strong 
pumping. Subsequently, the levels of lactate decreased immediately to 0.75 mM, while 
glucose levels remained low until almost disappearing (0.016 mM). The heart rate at this 
point was 145 beats/min and the saturation pressure of oxygen 50%. The veterinary 
resolved that the animal was dead. A second non-stimulated lactate peak before to the final 
drop; the lactate levels peaked to 1.94 mM before decreasing to 0.48 mM at the end of the 
recording. This pattern was observed previously in the experiment where euthanasia was 
induced.  
0
1
2
3
0
0.3
0.6
0.9
13:56 14:06 14:16 14:26 14:36 14:46 14:56
[L
ac
ta
te
] /
 m
M

[G
lu
co
se
] /
 m
M

Time of day / hh:mm
D
EA
TH
 
pi
g 
hy
po
xi
c 
at
ro
pi
ne
 in
je
ct
io
n 
 
Chapter 5: Microdialysis Monitoring of Anastomosis Bowel of Animal Models 
 165 
The three hypoxic experiments, either by reduction of spO2 or by euthanasia in pig 3, or by 
the unexpected death of pig 2, showed a hypoxic event, however the means of this event 
were different for each experiment. Following the shut down of the ventilation, dialysate 
glucose and lactate levels decreased dramatically. However, this drop became less 
pronounced, probably due to the fact that the heart was pumping to compensate the 
deficiency of oxygen. Following the return of the ventilation, the concentrations of glucose 
and lactate returned to normal levels (Figure 5.14). On the other hand, when euthanasia 
was induced a different effect was observed. At the moment of the lethal injection, both 
metabolites showed a minor increase followed by a dramatic decrease in glucose to 
negligible levels. Lactate instead peaked after one hour in a rapid time scale to decrease to 
zero levels (Figure 5.16). In the case where the pig died, the same pattern of lactate levels 
(an increase before a dramatically drop) was observed (Figure 5.17). This is thought to be 
the metabolic mechanism of cell death [295]. 
5.6 In vivo Recovery of Microdialysis Probe 
Relative recovery (R) has been measured in vitro in chapter 3 and showed to vary with flow 
rate. In vivo, the tissue environment adds many additional factors that cannot be recreated 
in the beaker. In general in vitro, the extent of concentration is known, and recovery can be 
measured. In vitro, the probe is exposed to a greater number of homogenous solutions with 
unimpeded diffusion of analytes to the probe. In contrast in vivo, only a small fraction is 
sampled, molecules diffuse through tortuous paths to reach the probe and some of the 
molecules may be metabolised [175]. Thus, in vitro recovery cannot accurately be used for 
in vivo calibration. Since we were unable to do in vivo monitoring with patient during surgery 
we overcame this difficulty by recording in vivo recovery in animal models.  
In order to determine CEXT, a Microbiotech (for use experimentally, with a length of 1 cm) 
and a CMA probe (for use in the bowel of humans, with a length of 3 cm) were tunnelled 
into the seromuscular layer of the colon of pig 2. These probes were implanted in a 
separate segment of the bowel, 2 metres away from the induced changes, and measured 
off-line. Saline solutions with different concentrations (0, 0.25, 0.5, 1, 2, 3 and 4 mM) of 
glucose and lactate standards were perfused. The dialysate was collected every 30 minutes 
in 500 µl eppendorfs and the samples analysed after a day of monitoring was completed. 
The current data obtained from these recording was analysed and converted to 
concentration and the difference between concentration in perfusate and concentration in 
dialysate was plotted versus concentration in the perfusate (Figure 5.19 and 5.20). Glucose 
values of this animal (pig 2) measured with the control probe were 0.34 ± 0.15 mM. These 
levels are comparables with those of pig 3, but not with pig 1, which were lower.  
Recovery until perfusion of 1 mM of glucose and lactate standards was completed before 
this pig died. Recovery experiment was continued. However, recoveries following 1 mM of 
perfused standards cannot be taken into account. 
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For the Microbiotech microdialysis probe, the in vivo recovery experiments in porcine 
models produced the data shown in figure 5.18. 
 
 
 
Figure 5.18: In vivo recovery for Microbiotech microdialysis probe.  
a) The whole range of perfused concentration is plotted. b) Linear range of perfusate concentration is selected. 
The linear equation is y = -0.157 ± 0.011 + 0.421 ± 0.019x, calculated with linear regression using Igor software. 
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The data obtained with CMA microdialysis probe is shown in figure 5.19. 
 
 
Figure 5.19: In vivo recovery for CMA microdialysis probe.  
a) The whole range of perfused concentration is plotted. b) Linear range of perfusate concentration is selected. 
The linear equation is y = -0.233 ± 0.021 + 0.499 ± 0.036x, calculated with linear regression using Igor software.  
It is interesting to note that the recovery levels after perfused standards of 1 mM did not 
follow the trend of the first values. This is probably due to the fact that the dying tissue is 
attempting to survive using the glucose that was being perfused.  
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Figures 5.18b and 5.19b show the calibration curve for the NNF recovery method. The CECF 
was calculated from the intersection with the x-axis of the data points linear regression. To 
calculate the standard deviation of these values, equation 5.3 was applied to the linear 
regression in graph 5.18b, y = -0.147 ± 0.011 + 0.421 ± 0.019x. 
€ 
x = X aA
 
 
 
 
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2
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b
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 
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2
  (5.3) 
x = stdev of variable (CECF), X = variable (CECF), a = stdev of intersection with y-axis, A = 
value of intersection with y-axis, b = stdev of slope, B =  value of slope. These values can 
be obtained from the linear regression of the graph. 
Glucose concentration in the bowel of the pig at 4 µl/min of perfusion flow rate can be 
estimated, CEXT = 0.357 ± 0.045 mM (when CIN-COUT=0). The slope of the straight line 
shows in percentage the coefficient of extraction (E) for Microbiotech microdialysis probe, E 
= 42.1% at 4-µl/min. 
From the linear regression in graph 5.19b, y = -0.233 ± 0.021 + 0.499 ± 0.036x, and from 
equation 5.3, the glucose concentration in the pig intestine was determined to be 0.467 ± 
0.053 mM. The coefficient of extraction for the CMA probe was 49.9%. 
The Microbiotech probe showed a slightly smaller CEXT, 0.357 ± 0.045 mM compared to 
0.467 ± 0.053 mM from the CMA probe. These values are considered not significant 
different (p = 0.052, ns, df = 3), so this is pleasing as it shows that the NNF method has 
reproved the influence of the sampling probe. The slopes of the graphs (Figure 5.18b and 
5.19b) gave an extraction coefficient of 42.1% from the Microbiotech probe and 49.9% for 
the CMA probe. This is consistent with the fact that the CMA probe has a longer membrane 
(3 cm vs 1 cm). However, it is interesting to note that at 4-µl/min the effect of an additional 2 
cm of implanted membrane is only 8% in recovery terms. 
While this result was predictable [206] the little variation of extraction coefficient from both 
probes does not present a significant diversity, which may confirmed the dependency of the 
recovery in many other factors, such a tissue viability, or probe implantation damaged.  
 
 
Chapter 5: Microdialysis Monitoring of Anastomosis Bowel of Animal Models 
 169 
5.7 Discussion 
This study shows that the on-line rapid sampling microdialysis system can be used to 
predict an early ischemic event in the anastomotic segment of porcine animal models. 
Baseline values were obtained following anastomosis construction and intramural probe 
tunnelling in pig 1. Glucose and lactate dialysate levels were 0.044±0.007 mM (n=5) and 
0.280±0.046 mM (n=5), respectively, which represents lower levels of metabolites than in 
the other experiments, indicating a lower metabolism in this pig. This lower metabolism rate 
can be confirmed using the control probe levels, which remain the same throughout the 
entire experiment. After clamping the artery feeding the anastomoses, averaged glucose for 
the 5 anatomoses decreased constantly for 30 minutes, which can be explained by its 
consumption by the tissue metabolic demand and the inability to replenish it from the 
compromised blood supply. Lactate, on the other hand, increased during the first 20 
minutes, which can be justified by the inefficient oxygen delivery to the tissue characteristic 
of anaerobic metabolism and not by systemic hyperlactatemia as shown by Tenhunen et al. 
[184]. Lactate subsequentially decreased, caused by the flushing effect of the microdialysis 
probe perfusion rate, where the rate of delivery of perfusate was faster than the rate of 
lactate production.  
The same pattern was observed in the L/G ratio, 20 minutes after clamping, from baseline 
of 2.96 ± 0.48 to a maximum of 23.64 ± 8.33, and then fall to 15.35 ± 3.18. The use of the 
L/G ratio gives a better understanding of the consumption of glucose coupled with the 
excessive production of lactate, the signature of metabolic changes occurring when the 
tissue is subjected to ischemia.  
From the human data (Chapter 4), it was observed that the L/G ratio varied from 0.45 ± 
0.08 to 8.05 ± 0.96. However, little information could be extracted from the L/G ratio of the 
pig compared to human. On the other hand, when percentages were calculated and 
compared, a stronger effect could be observed. Healthy human bowel presents collateral 
flow, which protects the tissue from the ischaemic insult. However, the compromised 
anastomotic animal tissue collapsed 5 minutes after arterial clamping.  
We hypothesis that this anastomotic tissue is damaged tissue, such as that observed in the 
single ischaemia/reperfusion event. Kuzu et al. showed that the anastomosis leakage and 
septic complication could be caused by the compromised healing process of the intestine 
segment from a reperfusion injury [296]. Posma et al. showed that I/R effect before 
anastomosis construction did not reduce intestine wound strength, however, this study was 
carried out in rats [297]. Here, we established that following an anastomosis construction 
the ischaemic insult sets in faster and therefore the tissue does not have time to recover 
through collateral flow. 
Physiology experiments were carried out to analyse the effect of ischaemia in the 
anastomosis site. Effects of ischaemia/reperfusion, hypoxia and hypothermia were 
examining in pig 3 to identify any possible differences between human and pig physiology.  
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The single run I/R experiment showed a decrease in glucose and an increase in lactate 
after arterial clamping, compared to baseline levels. The baseline stabilised within the 15 
minutes period proposed (Chapter 4) after probe implantation. A slow increase could be 
observed during the following 30 minutes, which can be judged as an invasive 
consequence of the implantation of the microdilaysis probe. Khan et al. suggested 
extensive invasive consequences after microdialysis probe implantation in the brain, such 
as microcirculation disturbance, oedema, changes in the rate of glucose utilisation, loss of 
integrity of the blood barrier and production of cytokines. [298] All these conditions could 
lead to a longer period of stabilisation being required. However, when L/G ratio for this 
period was calculated, the trace showed an increase that stabilised returning to previous 
levels. We suggest that this variation can be due to a change in recovery or plasma levels, 
more conclusive data was not available since we lacked any additional method of perfusion 
measurement. Nonetheless, the literature suggests that a reduction of stabilisation time 
could be attained with a higher control of the implantation and equilibration of the probe 
[299], [300]. This would provide reliable chemical information of the living tissue. 
Furthermore, smaller microdialysis probes are necessary to reduce tissue damage.  
While the levels of metabolites recovered after unclamping the artery, the concentrations 
did not return completely to previous levels after reperfusion. This reveals that tissue after a 
period of ischaemia appears damaged and it does not totally recover following reperfusion. 
Kuzu et al. stated I/R as a high risk factor for mortality and morbidity associated with organ 
failure. Intestinal I/R releases gut-derived toxins or inflammatory mediators, such as 
reactive oxygen species and cytokines that stimulate a systemic response [296]. 
Reperfusion of ischaemic intestine has been shown to cause functional and morphologic 
changes to organs distant to the primary site of injury, such the lungs [301]. Finally, the total 
clamping showed a prominent decrease in glucose and an increase in lactate, indicating 
total ischaemia. 
At this point we could suggest a value of glucose and lactate, measured with our on-line 
rapid sampling assay, for the bowel of the pig. Values found in the literature, measured with 
other assays are compared with our experimental values in table 5.1:  
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Authors Anaesthesia Probe Length (cm) 
Flow 
(µl/min) 
Time 
period 
(min) 
Glc (mM) 
mean±sdev 
Lct (mM) 
mean±sdev 
Our 
study: 
pig 3 
Pentobarbital       
6 mg/kg 
Microbi-
otech  1 4 15 - 60 0.71 ± 0.27 1.35 ± 0.06 
Korth 
[302] 
Midazolam      
10 mg         
Ketamine      
200 mg 
Filtral 
AN-69 
HF 
1.5 2 60 1.23 ± 0.88 0.91 ± 0.45 
Sommer 
[183] 
Propofol            
0.5 mg/kg 
CMA 60  1 0.3 >30 3.6 ± 0.6 2.11 ± 0.19 
Table 5.1: Levels of metabolites in the pig bowel throughout the literature. 
Dialysate levels of glucose and lactate in pigs found in the literature are stated. The table also shows the types 
of anaesthesia given to the animal, the type of probe, the membrane length, the flow rate of the perfusate and 
the period of measurement. 
The table 5.1 compares the dialysate metabolites levels in the pig intestine wall found in the 
literature and the values reported from our study in pig 3. For clarity the table also gives the 
type of anaesthesia, microdialysis probes, perfusion flow rate used and the period of 
measurement. For glucose values the expected rise in dialysate levels with reduced dialysis 
flow rates is found. This pattern does not hold true for the lactate values. Our value is 
higher that would be predicted from the other two. This could be an effect of anaesthetic or 
of surgical technique. Unfortunately, a no-net flux experiment to measure lactate levels 
failed due to technical issues. 
From the hypoxia experiments reliable data could not be obtained due to the lack of an 
accurate method of determination arterial blood gases. However, in both hypoxic cases (in 
the course of euthanasia and during the unexpected death of pig 2) the same pattern was 
observed. While glucose linearly decreased to negligible levels, lactate peaked before 
decreasing to zero levels. Very similar traces have been seen in the brain and seem to 
reflect cell death [295]. 
In the case of the effect of hypothermia, the most interesting finding was the increase in 
glucose and lactate flux in the bowel when a rise in abdominal temperature was applied. 
Vejchapipat et al. described the beneficial effect of moderate hypothermia resulting in a 
reduction of mucosal damage [303]. Nevertheless, when ischaemia sets in, avoiding low 
bowel temperatures would lead to an increase in perfusion and difussion of metabolites and 
hence favorable outcomes. 
In vivo recovery was studied in pig 2 to learn the extracellular concentration of glucose and 
lactate in porcine bowel. To explore further any cause of disagreement between porcine 
and human data, no-net flux recovery experiments were carried out with human CMA 
microdialysis probe and experimental Microbiotech probe used in anastomotic pigs. The 
concentration in the extracellular fluid of the pig intestine found by the NNF experiment was 
0.357 ± 0.045 mM and 0.467 ± 0.053 mM for Microbiotech and CMA probe, respectively, 
which are no significantly different. A slightly higher extraction coefficient was observed 
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from the CMA probe (49.9%) compared with the Microbiotech probe (42.1%). Since the 
Microbiotech probe had a length of 1 cm compared with the 3 cm of the CMA probe, this 
result was considered correct [206]. Furthermore, an interesting fact was observed in 
chapter 4, when the 3 cm probe was displaced from the tissue, leaving only 1 cm inside the 
tissue and the signal was not altered. This suggests that the probe length does not 
introduce as much variation in recovery as the perfusion flow rate. The coefficient of 
extraction (49.9%) obtained in the in vivo recovery experiment agreed with the relative 
recovery obtained in vitro (45.8%), in chapter 3, both measured at a flow rate of 4 µl/min. 
This confirms the validity of the in vitro experiment (well stirring conditions, created good 
mass transport).   
Microdialysis monitoring has been used before, clinically, with an off-line analyser and the 
probe implanted free in the intra-abdominal cavity in the peri-anastomotic area to predict 
leaks in patients. Mathiessen et al. showed encouraging results portraying ischemia, where 
dialysate glucose decreased and lactate increased during the first 24-48 hours post-
operation [290]. This monitoring could alert the physician of anaerobic metabolism 
processes occurring in the vicinity of the anastomosis, either from ischaemic anastomosis 
or from an inflammatory response caused by an anastomosis leak. However, the off-line 
sampling mode, normally operating every 3-4 hours, introduces a long lag period, is 
laborious, and has a high probability of failing to reveal events due to dilution into a pooled 
sample.  
Our on-line rapid sampling microdialysis system eliminates all of these disadvantages, as 
described intra-operatively [193] and post-operatively [194] in neurosurgical procedures and 
intra-operatively in bowel surgery (Chapter 4). Since our system samples every 30 seconds 
using an automatic mechanism, there is an immediate feedback to the clinician [193].  
In conclusion, this study has confirmed that the on-line rapid sampling microdialysis system 
can be use to monitor ischemia in a pig model of bowel anastomosis. However, additional 
physiological measurements and a greater number of animal subjects are necessary to 
confirm metabolic results found.  
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Chapter 6: 
Microdialysis Monitoring of Abdominal 
Aortic Aneurysm Post-Operatively in 
the Intensive Care Unit 
 
 
 
This chapter describes the monitoring of patients in the intensive care unit to check the 
viability of the colon after abdominal aortic aneurism repair surgery. Following the surgery 
the colon does not receive the blood supply through the inferior mesenteric artery and 
therefore relies on collateral flow. The microdialysis probe was implanted in the mesenteric 
border of the sigmoid colon once the operation was completed and before closing the 
abdomen. An in vivo recovery was performed in one patient using variable flow rate 
method. 
 
 
Chapter 6: Microdialysis Monitoring of Abdominal Aortic Aneurysm Post-Operatively in Intensive Care Unit 
 174 
6.1 Introduction 
Abdominal aortic aneurysm (AAA) refers to the aneurysm formed in the aorta artery, in the 
abdomen. Four types of abdominal aneurysms are known, depending on the area 
comprised by the aneurysm itself. Our study was carried out in patients presenting 
aneurysm type IV, which comprised the area between the diaphragm and the femoral 
arteries. The AAA repair consists of the insertion of a plastic graft into the artery, which 
stops the feeding of blood supply into the aneurysm (Figure 6.1). 
a)        b) 
 
Figure 6.1: Abdominal aortic aneurysm repair. 
a) In general the aneurysm occurs below the SMA and IMA. The bowel is not compromised but the extremities 
are, and risk of rupture increase with time, b) insertion of a graft to repair the aneurysm blocks the IMA, 
compromising the blood supply to the left colon. Picture modified from [304].  
During the surgery, the graft is inserted in the aorta, which also occludes the entry to the 
SMA and IMA. While SMA and other arteries feeding the right colon are opened during 
surgery, IMA remains blocked by the graft. This repair permits blood to run through the 
aorta to the extremities, impeding the feeding of the aneurysm. However, the left colon, 
previously supplied with blood by the inferior mesenteric artery, now relies on collateral flow 
only, and hence it is more likely to present complications. These complications occur in 
42% of the cases, the most common of these is ischaemic colitis with 15% of occurrence 
[305]. The post-surgical complication represents an increase in morbidity, mortality and 
prolongation of surgical stay [306]. Several risk factors have been indentified influencing 
this complication, however, the lag time between the onset of ischaemia and its diagnosis 
causes difficulties in the supervision of the patient post-operatively.  
Some of these above mentioned risk factors are rupture, intra-operative hypotension, cross-
clamping time, arrhythmias, age, low cardiac output, hypothermia, postoperative acidosis 
among others [307]. They present a strong influence on the development of ischemic colitis 
and gangrene, threatening patientsʼ life or increasing subsequent problems. In such 
situations, reducing sepsis causes a favourable outcome in the patients. Therefore, 
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obtaining an early diagnosis provides both improved management and reduces the threat of 
mortality. 
Previous chapters have demonstrated the successful use of rapid sampling microdialysis 
monitoring for the detection of ischaemia in the bowel during surgical resection (Chapter 4) 
and in anastomosis sites of swine models (Chapter 5). This study aims to use the on-line 
rapid sampling microdialysis system to assess the colon viability, postoperatively in the 
intensive care unit, of patients who underwent repair of AAA. To evaluate if this technology 
can predict ischemia biochemically before clinical signs sets in, these cases with 
compromised blood supply to the colon were observed. 
6.2 Methodology 
Patients Procedure 
Patient undergoing aortic repair surgery were asked for their consent on arrival at the 
hospital for the operation. The microdilaysis probe was implanted during surgery, only 
minutes before the surgeon closed the abdomen.  
Once the patient was in ICU data was collected and anonymously analysed. Since the 
monitoring was carried out during the period when the patient was in ICU, often sedated, 
the patient rest was not compromised and no additional pain than due to the surgery itself 
was caused. All procedures were specifically approved by the regional hospital ethical 
committee (number 06/Q0403/160 from St. Marysʼs Hospital) 
Microdialysis Procedure 
The microdialysis probe (CMA 61 hepatic probe with a longer shaft 310 mm compared with 
180 mm from the CMA 62 used in chapter 4) was inserted in the mesenteric border of the 
sigmoid colon just at the junction of the mesentery with the colon. This was done under 
advice from the surgeon in the ethics committee to avoid any leaks from the tunnelling 
process. Mesentery refers to the tissue, containing blood vessels, nerves and lymphatic, 
that supplies the bowel and attaches the organ to the body wall. The probe was tunnelled 
outside the abdominal cavity like any other surgical drain. The inlet and outlet of the 
microdialysis probe were extended to 2 metres to allow flexibility of nursing care. 
After the insertion of the probe and once the patient was in intensive care unit, the inlet of 
the microdialysis probe was attached to the syringe and saline solution pumped at high flow 
rates (5-8 µl/min) for an average of 15 minutes until dialysate was obtained through the 
outlet. Since the monitoring of these patients occurred in intensive care and for long a 
period of time, there was no need to continue to perfuse at high flow rates. Hence, the 
pump was set to 2 µl/min, the outlet of the microdialysis probe attached to the needle, 
which was inserted into the valve of the system. 
Following 48 hours of recording and before the patient was out of ICU, the microdialysis 
probe was removed by cutting the fixation sutures on the abdominal wall and pulling it out. 
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Figure 6.2: On-line rapid sampling Microdialysis system set up in ICU.  
The system is set up next to the patientsʼ bed and the monitoring occurs for 48 hours while the patient is 
sedated in ICU. A camera records the movement of the nurses around the patient to detect any disturbance or 
artifact in the measurements. The inlet and outlet of the microdialysis probe are extended for better flexibility of 
the nurse care.   
A camera (Webcam, Agent V3, Melbourne, Australia) was set on the trolley, connected to 
the computer and recording at low resolution (1 frame/s, keyframe every 10 s, H264 
compression) to avoid oversized files. The video recording is coupled to the data recording 
via Chart and has the advantage that when scrolling down the data file, the video shows the 
recording in parallel with the data. Nursing action or any disturbance around the patient 
abdomen was recorded this way. 
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The microdialysis probe did not cause any interference in the patientʼs postoperative care 
or subsequent recovery, however the tunnelling of the catheter in the bowel caused a mild 
hematoma. This was minimised by the technique mastered by the clinician in charge of the 
study, and the use of the tunneller (plastic Angiocath Gauge 18). 
Analysis of Data 
The data was processed as explained in chapter 2. Since the monitoring was, in general, 
continuous during 48h, the reactors lost sensitivity over that period of time. A calibration 
was carried out periodically, however, the overnight period, approximately 12 hours, 
occurred without calibrations. Calculating the data with either the last pre-night calibration 
or the first overnight calibration introduced errors, hence the slope of a calibration curve at a 
time (tt) was calculated. 
€ 
Slope tt( ) = Slope t0( )−
tt − t0( )
t f − t0( )
× Slope t0( )− Slope t f( )( )
 
 
 
 
 
 
 
 
 (6.1) 
where, tt= time of calculation, tf= time of first overnight calibration, t0= time of last pre-night 
calibration, slope tt= slope for calculation, slope tf= slope of first overnight calibration, slope 
t0= slope of last pre-night calibration 
Hence, with slope at time (tt) the current was transformed into concentration. 
Once the concentration was calculated a 3 points weighted moving average was performed 
to smooth the data curve from any outlier. Data recording missing for technical or other 
reasons was also plotted, i.e. the gap appears as a blank in the concentration plot. 
The glucose and lactate plasma levels were taken from the patient records during the ICU 
stay. The nurses recorded these and other physiological measurements every few hours.  
In order to construct a graph comparing plasma and dialysate levels, 5 minutes of dialysate 
levels, at the time of the plasma measurement, were averaged and plotted versus plasma 
levels. Linear regression analysis for the study of the correlation of these two variables was 
applied and regression coefficient (r2) and p values were obtained. 
6.3 In vivo Recovery (variable-flow-rate method) 
Microdialysis probe recovery has been an important factor of study throughout this work. 
For safety and regulation issues it was more difficult to perform the no-net flux in vivo 
calibration method used before (Chapter 5). However, another in vivo method to measure 
recovery was applied, the variable-flow-rate method.  
The method was carried out in patient 1, following 24 hours of on-line monitoring and when 
all the clinical parameters were stable indicating a successful recovery of the patient. Flow 
rates as low as 0.1 µL/min or less were typically used, however, due to the long times 
required for the sample to travel down the extension tube, the lowest flow rate used here 
(Figure 6.3) was 0.3-µl/min. Nevertheless, the long membrane (3 cm) used in this trial, 
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increases recovery of the probe and higher flow rates are feasible. [206] Hence, a range of 
flow rates between 0.3 - 4 µl/min were used. Transit time from the probe in the tissue to the 
assay at the new flow rate was allowed then 20 minutes of data recorded. 
a)  
 
b) 
 
Figure 6.3: Variable-flow-rate in-vivo recovery. 
The flow rate perfused through the microdialysis probe was varied from 4 µl/min to 0.3 µl/min. The values 
represent the mean ± stdev of five measures taken at each stabilised flow rate. The curve was fitted with an 
exponential function using Igor and an extrapolation to zero was completed. a) [G] at 0 µl/min = 7.4 ± 0.3 mM. 
However, the function curves at lower flow rates giving [G] = 5.8 ± 0.3 mM, b) [L] at 0 µl/min = 3.3 ± 0.2 mM.  
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From the extrapolation to zero flow in the variable-flow-rate method, the concentration 
obtained in the extracellular tissue of the patient colon was 7.4 ± 0.3 mM for glucose and 
3.3 ± 0.2 mM for lactate. Nevertheless, the extrapolation to zero flow could cause an 
overestimation of the extracellular concentration. Jacobson et al. suggested that when flow 
rates are high, the extrapolation of the curve will rise to infinite values and hence it would 
not be indicative of extracellular concentrations. [220]. In fact, in the case of glucose the 
extrapolation to zero flow was rejected, since the data suggests that at low flow rate the 
dialysis concentrations were reaching a plateau, presumably due to 100% recovery being 
obtained, as it is seen in figure 6.3. Although another data point was necessary to obtain an 
accurate estimation, the extracellular glucose level was considered 5.8 ± 0.3 mM. Lactate, 
on the other hand, does not show such an indication taken as plateau formation. Low flow 
rate data points were innacurate in this case, hence, the zero extrapolation was considered 
as an estimation of extracellular level. Since the patient was stable at the time of the in vivo 
recovery calibration and the normal plasma levels measured for glucose and lactate were 
between 5 - 10.6 mM and 1.06 - 2.25 mM, respectively, the values were considered correct. 
This is a very different response than that found in the brain [308], where brain glucose and 
lactate levels obtained by quantitative microdialysis are much lower than plasma values. 
6.4 Abdominal Aortic Aneurysm Monitoring 
In all patients an abdominal aortic aneurysm (AAA) repair surgery was performed. 
Following the operation the patient was monitored for two consecutive days in ICU. Patient 
1 is analysed in more detail than the other patients. 
6.4.1 Patient 1  
History 
I.W 22/05/08: male, 81 years old, presenting an abdominal aorta aneurysm type IV. 
Baseline levels  
The levels of glucose and lactate, over the first 24 hours, covered a range between 2.5-5.5 
mM for glucose and 1.0-2.5 mM for lactate.  
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Figure 6.4: Patient 1 (I.W 22/05/08) ICU monitoring after AAA repair surgery. 
Glucose data is represented in red and lactate in green, over a period of 24 hours. The current was transformed 
into concentration with slope at time (t) and 3 points weighted moving average was performed in the data.  
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Transient changes 
Clearly visible in figure 6.4 is an event at the time scale of 400 to 700 minutes, where 
glucose and lactate presented an opposite direction change.  
 
Figure 6.5: Glucose and lactate opposite direction change event in patient 1.  
Lactate (green) increased at the same time as glucose (red) decreased, event marked with an arrow, 
maintaining these levels for over 6 hours. A quasi-periodic oscillating pattern is emphasised with the blue 
rectangle marker.  
Figure 6.5 shows a magnified version of the change observed in figure 6.4. The reason of 
this event is unknown. Due to the nature of the event, where both metabolites move in 
opposite direction, it can be asserted that this is a genuine metabolic event, presumably a 
failure of local glucose supply compared to need, and not an artifact [206], [194]. From the 
video coupled to chart data recording, (see section 6.2) this can be confirmed as a 
spontaneous event and not induced by nurse activity. We do know however, that in this 
case the transient fall glucose levels return to pre-drop values by 1200 minutes (Figure 6.4). 
Another interesting feature can be observed in both glucose and lactate series in figure 6.5, 
where a quasi-periodic oscillation repeats over a period of time. Importantly, these 
oscillations occur in opposite directions for glucose and lactate, and hence are not 
microdialysis artifacts. These oscillations occur every 20 - 40 minutes for lactate, and 
appear to be fairly stereotypical in shape. For glucose however, the repeated shapes are 
not as clear, and might be considered artifacts, apart from the regularity of the repeat period 
and the consistency of their relation to the lactate changes. 
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We have been previously well aware of quasi-periodic noise due to an aliasing of sample 
injection and pump noise in our system, and have developed strategies to remove them 
[230]. However, in these measurements the pump noise can be ruled out, first because the 
pump noise is imperceptible and secondly because the maxim period of the pump noise is 
6.67 seconds at a flow rate of 200 µl/min, aliasing with our signal every 5 peaks (or every 5 
minutes at 1 peak/min). Other effects such as heart rate, typically 60-70 beats/min and 
breathing rate 20-30 breath/min were discarded as they are much faster than the 1 
sample/min of our sampling (Figure 6.6 a,b). 
Nursing action could be a possibility, however, the strong periodicity of these events does 
not seem to match such an action. Furthermore, examination of the video recording coupled 
to the original data files (see section 6.2) allows us to definitely rule this out as a cause.  
Bowel movement, such as peristalsis waves, fluctuates between the different parts of the 
gut. In theory, the right colon (cecum) presents 2 waves of contractions per minute, 
increasing as it goes further to the left side until in the sigmoid reaches to 6 waves of 
contractions per minute. Other major movements are mass action contraction or propelling 
movement in the large intestine occur 1 - 3 times a day according to individuals. In practice, 
the rate is unknown, since the patient was sedated and the colon was empty there is no 
need of propelling action. The left colon could also present, in these conditions, between 1 - 
2 contractions per minute. Hence aliasing in this case is a possibility (Figure 6.6 c).  
The surgeon observed the peristalsis waves when operating, though the rate was 
minimised by the anaesthesia. When monitoring intraoperatively (chapter 4), these 
oscillatory features were not observed, probably due to the anaesthesia. However, the 
colon was also moved constantly to proceed with the operation and the overall recording 
times were about 2 hours. Nevertheless, when the bowel was excised, these oscillations 
were not seen. These quasi-periodic oscillations in patients might be an important feature 
that proves the bowel is alive and functioning.  
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Figure 6.6: Possible aliasing signals of the metabolic peak sampling.  
At 2 µl/min of perfusion flow rate and 200 nl loop, the sample size in time terms is of 6 seconds. a) average of 6 
heart beats/sample, b) average of 3 breaths/sample, c) sampling rate = 1 sample per minute (red dots). If the 
peristalsis occurs approximately at 1.1 minutes (purple signal) then the aliasing signal appears at (1.1 - 1.0 ) / 2 
= 0.05 beats/min = 1 beat / 20 min. Taken a sample every minute (red dots) would take a portion of the aliasing 
signal and the result signal would be modified. 
Relation to Plasma levels 
As a routine in the ICU the nurse takes records of glucose and lactate plasma levels every 
2-4 hours.  
To observe any possible relationship between plasma and local tissue levels, an average of 
5 minutes of dialysate levels at the time of plasma records was calculated. The data is 
presented as bars, where half of the bar represents the mean value, the top and bottom of 
the bar is the standard deviation and the error bars are standard error of the mean. 
Dialysate glucose versus plasma glucose, dialysate lactate versus plasma glucose and 
dialysate lactate versus plasma lactate are shown, respectively, in figure 6.7.  
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Figure 6.7: Dialysate vs plasma levels in patient 1. 
Five minutes of dialysate levels, at the time of the plasma measurement, were averaged and plotted versus 
plasma levels. Mean ± stdev are plotted as bars, where half of the bar is the mean value and the top and the 
bottom parts of the bar the stdev. Sem values are represented with y-error lines (n=5). a) dialysate glucose vs 
plasma glucose (r2 = 0.04, p = 0.52, ns, df = 11), b) dialysate lactate vs plasma glucose (r2 = 0.64, p = 0.45, ns, 
df = 11), c) dialysate lactate vs plasma lactate (r2 = 0.19, p = 0.16, ns, df = 11). 
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There is no linear relationship between dialysate and plasma levels for glucose and lactate. 
This is an important finding because although plasma levels vary by a factor of 2, the 
microdialysis levels are not driven by this change. Consequently, in comparing patients we 
do need to normalise for plasma levels. Furthermore, we can rule out changes in plasma 
levels as a cause of spontaneous changes in microdialysis levels. 
Lactate/Glucose Ratio  
Lactate/glucose ratio has been established previously (chapter 4 and 5) to be an important 
measurement of the degree of ischaemia. The ratio for patient 1 is shown in figure 6.8. 
 
Figure 6.8: Patient 1 Lactate/Glucose ratio traces. 
Lactate over glucose concentration was calculated to plot the ratio versus time.  
Figure 6.8 shows the trace of the ratio lactate/glucose over 30 hours period for patient 1. 
The levels increased by 0.2 after 400 minutes, which represents the transient event shown 
in figure 6.5, but then decreased to previous levels. This transient change can be 
considered as a partial ischaemic event. Nevertheless, no major changes were observed, 
suggesting that L/G ratio was constant. The patient was discharged without complications, 
hence the lack of ischaemic event was also confirmed by clinicians. 
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6.4.2 Patient 2   
 
 
Figure 6.9: Patient 2 (J.C 
13/08/08) ICU 
monitoring after AAA 
repair surgery. 
Glucose data is 
represented in red 
and lactate in green. The graph 
shows a recording for 30 hours. 
The current was transformed into 
concentration with slope at 
time (t) and 3 points 
weighted moving 
average was 
performed in the 
data. 
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History 
J.C. 13/08/08: male, 73 years old, presenting an abdominal aorta aneurysm type IV. 
Baseline  
Figure 6.9 shows the first 6 hours were lost due to technical problems. Following a period of 
a slightly instability the levels were constant, both, glucose and lactate at 2mM. At about 
1200 minutes from the beginning of the recording lactate levels decreased slowly to 1 mM 
and glucose increased to reach a range between 2-3 mM.  
Lactate/Glucose Ratio 
Figure 6.10 shows the lactate/glucose ratio for patient 2 data.  
 
 
Figure 6.10: Patient 2 Lactate/Glucose ratio traces. 
Lactate over glucose concentration was calculated to plot the ratio versus time.  
Figure 6.10 shows L/G ratio for patient 2 for over 24 hours. The first 400 minutes cannot be 
considered, since technical problems occurred. The trace was kept constant for the rest of 
the recording with changes lower than 0.5, hence no ischaemic events were recognised. 
This patient was also discharged without complication. 
Relation to Plasma Levels 
The three plasma – dialysate correlations plots are shown in figure 6.11. 
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Figure 6.11: Dialysate levels versus plasma levels in patient 2.  
Five minutes of dialysate levels, at the time of the plasma measurement, were averaged and plotted versus 
plasma levels. Mean ± stdev are plotted as bar, where half of the bar is the mean value and the top and the 
bottom parts of the bar the stdev. Sem values are represented with y-error lines. a) dialysate glucose vs plasma 
glucose (r2 = 0.007, p = 0.778, ns, df = 12), b) dialysate lactate vs plasma glucose (r2 = 0.07, p = 0.38, ns, df = 
12), c) dialysate lactate vs plasma lactate (r2 = 0.12, p = 0.25, ns, df = 12). 
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6.4.3 Patient 3 
History 
A.F. 11/09/08: male, 75 years old, presenting an abdominal aorta aneurysm type IV. 
 
 
Figure 6.12: Patient 3 (11/09/08). Probe displacement during ICU monitoring. 
Glucose data is represented in red and lactate in green over a period of 6 hours. The event marked as 1 
indicates the possibility of the partial displacement of the probe and event 2 indicates the possibility of the total 
displacement of the probe. 
Figure 6.12 shows the displacement of the probe in the patient bowel. Both metabolites 
showed an important increase at 30 minutes from the beginning of the recording. However, 
in the next 20 minutes a pronounce decrease, also in parallel, was observed (event 1). The 
recording continued, but 5 hours later the probe displaced completely from the patients 
abdomen (event 2). From the total displacement of the probe, it was hypothesised event 1 
as a partial displacement of the probe, caused by patient movement from nursing action, 
contributing to the increase of both metabolites and followed by the sudden decrease. The 
low levels of both glucose and lactate suggested that the measurements were being taken 
place in the peritoneal cavity. 
Baseline 
Glucose and lactate levels were roughly 4 and 3 mM, respectively at the beginning of the 
monitoring. Both of them increased, glucose to 9 mM and lactate to 4 mM to decrease after 
1 hour of monitoring to 1 mM in both glucose and lactate. 
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Lactate/Glucose Levels 
Lactate/glucose ratio for patient 3 is shown in figure 6.13. 
 
 
Figure 6.13: Patient 3 Lactate/Glucose ratio traces. 
Lactate over glucose concentration ratio versus time recorded for over 5 hours.  
In this case, the L/G ratio trace showed a slight and constant increase over time. This 
cannot be considered an ischaemic event due to the displacement of the probe. However, it 
is interesting to note that over the first 10 hours after the AAA repair surgery, the colon 
presents a tendency to ischaemia.  
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6.4.4 Patient 4 
 
Figure 6.14: Patient 4 (M.M 17/09/08) ICU monitoring after AAA repair surgery. 
Glucose data is represented red and lactate in green, over a period of 20 hours. The current was transformed 
into concentration with slope at time (t) and moving average was performed in the data. 
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History 
M.M. 17/09/08: male, 65 years old, presenting an abdominal aorta aneurysm type IV. 
Baseline 
The beginning of the monitoring in figure 6.14 shows unstable glucose and lactate levels. 
However, that is typically due to the high perfusion flow rates that the CMA pump was set 
when the probe has been attached to the syringe from one side and to the system to the 
other (see section 6.2). High perfusion flow rates reduce the recovery obtaining a lower 
signal response (Chapter 3).  
Glucose and lactate levels were in the order of 3 mM for glucose and 2 mM for lactate 
during the first stable 100 minutes of monitoring. Following this time both glucose and 
lactate levels increase to approximately 6 and 3 mM, respectively. This raise could be due 
to an increase of plasma levels or higher probe recovery. Glucose levels decreased to 
previous values, however, the signal was lost overnight due to the failure of the HPLC 
pump. The following morning the monitoring was reestablished, obtaining levels of glucose 
of 2 mM and lactate 3 mM. 
Even though, nearly over 8 hours were lost, the levels at the beginning and at the end of 
the monitoring were similar, suggesting a constant pattern. The patient was very agitated 
the following day, pulling the air entrances and other catheters, therefore the microdialysis 
probe was removed and the monitoring stopped. Nevertheless, the patient recovered 
without complications. 
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Lactate/Glucose Ratio 
Lactate/glucose ratio was obtained for patient 4 and showed in figure 6.15. 
 
Figure 6.15: Patient 4 Lactate/Glucose ratio traces. 
Lactate concentrations over glucose concentrations were calculated to plot the ratio versus time.  
It is noticeable at the end of the monitoring in figure 6.14 that lactate levels were higher 
than glucose unlike at the beginning of the monitoring. This can also be seen in L/G ratio in 
figure 6.15, where at the end of the recording the ratio tends to rise. However, the increase 
in the ratio is of 1 unit, which suggests that a unit in L/G ratio is not enough to claimed 
ischaemia. 
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6.4.5 Patient 5 
 
 
Figure 6.16: Patient 5 (M.M 10/11/08) ICU monitoring after AAA repair surgery. 
Glucose data is represented red and lactate in green, over a period of 40 hours. The current was transformed 
into concentration with slope at time (t) and moving average was performed to smooth the data. 
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History 
M.M. 10/11/08: female, 68 years old, presenting an abdominal aorta aneurysm type IV. 
Baseline 
The beginning of the monitoring shows again unstable levels due to the high perfusion flow 
rates. The signal was lost this time when the nurse walked past and disconnected the outlet 
connection from the probe to the system. 
The following morning, glucose levels were found in a range between 1.5 and 3.5 mM and 
lactate between 0.5 and 2 mM. This oscillation, however, not very clear in this figure, is the 
same oscillating pattern as seen in figure 6.6 and can be observed in figure 6.16. 
After 1500 minutes from the beginning of the monitoring, glucose and lactate levels 
decreased in parallel, to then rise again with a greater increase in glucose levels. 
Relation to Plasma Levels 
Glucose and lactate levels in dialysate are compared to the levels in plasma as shown in 
figure 6.17. 
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Figure 6.17: Dialysate levels versus plasma levels in patient 5.  
5 minutes of dialysate levels, at the time of the plasma measurement, were averaged and plotted versus plasma 
levels. Mean ± stdev are plotted as bar, where half of the bar is the mean value and the top and the bottom 
parts of the bar the stdev. Sem values are represented with y-error lines. a) dialysate glucose vs plasma 
glucose (r2 = 0.09, p = 0.19, ns, df = 14), b) dialysate lactate vs plasma glucose (r2 = 0.24, p = 0.04, df = 14), c) 
dialysate lactate vs plasma lactate (r2 = 0.62, p = 6.8x10-5, df = 14). 
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The data in patient 5 seems to present a slight correlation between dialysate lactate and 
plasma lactate. However, the regression line is poor and the data points are scattered so 
widely, that a clear trend cannot be seen. 
Lactate/Glucose Ratio 
Figure 6.18 shows lactate/glucose ratio for patient 5. 
 
 
Figure 6.18: Patient 5 Lactate/Glucose ratio traces  
Lactate over glucose concentration was calculated to plot the ratio versus time for over 40 hours. 
The L/G ratio, following the block of missing data shows an increase in signal at 1000 
minutes to then decrease slowly to the end of the monitoring. In this case, it is interesting to 
observe also the oscillating pattern of the ratio trace, which was not as clear in any other 
patientsʼ L/G ratio trace. 
The ratio varies from 0.4 (at 200 minutes) to increase to 1 (at 900 minutes) and then drops 
again to levels approximately of 0.2 (at 1500 minutes). This drop in the ratio suggests a 
stabilisation of the tissue metabolic levels, probably due to a better perfusion of the colon 
through collateral flow.  
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6.4.6 Patient 6 
 
 
 
Figure 6.19: Patient 6 (P.W 8/12/08) ICU monitoring after AAA repair surgery. 
Glucose data is represented in red and lactate in green, over a period of 25 hours. The current was transformed 
into concentration with slope at time (t) and 3 points weighted moving average was performed in the data. 
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History 
P.W. 8/12/08: male, 47 years old, presenting an abdominal aorta aneurysm type IV. 
Baseline 
Glucose and lactate levels in this patient remain fairly constant for most of the recording. 
Levels at the beginning of the monitoring were of 1 mM for both glucose and lactate. At the 
end of the monitoring lactate levels dropped to 0.5 mM and glucose increased to 2 mM. 
Lactate/Glucose Ratio 
Figure 6.20 shows lactate/glucose ratio of patient 6 for a period of 25 hours. 
 
Figure 6.20: Patient 6 (P.W 8/12/08) Lactate/Glucose ratio traces. 
Lactate concentration over glucose concentrations were calculated to plot the ratio versus time. 
Lactate/glucose ratio remains constant to decrease continuously from levels of 0.8 to 0.2 
mM, which suggests the levels of glucose and lactate in the patient are stabilising. 
Relation to Plasma Levels 
Figure 6.21 shows the relation between glucose and lactate dialysate levels and plasma 
levels.  
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Figure 6.21: Dialysate levels versus plasma levels in patient 6.  
5 minutes of dialysate levels, at the time of the plasma measurement, were averaged and plotted versus plasma 
levels. Mean ± stdev are plotted as bar, where half of the bar is the mean value and the top and the bottom 
parts of the bar the stdev. Sem values are represented with y-error lines. a) dialysate glucose vs plasma 
glucose (r2 = 5.4x10-5, p = 0.9, ns, df = 9), b) dialysate lactate vs plasma glucose (r2 = 0.76, p = 0.02,  df = 9), c) 
dialysate lactate vs plasma lactate (r2 = 0.32, p = 0.12, ns, df = 9). 
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6.4.7 Patient 7 
 
 
Figure 6.22: Patient 7 (J.S 26/01/09) ICU monitoring after AAA repair surgery. 
Glucose data is represented red and lactate in green, over a period of 20 hours. The current was transformed 
into concentration with slope at time (t) and moving average was performed in the data. 
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History 
J.S. 26/01/09: female, 37 years old, presenting an abdominal aorta aneurysm type IV. This 
patient had a medical condition known as Marfanʼs syndrome, which is a soft connective 
tissue disease. In Marfanʼs syndrome there is a lack of type IV collagen, hence the tissue is 
very malleable. The constant pumping of the aorta produced stretching of the tissue leading 
to the formation of the aneurysm. 
Baseline 
Glucose was approximately 11 mM at the beginning of the recording and lactate 2 mM. The 
levels of glucose (but not lactate) found in this patient are the highest seen in any of our 
patients. This could either be due to a massive over supply of glucose to the tissue in 
excess of utilisation. This could be caused by high local blood flow or a poor barrier 
between blood and tissue leading to better glucose availability. Alternatively, if tissue blood 
supply is normal this would imply a hyper metabolism of glucose of the tissue characteristic 
of poorly functioning tissue. Hence, glucose levels approximate to plasma levels. In the 
absence of additional physiological data we are unable to distinguish between these two 
suggestions, but it is interesting to speculate that this might be characteristic of the patient 
condition. However, we know that the standards used for calibration were correct and that 
the current peak of this patient compared to other patient double in size or more. This 
confirms that the dialysate levels reflect tissue concentration and are not due to a faulty 
assay. 
The recording period was shorter than in other cases. This patient was a young woman and 
recovered very fast from the operation. After the first 20 hours in ICU the patient was 
released to the ward. First intentions were to follow the monitoring in the ward, but the 
nurses moved the patients without warning us, pulling the probe out of the patientʼs 
abdomen. Fortunately, the probe came out neatly and did not cause any damage to the 
patient. 
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Transient Changes 
In this patient four transient spontaneous events were observed. 
 
 
Figure 6.23: Glucose and lactate opposite direction change event in patient 7.  
Lactate (green) increased at the same time as glucose (red) decreased. Four of these events are seen and 
marked with horizontal blue bars.  
Figure 6.23 shows four transient changes, where glucose decreases at the same time as 
lactate increases. Due to the opposite direction of the change between glucose and lactate 
in the four events, these can be accepted as real spontaneous events and not artifacts.  
The first glucose and lactate opposite change occurs during a long period of time, lasting 
for up to 200 minutes. Successive changes are shorter in time, recovering to previous 
levels faster. This rapid recovering suggests an improvement in bowel tissue healing or in 
other words, improvement of bowel perfusion through collateral routes. 
Relation to Plasma Levels 
Glucose and lactate dialysate levels are plotted versus plasma levels as shown in figure 
6.24.   
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Figure 6.24: Dialysate levels versus plasma levels in patient 7.  
5 minutes of dialysate levels, at the time of the plasma measurement, were averaged and plotted versus plasma 
levels. Mean ± stdev are plotted as bar, where half of the bar is the mean value and the top and the bottom 
parts of the bar the stdev. Sem values are represented with y-error lines. a) dialysate glucose vs plasma 
glucose (r2 = 0.52, p = 0.03, df = 8), b) dialysate lactate vs plasma glucose (r2 = 0.76, p = 0.002, df = 8), c) 
dialysate lactate vs plasma lactate (r2 = 0.17, p = 0.27, ns, df = 8). 
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Patients 6 and 7 presented a highly significant linear regression between dialysate lactate 
and plasma glucose level. While, it cannot be concluded that there exists a correlation 
between these two, we may suggest that at higher plasma glucose values, the correlation 
between dialysate and plasma is stronger. 
Lactate/Glucose Ratio 
L/G ratio for patient 7 is shown in figure 6.25. 
Figure 6.25: Patient 7 Lactate/Glucose ratio traces. 
Lactate over glucose concentration was calculated to plot the ratio versus time.  
The L/G ratio in this patient showed the four different transient changes marked in figure 
6.25 with horizontal orange bars. These changes were matched with the transient changes 
shown in figure 6.23 using the same time line. All four transient changes showed an 
increase in lactate/glucose ratio, hence this can be described as a temporal ischaemic 
event.  
Overall, L/G ratio decrease, from 0.2 to 0.5, which suggests the levels of glucose and 
lactate in the patient are stabilising. The L/G ratios in this patient are very low due to the 
high glucose levels. 
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6.5 Discussion  
This study shows that the on-line rapid sampling microdialysis system can be used to 
measure metabolic events of the descending colon after an abdominal aorta aneurysm 
repair surgery. 
The microdialysis probe was implanted intramural in the bowel wall and monitoring was 
carried out up to 48 hours in seven patients. The levels found agree well with those found 
acutely in chapter 4. This rejects the belief that long times (1 hour) after probe implantation 
into the tissue are needed to overcome tissue damage.  
The variable flow method of in vivo recovery was carried out in one patient once the subject 
was considered stable. The extracellular concentration obtained with this method for human 
bowel was 6.0 mM for glucose and 3.3 mM for lactate. This method is not convenient for 
conventional analytical techniques such as HPLC due to the long sampling times required 
to fill the standard HPLC sample loop at low flow rates. The on-line rapid sampling 
monitoring technique overcomes this problem due to the 200 nl sample loop. However, the 
time necessary for the analytes to travel down the probe and the extension tube connected 
to the system does introduce an impediment. In general, relative changes in the dialysis 
concentrations, where the balance between uptake and release change, are sufficient and 
in vivo calibrations are not strictly necessary. 
All the patients studied recovered without problems after the operation, hence total 
ischaemia was not observed in this study. However, transient metabolic changes that could 
be interpreted as temporal ischaemic events were observed. These transient changes are 
recognised by an increase of lactate and a parallel decrease of glucose. L/G ratio is an 
alternative measurement for these transient changes and they were observed as a 
temporal increase in the ratio levels. In general L/G ratio decrease from the beginning of the 
monitoring to the end, this suggested an improvement of local bowel perfusion through 
collateral flow. However, in a few cases there was an increase in the ratio levels. This 
increase was never over 2 units, hence it can be concluded that increases below this range 
are not an indication of acute ischaemia.  
An interesting pattern of quasi-periodic oscillatory signal was observed and recognised as 
an aliasing signal. Further studies need to be carried out measuring bowel contractions to 
describe this pattern. However, we hypothesise and aliasing signal from the peristalsis 
waves occurring in a healthy and functioning bowel tissue. Furthermore, we can confirm 
that this oscillatory pattern was not observed either intra-operatively, while the patient was 
anesthetised, silencing peristalsis waves, or in excised tissue.  
The lack of relationship between dialysate and plasma levels found in all patients tested, 
reaffirms our working hypothesis that the microdialysis levels reflect local rather than 
systemic conditions. Measuring glucose and lactate levels in plasma is not an indication of 
tissue glucose and lactate availability and therefore is not an early indicator of tissue 
ischaemia. From these we can conclude that with a factor of two changes in either plasma 
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lactate or plasma glucose, the dialysate levels are invariant. Hence, there is no systematic 
variability. 
An average of glucose and lactate dialysate levels calculated for the 5 minutes period of 
plasma measurements were average for each patient. These averages are plotted in figure 
6.26. 
 
Figure 6.26: Patients glucose and lactate dialysate levels.  
Glucose (red) and lactate (green) dialysate levels were averaged for each patient. Mean ± stdev was obtained 
from the total average of dialysate values compared with plasma values. 
The dialysate levels for glucose and lactate are found in the same range for the 7 patients. 
Only the last patient glucose levels stands out, however these agreed with plasma levels. 
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Chapter 7: 
Conclusions and Future Work  
 
 
 
This study has shown that using the on-line rapid sampling microdialysis is a feasible 
method in monitoring the ischemic changes in the metabolites of cellular respiration. Overall 
conclusions from this thesis are presented here together with a discussion of future work to 
improve the assay system and the monitoring of human bowel.  
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7.1 Summary of Results 
The primary aim of this thesis was the monitoring of the human bowel for a rapid indication 
of poor perfusion of the tissue. Intestinal ischemia is a major cause of postoperative organ 
failure and death. However, the diagnosis of intestinal ischemia still relies on visual 
inspection by the surgeon.  
The approach used was to monitor the metabolism in the bowel using the microdialysis 
technique to sample glucose and lactate as chemical markers. Past attempts at human 
bowel microdialysis have placed the probe in the peritoneal cavity with off-line analysis, 
inevitably resulting in poor coupling to bowel activity. We have implanted the microdialysis 
probe in the bowel wall of patients undergoing a gastrointestinal surgical procedure. The 
implantation technique was mastered by the clinician Mr. Deeba and outlined in chapter 2. 
For this thesis it was necessary to develop a new variant of rapid sampling microdialysis 
system previously developed in the Boutelle group for monitoring human brain. The system 
is based on flow injection analysis (FIA) coupled to enzyme reactors, which contain 
membranes loaded with the relevant enzymes. Chapter 3 describes the optimisation of the 
assay system for bowel levels of glucose and lactate and characterisation of the properties 
of bowel microdialysis probe.  
In chapter 4, the microdialysis probes were implanted intramurally in patientsʼ 
gastrointestinal tissue aimed for resection. This was monitored intra-operatively in St Maryʼs 
Hospital to explore the behaviour of the gastrointestinal tissue during an ischaemic event. 
Colon and stomach tissue were both studied. While stomach tissue showed slightly higher 
metabolites levels than colon, the stabilisation times after microdialysis probe implantation 
for both groups was 10 minutes.  
From individual observation of the seven colectomies, it was clear that a collateralisation of 
blood flow could support metabolism even when a number of feeding arteries were 
transected. 
From the average trace, it was observed that there was a therapeutic window of 20 
minutes, where levels of glucose and lactate remain constant after transection of the main 
feeding artery. This was hypothesised, from the metabolic point of view, as an additional 
supply by blood glucose held within the villi. From the surgical perspective, this could 
represent a highly important period for the surgeon, where other actions could be finished 
without compromising the tissue during the transplantation of organs or highly risky surgical 
operations.  
Currently, physical symptoms are the only measurements of intestinal ischaemia, which are 
not reliable and occur late in the development of sepsis. Hence, the prediction of failure of 
the anastomosis connection (union of two bowels after transection) is of a great interest to 
the clinicians. Chapter 5 investigates further the effects of ischemia in bowel tissue. In this 
case, the anastomotic site was the aim of this study, carried out in porcine models in the 
surgical labs of Covidien in Paris. 
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Anastomosis connections were constructed in the bowel of a pig and monitored with the on-
line rapid sampling microdialysis system. In this case, following the clamping of the artery 
feeding the anastomosis, there was an immediate decrease in glucose levels and increase 
of lactate levels. It was suggested that glucose was being consumed by the tissue 
metabolic demand and due to the blood supply being completely compromised, it was 
unable to be replenished. At the same time, the lack of oxygen provoked an increase in 
lactate generation, characteristic of anaerobic metabolism. 
We established that following an anastomosis construction the ischaemia insult sets in 
faster than in healthy tissue and therefore the tissue has no time to recover.  
In chapter 6, tissue viability with the possibility of prediction of ischaemia was examined in 
patients post-operatively, after abdominal aortic aneurysm repair surgery. The microdialysis 
probe was implanted intramurally in the bowel wall of the left colon, close to the inferior 
mesentery artery. Seven patients were monitored in ICU for up to 48 hours. 
Total ischaemia was not observed in any of the patients monitored. However, several 
transient changes, recognised by an increase of lactate and a parallel decrease of glucose 
or by an increase in L/G ratio (never higher than 2 units) were observed. These were 
described as temporal ischaemic events. Overall, there was a slow increase in glucose and 
decrease in lactate during the period of the monitoring. All the patientsʼ measurements 
presented an improvement of local bowel perfusion through collaterals. 
A quasi-periodic oscillatory signal was observed in these patients, not detected in 
anesthetised patient, or in excised tissue. We hypothesised that this pattern was an aliasing 
signal from the peristalsis waves occurring in a healthy and living bowel tissue.  
There was no correlation between dialysis levels and plasma levels of glucose and lactate 
over a 2-fold change in plasma values. 
In this thesis we have showed that the implantation of a microdialysis probe in the bowel 
wall does not affect bowel viability and does not change bowel function. We also showed 
that the changes observed represent local tissue changes. 
In conclusion we have used on-line rapid sampling microdialysis to measure successfully 
rapid metabolic responses in local gastrointestinal tissue.  
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7.2.Comparison of Results 
The levels found in chapter 4 to 6 are summarized in table 7.1. 
 
Patients1 Pig2  
Acute Chronic Pig 1 Pig 3 
Basal Levels     
Glucose (mM) 2.77±0.57 3.98±0.75 0.04±0.01 0.71±0.09 
Lactate (mM) 0.77±0.17 1.37±0.20 0.28±0.05 1.35±0.02 
L/G ratio 0.45±0.08 0.59±0.13 2.96±0.48 1.56±0.04 
Ichaemia     
L/G Ratio 8.05±0.96 - 23.64±8.33 3.5±0.1*,14.2±0.4** 
Table 7.1: Basal and Ischaemic levels in the three studies. 
Glucose, lactate and Lactate/Glucose ratio of the basal and maximum change in ischaemia levels are listed for 
human in acute, anaesthetised (n=7) and chronic, sedated cases (n=6) and for porcine models in pig 1 
(anastomosis, n=5) and pig 3 (single I/R run, n=1, *temporal clamp, **permanent clamp). For the single run 
experiment values are average of 5 minutes of data. Results are given by mean ± sdev. 1: CMA 61, 62 probes, 
3 cm membrane, 2: MBT 7.11.10, 1 cm membrane. 
7.2.1 Basal Levels 
Human Acute vs Human Chronic 
Human basal levels agreed, as shown in table 7.1, in both patients with acute condition and 
patients with chronic condition. 
In the chronic cases (Chapter 6, Figure 6.7) and acute cases (Chapter 4, Figure 4.11) 
measurements do not depend on glucose and lactate blood levels. Measuring metabolite 
plasma levels cannot be used as an indicator of local tissue availability. Hence, a technique 
for local tissue monitoring was proved to be necessary for the early detection of intestinal 
ischaemia.  
Human Surgery vs Pig Model Surgery 
The basal levels measured in patients acutely disagree with basal levels found by others 
[302] and us, in the pig used in this thesis.  
Difference in dialysate levels could be due to differences in:  
1- Plasma levels: pig plasma levels could not be measured in our experiments. To test the 
plasma levels idea directly, any difference in dialysate caused by external conditions would 
be eliminated with the use of lactate/glucose ratios. Pig plasma levels found in the 
literature, measured in arterial samples were 4.58 ± 0.22 mM for glucose and 1.28 ± 0.12 
mM for lactate [309]. Hence, pig plasma levels are similar to human plasma levels. 
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Furthermore, the stability of human dialysis levels in response to glucose levels changing 
from 3-11 mM suggests that a difference in plasma levels is not the cause. 
2- Recovery: in vivo recovery data for humans and pigs is compared in table 7.2. It is clear 
that the probe recovery is the same in the two cases. Thus, we can rule this out as the 
cause of difference. 
3- Extracellular Fluid (ECF): The ECF found in pig 2, where in vivo recovery was carried 
out, was 0.47 ± 0.05 mM. With an extraction coefficient of 49.9%, the dialysate glucose 
levels should be 0.2 mM. This compared with the glucose plasma levels of 4.58 ± 0.22 mM 
found in arterial samples of pigs, represents a difference in ECF between humanʼs gut and 
pigʼs gut. ECF of pigʼs bowel is 10% the values of plasma glucose. This result is 
comparable to the brain levels, where in human brain the ECF was found to be 1.7 mM 
[308] and in rat brain 0.47 mM [217]. Whereas the ECF of a human bowel resembles 
plasma levels. This discrepancy could be due to the difference of species.  
 
In vivo Recovery Methods  
In vitro Method 
No-Net-Flux (pig 2) Zero-Flow-Rate (human) 
Recovery @ 4µlmin 45.8% 49.9% 48.8 ± 4.2%* 
[G] ECF   (mM) - 0.47 ± 0.05 5.8 ± 0.3 
[L] ECF   (mM) - - 3.3 ± 0.2 
Table 7.2: Recovery in vivo and in vitro and extracellular concentration levels. 
Recovery in vitro and in vivo in pig models are listed, in vivo recovery in humans is calculated. Extracellular 
concentration for pig models with the no-net-flux method and for chronic patients with the variable flow rate 
method are also indicated. * Value calculated from the ECF levels obtained with the variable-flow-rate method. 
7.2.2. L/G Ratio 
The lactate/glucose ratio was presented as an extra tool for the determination of ischaemia.  
Human Acute vs Human Chronic 
• Basal levels 
In acute cases patients ratios are similar to those in chronic cases (Table 7.1). This is an 
important finding, first because it validates the use of microdialysis from the starting point 
(just following probe implantation) critical for intra-operative use. Secondly, it confirms the 
vital use of lactate/glucose ratios. 
Lactate/glucose ratios in chronic patients (0.59 ± 0.13, n = 6) remained fairly constant 
during a period of 1700 minutes (Figure 7.1).  
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Figure 7.1: Basal lactate/glucose ratios in chronic patients. 
Lactate/Glucose ratio of baseline levels 2 h after probe implantation during 30 h monitoring in human bowel in 
intensive care (n = 6, chapter 6). 
Human Surgery vs Pig Model Surgery 
• Basal levels 
Lactate/glucose ratios were calculated for the basal levels (between probe implantation and 
artery clamp) in acute human cases and pig surgery (Figure 7.2 a, b). 
a)             b)  
  
Figure 7.2: Basal lactate/glucose ratio for acute patients and animal models. 
a) 15 min baseline after probe implantation in human bowel (n=7, chapter 4), b) 10 min baseline after the 
anastomosis construction in porcine models and before clamping of arteries (n=5, chapter 5).  
Patient ratios in acute cases (Figure 7.2a) differ from those of pig models (Figure 7.2b). The 
ratio for the basal levels in the pig 1 was six times higher than that in patients. In pig 3 the 
ratio was only three times higher (Table 7.1). It is not clear, whether the anaesthesia used 
for the animals (typical anaesthesia used in the past in humans) has any effect.  
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• Ischaemic levels 
Ischaemia affects lactate/glucose ratios with an increase in both human healthy tissue and 
compromised anastomotic pig tissue. 
L/G ratios, previous to and following an arterial clamp, are plotted in figure 7.3 for 3 cases 
(acute human surgery, pig 1: anastomotic surgery and pig 3: ischaemia/reperfusion 
surgery).  
 
Figure 7.3: Ischaemia effect in lactate/glucose ratios in acute patients and pigs. 
Lactate/Glucose ratios, for patients monitored intra-operatively (purple trace, n = 7, chapter 4), porcine models 
(chapter 5), pig 1: anastomosis surgery (blue trace, n = 5), pig 3: I/R surgery (pink trace, n = 1). Values are 
presented as mean ± sem. Lactate/Glucose ratio levels before (negative x-axis) and after artery transection 
(positive x-axis). 
Lactate/glucose ratios of acute human cases remained constant for 20 minutes after arterial 
clamping, after which it increased to maximum values of approximately 8-9. In the 
compromised anastomotic tissue of pig 1, the ratio increased 5 minutes following arterial 
clamping to reach maximum levels of 20-25. On the other hand, the single I/R run in pig 3, 
presented a maximum rise in ratio to values of 3-4 following 20 minutes of arterial clamping. 
Reperfusion was allowed in this case and the clamp repeated. This time the ratio reached 
values of 14-15 in less than 5 minutes. These results confirm the hypothesis that already 
damaged tissue presents a higher and rapid ischaemic effect.  
From figure 7.3 we could suggest a threshold value for ischaemia onset when L/G ratios 
are larger than 3-4. However, this threshold value would depend on the tissue condition. To 
find a valid change in L/G ratio to alarm the clinician of an ischaemic onset, changes in L/G 
ratio relative to basal values were calculated. The ratios for each case was divided by its 
own initial values, considered at time zero, and plotted versus time (Figure 7.4). 
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Figure 7.4: Relative changes in L/G ratios due to ischaemia in acute patients and pigs. 
Lactate/Glucose relative ratios, for patients monitored intra-operatively (purple trace, n = 7, chapter 4), porcine 
models (chapter 5), pig 1: anastomosis surgery (blue trace, n = 5), pig 3: I/R surgery (pink trace, n = 1) Values 
are presented as mean ± sem. Lactate/Glucose ratio levels before (negative x-axis) and after artery transection 
(positive x-axis). 
Figure 7.4 shows L/G ratios basal levels, in the three previous cases, scaled to 1. Hence 
the changes in ratio due to an ischaemic event are relative changes. From these results we 
suggest a better threshold for the onset of ischaemia is when L/G ratios changes are larger 
than 3-4 times the historic average. 
7.3 Future Work 
7.3.1 System Developments 
Microdialysis Probe 
Currently, the tunnelling of the microdialysis probe has to be carried out by an experienced 
surgeon to avoid causing a perforation in the bowel wall. Improving the design of the probe 
would make the insertion easier and would minimise the risk of damaging the microdialysis 
membrane. However, a better approach to reduce tissue damage would be the 
miniaturisation of the microdialysis probes. This could allow, for example, a flat flexible 
probe that could be wrapped around the colon. 
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Detection 
• Flow cell biosensors 
The on-line system operates at a high time resolution of a sample every 30 seconds. 
However, other physiological events such as the peristalsis waves seem to be aliasing our 
signal. Thus, a faster detection technique is needed. Enzyme modified microelectrodes 
have been long studied in our group. Currently they are being fabricated in a flow cell to 
make them robust enough for a clinical environment. 
• Increase range of analytes 
Monitoring of other metabolic markers such as pyruvate (to allow Lactate/ Pyruvate ratios, 
often used in off-line microdialysis), urea (to allow in vivo measurements of recovery) [310] 
and glycerol (as marker of membrane degradation) [311] would provide a better 
understanding of the human bowel metabolism.  
Miniaturisation 
Unlike with brain injury [178] where the system is conveniently placed behind the patientʼs 
head, the probes in the patient bowel necessarily are in the middle of the patient where 
routine nursing access is required. Miniaturisation of the system would bring the advantage 
of a mobile system that could be place under the patientʼs bed. This will reduce the need of 
long tube extension attached to the probe and hence the possibility to work at lower flow 
rates obtaining higher recovery. To miniaturise the system we propose: 
• Fabrication of smaller electrical isolated potentiostats 
• Two smaller individual pumps will get rid off the problem of the flow splitting  
• Microfluidic channel fabrication coupled to biosensors  
Small microdialysate sample volumes (even smaller if probes sizes are reduced) taken 
through long outlet tubing produce dispersion effects. Microfluidic channels coupled to 
microdialysis probes have been fabricated in the Kennedy group [258]. Flow segmentation 
chips would allow transport of dialysate without dispersion and in a format ideally suited to 
coupling to microfabricated biosensors.  
Such a minituarisation system could find many other clinical applications such as assessing 
viability of organs in transit for transplantation.  
Signal Processing 
Until now the raw data has been post-processed to produce concentration versus time 
traces. This is time consuming, but most importantly delays the time for the recognition of a 
specific event for non-technical personal, such as doctors and nurses.  
A member of our group has developed signal processing algorithm to recognise the peaks 
and convert them in concentration. The next step will be to integrate this signal processing 
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in parallel with data recording to obtain automatic concentration traces, to calculate and to 
display L/G ratios, and to automatically show a flag when L/G exceeds and agreed value. 
7.3.2. Physiology 
Parallel measurements of important physiological variables need to be introduced in our 
microdialysis monitoring routine. Tissue blood flow and tissue oxygen pressure 
measurement would provide vital data to help understand the changes we see in bowel 
metabolism and would facilitate the explanation of certain spontaneous events. 
Furthermore, and from the observation of the quasi-periodic oscillatory patterns described 
as peristalsis movement, it will be of outstanding interest to introduce electrical probes to 
measure bowel contractions.  
The experiments carried out in porcine models were based only in two animals. This is a 
not significant figure to state any conclusion. However, we raise here a controversy, is the 
pig an accurate model for human bowel physiology? 
This work needs to be extended to a longer experimental series in which it is possible to 
have measurements of blood glucose, blood pressure, local blood flow, with the possibility 
of controlling blood glucose and blood pressure. A key experiment would be to establish 
whether porcine ECF levels of glucose are much lower than plasma levels. 
7.3.3. Pathology 
In the intraoperative monitoring, where ischaemia was induced when the arteries feeding 
the tissue were transected, an interesting observation was the response when arteries 
transection order was different. This has very important implications. If the order of the 
transections of different arteries affects the outcome of an organ, then a study should be 
carried out to understand which transection order results in the least ischaemia. This could 
be an important finding for organ transplantation routines. 
In this thesis we have been able to compare for the first time the effects of ischaemia in 
humans with ischaemia at the anastomosis site in pigs. This led to an important result. To 
strengthen this data measurements need to be carried out in the same species under the 
same conditions. This would involve comparing 4 groups: normal tissue, ischaemia alone, 
anastomosis alone and anastomosis with ischaemia. Since this is impossible in the 
humans, this will need to be carried out in the pig model. 
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APPENDICES 
Appendix I 
Debye-Hückel law:  
€ 
log γ±( ) = -
z±2q2k
8Πεrε0KBT
= −
z±2q3
4Π εrε0kBT( )
32
I
2 = −Az±
2 I   
z± is the charge number of ion species 
q is the elementary charge 
k is the Debye screening length 
ε r is the relative permittivity of the solvent 
ε0 is the permittivity of free space 
kB is Boltzmann's constant 
T is the temperature of the solution 
I is is the ionic strength of the solution 
A is a constant that depends on the solvent, for water at 25°C, A≅0.5 
Appendix I I 
A model of Enzyme action: 
€ 
E + S K1← →  ES Kcat →   E + P  (1) 
The first step is binding to the enzyme the second is the reaction of the enzyme substrate 
complex. If V0 is the initial velocity of reaction. Then, 
€ 
V0 = kcat[ES] (2) 
The maximum velocity Vmax occurs when the enzyme is saturated, that is when all enzymes 
molecules are bonded with S, or 
€ 
[ES] = [E]total   
so   
    
€ 
Vmax = kcat[E]total     (3) 
Stationary state approximation: 
During the initial phase of the reaction, as long as the reaction velocity remains constant, 
the reaction is in a steady state, with ES being formed and consumed at the same rate. 
During this phase, the rate of formation of [ES] equals its rate of consumption. According to 
model (1) 
Rate of formation of 
€ 
[ES] = k1[E][S]  
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Rate of consumption of 
€ 
[ES] = k−1[ES]+ kcat[ES]  
So in the steady state,  
€ 
k−1[ES]+ kcat[ES] = k1[E][S]  (4) 
And  
€ 
(k−1 + kcat )[ES] = k1[E][S]
(k−1 + kcat )
k1
=
[E][S]
[ES]
 (5) 
Grouping the kinetic constants by defining them as KM: 
€ 
km =
(k−1 + kcat )
k1
 (6) 
And then express [E] in terms of [ES] and [E]total: 
€ 
[E] = [E]total − [ES]   (7) 
Substitute (6) and (7) in to (5): 
€ 
km =
([E]total − [ES])[S]
[ES]  (8) 
Solving (8) for [ES]: first both sides are multiplied by [ES]:  
€ 
[ES]km = [E]total[S]− [ES][S]  
Then collecting terms containing [ES] on the right: 
€ 
[ES]km +[ES][S] = [E]total[S]  
Factor [ES] from the left-hand terms: 
€ 
[ES](km + [S]) = [E]total[S]  
and finally, dividing both sides by (Km+[S]): 
€ 
[ES] = [E]total[S](km + [S])
 (9) 
(9) is substitute into (2): 
€ 
v0 =
kcat[E]total[S]
(km + [S])
  (10) 
Recalling (3), VMAX is substitute into (10) for Kcat[E]total: 
€ 
v0 =
vmax[S]
(km + [S])
 (11) 
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Appendix I I I :  
Use of Rapid Sampling Microdialysis for Intraoperative Monitoring of Bowel 
Ischemia 
Deeba S, Corcoles EP, Hanna BG, Pareskevas P, Aziz O, Boutelle MG, Darzi A.   
Diseases of the Colon and Rectum, vol. 51: 1408–1413 (2008) DOI: 10.1007/s10350-008-
9375-4  
Appendix IV:  
Use of online rapid sampling microdialysis for monitoring of bowel anastomosis in 
swine model 
Deeba S, Corcoles E, Hanna GB, Paraskevas P, Boutelle MG, Darzi A. Submitted to 
American Journal of Surgery  
 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
“Η επιστήμη έχει πικρές ρίζες αλλα γλυκούς καρπούς” 
     (Aristotelis) 
 
Science has bitter roots, but sweet fruits. 
 
